_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,baseline-decision,orig_e1,orig_e2,relation,sent_id,orig_sentence,term1,term2
724123685,5/20/2015 22:54:26,1639899467,5/20/2015 22:54:12,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,211,248,,,223,255,HYPERTENSION,TIMOLOL,"Adrenergic beta antagonists Esophageal and gastric varices HYPERTENSION, portal Liver cirrhosis Timolol ACP Journal Club.",152-163-168-180-191-195-203-211-225-232-238-248-257-261-269,225-232-238-248-257-261-269-211,"Hypertension, portal Liver cirrhosis TIMOLOL ACP Journal Club.","A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123685,5/20/2015 23:00:55,1639902002,5/20/2015 23:00:31,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,211,248,,,223,255,HYPERTENSION,TIMOLOL,"and gastric varices HYPERTENSION,",191-195-203-211,225-232-238-248-257-261-269,portal Liver cirrhosis TIMOLOL ACP Journal Club.,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123685,5/20/2015 23:23:13,1639909911,5/20/2015 23:22:52,false,prodege,1,2145087,USA,"","",40.143.102.85,211,248,,,223,255,HYPERTENSION,TIMOLOL,"gastric varices HYPERTENSION,",195-203-211,232-238-248,Liver cirrhosis TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123685,5/20/2015 23:23:37,1639910132,5/20/2015 23:22:42,false,points4rewards,1,28703583,USA,"","",97.73.90.127,211,248,,,223,255,HYPERTENSION,TIMOLOL,"HYPERTENSION, portal Liver cirrhosis",211-225-232-238,225-232-238-248-211,"Hypertension, portal Liver cirrhosis TIMOLOL","A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123685,5/21/2015 00:05:46,1639928644,5/21/2015 00:05:33,false,neodev,1,31066862,USA,CA,San Jose,128.107.241.174,211,248,,,223,255,HYPERTENSION,TIMOLOL,"gastric varices HYPERTENSION,",195-203-211,225-232-238-248,portal Liver cirrhosis TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123685,5/21/2015 00:08:37,1639929923,5/21/2015 00:08:20,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,211,248,,,223,255,HYPERTENSION,TIMOLOL,"HYPERTENSION,",211,248,TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123685,5/21/2015 00:12:29,1639931820,5/21/2015 00:12:15,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,211,248,,,223,255,HYPERTENSION,TIMOLOL,"HYPERTENSION,",211,248-257,TIMOLOL ACP,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123685,5/21/2015 00:17:36,1639934251,5/21/2015 00:16:29,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,211,248,,,223,255,HYPERTENSION,TIMOLOL,"gastric varices HYPERTENSION,",195-203-211,248,TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123685,5/21/2015 00:17:54,1639934375,5/21/2015 00:15:45,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,211,248,,,223,255,HYPERTENSION,TIMOLOL,"gastric varices HYPERTENSION,",195-211-203,248,TIMOLOL,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123685,5/21/2015 00:24:15,1639937482,5/21/2015 00:24:11,false,neodev,1,31789301,USA,CA,San Jose,23.27.248.79,211,248,,,223,255,HYPERTENSION,TIMOLOL,"and gastric varices HYPERTENSION, portal Liver cirrhosis",191-195-203-211-225-232-238,225-232-238-248-257-261-269,portal Liver cirrhosis TIMOLOL ACP Journal Club.,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club.",211,248,211,248,-1,223,255,TWrex-cause,805244,"A nonselective β-blocker did not prevent gastroesophageal varices in cirrhosis and portal hypertension  Gastroenterology  About Star Ratings  Keywords: Adrenergic beta-antagonists Esophageal and gastric varices Hypertension, portal Liver cirrhosis Timolol  ACP Journal Club",hypertension,timolol
724123686,5/20/2015 20:46:27,1639862224,5/20/2015 20:46:12,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",66-77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123686,5/20/2015 21:01:15,1639868135,5/20/2015 21:00:56,false,prodege,1,3587109,CAN,NS,Sydney,142.166.207.11,77,8,,,81,11,PAIN,RSD,"Gout Acute, spontanous PAIN, most commonly in first metatarsophalangeal joint",53-59-66-77-83-88-97-100-106-126,0-5-8-12-19-29-97-100-106-126,Pain in RSD starts typically more in first metatarsophalangeal joint,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123686,5/20/2015 21:01:52,1639868363,5/20/2015 21:01:23,false,neodev,1,31670127,USA,FL,Key West,162.233.108.112,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",66-77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123686,5/20/2015 21:02:53,1639868670,5/20/2015 21:02:38,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,77,8,,,81,11,PAIN,RSD,"PAIN,",77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123686,5/20/2015 21:05:05,1639869547,5/20/2015 21:04:50,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",66-77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123686,5/20/2015 21:13:12,1639872488,5/20/2015 21:11:56,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",66-77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123686,5/20/2015 21:20:52,1639875784,5/20/2015 21:20:31,false,instagc,1,24252915,GBR,B7,Bristol,92.236.71.128,77,8,,,81,11,PAIN,RSD,"Acute, spontanous PAIN,",59-66-77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123686,5/20/2015 21:26:57,1639878006,5/20/2015 21:26:38,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,77,8,,,81,11,PAIN,RSD,"spontanous PAIN,",66-77,0-5-8,Pain in RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123686,5/20/2015 21:31:07,1639879290,5/20/2015 21:30:42,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,77,8,,,81,11,PAIN,RSD,"PAIN,",77,8,RSD,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123686,5/20/2015 21:32:27,1639879650,5/20/2015 21:30:52,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,77,8,,,81,11,PAIN,RSD,"Pain in RSD starts typically more distally in a limb Gout Acute, spontanous PAIN, most commonly in first metatarsophalangeal joint but can affect other joints (ankle &gt;knee &gt;wrist.",0-5-8-12-19-29-34-43-46-48-53-59-66-77-83-88-97-100-106-126-132-136-140-147-153-160-167-173,0-5-8-12-19-29-34-43-46-48-53-59-66-77-83-88-97-100-106-126-132-136-140-147-153-160-167-173,"Pain in RSD starts typically more distally in a limb Gout Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle &gt;knee &gt;wrist.","Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist.",77,8,77,8,1,81,11,TWrex-cause,813857,"Pain in RSD starts typically more distally in a limb Gout  Acute, spontanous pain, most commonly in first metatarsophalangeal joint but can affect other joints (ankle >knee >wrist",pain,RSD
724123687,5/20/2015 21:24:00,1639877080,5/20/2015 21:23:41,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123687,5/20/2015 21:35:49,1639881003,5/20/2015 21:35:23,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123687,5/20/2015 21:37:38,1639881519,5/20/2015 21:37:19,false,instagc,1,19080822,USA,MD,Reisterstown,96.26.47.22,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123687,5/20/2015 22:10:44,1639883898,5/20/2015 22:09:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,253,336,,,260,349,GIARDIA,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28] [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation Pregnant patients who are infected but asymptomatic are advised not to receive treatment for GIARDIA because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",0-3-8-19-24-32-39-42-46-61-68-76-90-93-104-112-119-124-128-135-145-149-160-169-178-182-186-195-199-212-216-224-228-231-239-249-253-261-269-275-279-290-296-299-307-322-326-336-350-353-361-370-374-381-388-394,0-3-8-19-24-32-39-42-46-61-68-76-90-93-104-112-119-124-128-135-145-149-160-169-178-182-186-195-199-212-216-224-228-231-239-249-253-261-269-275-279-290-296-299-307-322-326-336-350-353-361-370-374-381-388-394,"It also interferes with glucose uptake of the organism.[28] [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.","It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123687,5/20/2015 22:11:02,1639884121,5/20/2015 22:09:40,false,clixsense,1,6375330,CAN,ON,Ottawa,209.195.106.138,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123687,5/20/2015 22:14:17,1639885574,5/20/2015 22:14:00,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123687,5/20/2015 22:18:28,1639886886,5/20/2015 22:17:16,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123687,5/20/2015 22:24:37,1639888971,5/20/2015 22:22:13,false,quickrewards,1,8672587,USA,TX,El Paso,209.194.208.150,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123687,5/20/2015 22:28:11,1639890167,5/20/2015 22:27:25,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,253,336,,,260,349,GIARDIA,METRONIDAZOLE,treatment for GIARDIA,239-249-253,336-350-353-361-370-374-381-388-394,METRONIDAZOLE is rapidly absorbed and easily enters fetal circulation.,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123687,5/20/2015 22:32:48,1639891721,5/20/2015 22:32:35,false,neodev,1,11382239,AUS,02,Strathfield,60.241.129.81,253,336,,,260,349,GIARDIA,METRONIDAZOLE,GIARDIA,253,336,METRONIDAZOLE,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation.",253,336,253,336,-1,260,349,TWrex-cause,800137,"It also interferes with glucose uptake of the organism.[28]  [edit] Special circumstances in management therapy [edit] Drug use during pregnancy and lactation  Pregnant patients who are infected but asymptomatic are advised not to receive treatment for Giardia because there are underlying risks in current therapies.[28] For instance, metronidazole is rapidly absorbed and easily enters fetal circulation",giardia,metronidazole
724123688,5/20/2015 22:21:44,1639887937,5/20/2015 22:21:16,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152,SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123688,5/20/2015 22:30:42,1639890974,5/20/2015 22:29:59,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152,SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123688,5/20/2015 22:36:00,1639892952,5/20/2015 22:35:20,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,121,152,,,130,155,ARTHRITIS,SLE,Musculoskeletal exam ARTHRITIS,99-115-121,121-131-136-144-147-152-156-160-163-134,Arthritis is a feature of both SLE and WG Physical,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123688,5/20/2015 22:40:19,1639894458,5/20/2015 22:40:06,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152-163-172,SLE Physical exam,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123688,5/20/2015 22:40:26,1639894512,5/20/2015 22:40:00,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS SLE and WG Physical exam Peripheral vascular exam,121-152-156-160-163-172-178-189-198,152-121,Arthritis SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123688,5/20/2015 22:43:29,1639895657,5/20/2015 22:43:13,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,121,152,,,130,155,ARTHRITIS,SLE,exam Musculoskeletal exam ARTHRITIS is a feature of both SLE and WG Physical exam,93-99-115-121-131-134-136-144-147-152-156-160-163-172,121-131-134-144-147-152-156-160-163-172-136,Arthritis is a feature of both SLE and WG Physical exam,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123688,5/20/2015 22:51:04,1639898355,5/20/2015 22:50:21,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,121,152,,,130,155,ARTHRITIS,SLE,exam Musculoskeletal exam ARTHRITIS,93-99-115-121,136-144-147-152-156-160-163,feature of both SLE and WG Physical,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123688,5/20/2015 23:02:28,1639902449,5/20/2015 23:01:12,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS vasculitis,121-271,152-271,SLE vasculitis,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123688,5/20/2015 23:18:55,1639908481,5/20/2015 23:18:38,false,prodege,1.0,2145087,USA,"","",40.143.102.85,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152,SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123688,5/20/2015 23:35:57,1639916123,5/20/2015 23:35:45,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,121,152,,,130,155,ARTHRITIS,SLE,ARTHRITIS,121,152,SLE,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease.",121,152,121,152,1,130,155,TWrex-cause,813386,"Abdominal pain related to serositis, vasculitis, or panniculitis may occur with SLE Physical exam  Musculoskeletal exam  Arthritis is a feature of both SLE and WG Physical exam  Peripheral vascular exam  Asymmetry of pulses or the presence of vascular bruits may suggest vasculitis or large vessel arterial disease",arthritis,SLE
724123689,5/21/2015 00:41:03,1639947199,5/21/2015 00:40:50,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"visual HALLUCINATIONS,",100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123689,5/21/2015 01:05:21,1639961245,5/21/2015 01:04:54,false,neodev,1,11001780,AUS,07,Elwood,14.201.215.31,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"HALLUCINATIONS,",107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123689,5/21/2015 01:10:27,1639964482,5/21/2015 01:10:13,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"visual HALLUCINATIONS,",100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123689,5/21/2015 01:12:01,1639965294,5/21/2015 01:11:34,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"recurrent visual HALLUCINATIONS,",90-100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123689,5/21/2015 01:47:23,1639985588,5/21/2015 01:46:49,false,memolink,1,6556053,USA,IL,Zion,76.245.204.32,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"visual HALLUCINATIONS,",100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123689,5/21/2015 02:03:10,1639993000,5/21/2015 02:02:52,false,clixsense,1,32609988,USA,IL,Chicago,172.56.13.97,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"HALLUCINATIONS,",107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123689,5/21/2015 02:21:18,1640001404,5/21/2015 02:20:49,false,prodege,1,28592189,CAN,ON,Toronto,99.231.49.180,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"Dementia with Lewy bodies HALLUCINATIONS,",2-11-16-107-21,0-2-11-16-21,◊ DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123689,5/21/2015 02:25:15,1640003267,5/21/2015 02:24:46,false,cotter,1,29964039,USA,NV,Reno,71.94.24.147,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"visual HALLUCINATIONS,",100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123689,5/21/2015 02:29:02,1640005217,5/21/2015 02:28:47,false,prodege,1,26499212,CAN,ON,Cambridge,70.27.23.230,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"recurrent visual HALLUCINATIONS,",90-100-107,2-11-16-21,DEMENTIA WITH LEWY BODIES,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123689,5/21/2015 02:29:12,1640005281,5/21/2015 02:28:49,false,neodev,1,32087449,GBR,"","",77.245.71.12,107,2,,,121,27,HALLUCINATION,DEMENTIA WITH LEWY BODIES,"symptoms, recurrent visual HALLUCINATIONS, and spontaneous, extrapyramidal",80-90-100-107-123-127-140,0-2-11-16-21-28-31-33-127-140-123,"◊ DEMENTIA WITH LEWY BODIES is a progressive and spontaneous, extrapyramidal","◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45.",107,2 11 16 21,107,2,1,121,27,TWrex-cause,812738,"◊ Dementia with Lewy bodies is a progressive cognitive decline with fluctuating symptoms, recurrent visual hallucinations, and spontaneous, extrapyramidal signs ( 45",hallucination,dementia with lewy bodies
724123690,5/20/2015 20:48:34,1639863183,5/20/2015 20:48:09,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123690,5/20/2015 21:04:54,1639869457,5/20/2015 21:04:15,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,160,245,,,169,257,PSORIASIS,METHOTREXATE,plaque PSORIASIS,153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123690,5/20/2015 21:06:47,1639870224,5/20/2015 21:06:30,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,160,245,,,169,257,PSORIASIS,METHOTREXATE,PSORIASIS,160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123690,5/20/2015 21:08:10,1639870569,5/20/2015 21:07:49,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,153-160-140,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123690,5/20/2015 21:22:48,1639876631,5/20/2015 21:22:27,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123690,5/20/2015 21:28:06,1639878204,5/20/2015 21:26:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123690,5/20/2015 21:34:09,1639880345,5/20/2015 21:33:30,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123690,5/20/2015 21:36:12,1639881084,5/20/2015 21:35:46,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,160,245,,,169,257,PSORIASIS,METHOTREXATE,plaque PSORIASIS,153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123690,5/20/2015 21:37:16,1639881354,5/20/2015 21:36:54,false,prodege,1,19907188,USA,MI,Adrian,50.37.37.250,160,245,,,169,257,PSORIASIS,METHOTREXATE,recalcitrant plaque PSORIASIS,140-153-160,245,"METHOTREXATE,","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123690,5/20/2015 21:58:33,1639882189,5/20/2015 21:56:47,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,160,245,,,169,257,PSORIASIS,METHOTREXATE,"Psoriasis Treatment of immunocompetent adults with severe (i.e., extensive and or disabling), recalcitrant plaque PSORIASIS that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",45-56-66-69-85-92-97-104-111-121-125-128-140-153-160-170-175-178-182-193-204-207-210-219-227-234-245-259-265-268-271-280-284-289-295-304-312-315-331-334-341-344,45-56-66-69-85-92-97-104-111-121-125-128-140-153-160-170-175-178-182-193-204-207-210-219-227-234-245-259-265-268-271-280-284-289-295-304-312-315-331-334-341-344,"Psoriasis Treatment of immunocompetent adults with severe (i.e., extensive and or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, METHOTREXATE, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.","367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated.",160,245,160,245,-1,169,257,TWrex-cause,804393,"367 ,   369 ,   373 ,   374 ,   375 ,   376  Psoriasis  Treatment of immunocompetent adults with severe (i.e., extensive and/or disabling), recalcitrant plaque psoriasis that is not adequately responsive to ≥1 systemic therapy (e.g., retinoids, methotrexate, PUVA) or in patients for whom other systemic therapy is contraindicated or cannot be tolerated",psoriasis,methotrexate
724123691,5/21/2015 00:41:17,1639947328,5/21/2015 00:41:03,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,otoscope ENDOTOXEMIA,19-7,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123691,5/21/2015 01:05:44,1639961506,5/21/2015 01:05:24,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,ENDOTOXEMIA,19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123691,5/21/2015 01:10:46,1639964630,5/21/2015 01:10:28,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,otoscope ENDOTOXEMIA audio Toxemia,7-19-65-56,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123691,5/21/2015 01:12:25,1639965572,5/21/2015 01:12:02,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,ENDOTOXEMIA,19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123691,5/21/2015 01:47:59,1639985844,5/21/2015 01:47:23,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,ENDOTOXEMIA,19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123691,5/21/2015 02:03:24,1639993096,5/21/2015 02:03:11,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,ENDOTOXEMIA,19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123691,5/21/2015 02:21:45,1640001551,5/21/2015 02:21:18,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,otoscope ENDOTOXEMIA,7-19,96-107-110-114,ENDOTOXINS in the blood.,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123691,5/21/2015 02:25:33,1640003436,5/21/2015 02:25:16,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,otoscope ENDOTOXEMIA,7-19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123691,5/21/2015 02:29:17,1640005344,5/21/2015 02:29:03,false,prodege,1.0,26499212,CAN,ON,Cambridge,70.27.23.230,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,otoscope ENDOTOXEMIA,7-19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123691,5/21/2015 02:29:43,1640005552,5/21/2015 02:29:10,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,19,96,,,30,106,ENDOTOXEMIA,ENDOTOXIN,otoscope ENDOTOXEMIA,7-19,96,ENDOTOXINS,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood.,19,96,19,96,1,30,106,TWrex-cause,812064,SYN:   otoscope    endotoxemia    (                     audio )  Toxemia due to the presence of endotoxins in the blood,endotoxemia,endotoxin
724123692,5/20/2015 22:23:26,1639888644,5/20/2015 22:22:33,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123692,5/20/2015 22:32:21,1639891526,5/20/2015 22:31:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123692,5/20/2015 22:36:51,1639893292,5/20/2015 22:36:28,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,124-131-137-140,rabies VIRUS in humans,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123692,5/20/2015 22:40:41,1639894601,5/20/2015 22:40:33,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123692,5/20/2015 22:44:11,1639895948,5/20/2015 22:43:52,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,184,131,,,190,136,RABIES,VIRUS,Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic RABIES.,103-112-124-131-137-140-147-158-171-174-184-121,112-121-124-131-137-140-147-158-171-174-184-103,Sequence analysis of rabies VIRUS in humans exhibiting encephalitic or paralytic rabies.,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123692,5/20/2015 22:52:13,1639898733,5/20/2015 22:51:28,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,184,131,,,190,136,RABIES,VIRUS,encephalitic or paralytic RABIES.,158-171-174-184,112-121-124-131-137-140,analysis of rabies VIRUS in humans,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123692,5/20/2015 23:04:18,1639903346,5/20/2015 23:03:22,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,184,131,,,190,136,RABIES,VIRUS,encephalitic paralytic RABIES.,158-174-184,131-158-174-184,VIRUS encephalitic paralytic rabies.,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123692,5/20/2015 23:19:24,1639908611,5/20/2015 23:19:12,false,prodege,1.0,2145087,USA,"","",40.143.102.85,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123692,5/20/2015 23:36:21,1639916264,5/20/2015 23:36:10,false,clixsense,1.0,21933552,CAN,ON,Ottawa,70.49.14.161,184,131,,,190,136,RABIES,VIRUS,encephalitic or paralytic RABIES.,158-171-174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123692,5/20/2015 23:58:48,1639925589,5/20/2015 23:57:43,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,184,131,,,190,136,RABIES,VIRUS,paralytic RABIES.,174-184,124-131,rabies VIRUS,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies.",184,131,184,131,1,190,136,TWrex-cause,815099,"2]  Hemachudha T, Wacharapluesadee S, Lumlertdaecha B, Orciari L A, Rupprecht CE, La-Ongpant M, et al. Sequence analysis of rabies virus in humans exhibiting encephalitic or paralytic rabies",rabies,virus
724123693,5/20/2015 20:40:57,1639860200,5/20/2015 20:40:43,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,143,205,,,151,215,SEIZURE,RED FIBER,"muscle contractions (myoclonic SEIZURES),",112-119-132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123693,5/20/2015 20:50:53,1639864173,5/20/2015 20:49:52,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123693,5/20/2015 20:54:14,1639865618,5/20/2015 20:53:39,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123693,5/20/2015 20:55:15,1639865911,5/20/2015 20:55:03,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,143,205,,,151,215,SEIZURE,RED FIBER,"muscle contractions (myoclonic SEIZURES), dementia, ataxia, and",112-119-132-143-154-164-172,205-209-228-242-216,RED FIBERS (indicating mitochondrial proliferation),"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123693,5/20/2015 20:55:32,1639865978,5/20/2015 20:55:19,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,143,205,,,151,215,SEIZURE,RED FIBER,"Myoclonic epilepsy muscle contractions (myoclonic SEIZURES), dementia, ataxia, and",0-112-119-132-143-154-164-172-10,0-186-192-198-205-209-228-242-10,Myoclonic epilepsy which shows ragged RED FIBERS mitochondrial proliferation),"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123693,5/20/2015 20:56:47,1639866518,5/20/2015 20:56:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,205-209,RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123693,5/20/2015 21:00:17,1639867770,5/20/2015 20:59:57,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123693,5/20/2015 21:02:45,1639868627,5/20/2015 21:02:32,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,143,205,,,151,215,SEIZURE,RED FIBER,"SEIZURES),",143,205-209,RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123693,5/20/2015 21:04:39,1639869357,5/20/2015 21:04:34,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,143,205,,,151,215,SEIZURE,RED FIBER,"muscle contractions (myoclonic SEIZURES), dementia, ataxia, and",112-119-132-143-154-164-172,186-192-198-205-209-228-242,which shows ragged RED FIBERS mitochondrial proliferation),"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123693,5/20/2015 21:16:03,1639873688,5/20/2015 21:15:46,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,143,205,,,151,215,SEIZURE,RED FIBER,"(myoclonic SEIZURES),",132-143,198-205-209,ragged RED FIBERS,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied.",143,205 209,143,205,1,151,215,TWrex-cause,813797,"Myoclonic epilepsy with ragged-red fibers (MERRF):  This is a progressive disease characterized by uncontrolled muscle contractions (myoclonic seizures), dementia, ataxia, and myopathy, which shows ragged-red fibers (indicating mitochondrial proliferation) with specialized stains when biopsied",seizure,red fiber
724123694,5/20/2015 20:47:03,1639862526,5/20/2015 20:46:44,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,23-31-36-42,"develop late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123694,5/20/2015 21:02:23,1639868511,5/20/2015 21:01:41,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,118,42,,,128,49,RHINOPHYMA,ROSACEA,"and nose (RHINOPHYMA) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",108-112-117-130-137-140-147-161-170-182-186-196-202,23-31-36-42-51-65-68-75-82-94-97-101-130-137-140-147-161-170-182-186-202-196,"develop late stage ROSACEA, characterized by coarse tissue hyperplasia of the cheeks caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123694,5/20/2015 21:02:45,1639868637,5/20/2015 21:02:22,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,42,"ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123694,5/20/2015 21:03:30,1639868910,5/20/2015 21:03:15,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,42,"ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123694,5/20/2015 21:06:36,1639870143,5/20/2015 21:06:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123694,5/20/2015 21:15:57,1639873642,5/20/2015 21:14:27,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123694,5/20/2015 21:21:25,1639876007,5/20/2015 21:21:09,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123694,5/20/2015 21:29:03,1639878690,5/20/2015 21:28:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,118,42,,,128,49,RHINOPHYMA,ROSACEA,coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA),68-75-82-94-97-101-108-112-117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123694,5/20/2015 21:32:03,1639879577,5/20/2015 21:31:26,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,118,42,,,128,49,RHINOPHYMA,ROSACEA,(RHINOPHYMA),117,31-36-42,"late stage ROSACEA,","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123694,5/20/2015 21:35:44,1639880976,5/20/2015 21:33:55,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,118,42,,,128,49,RHINOPHYMA,ROSACEA,"Some patients go on to develop late - stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (RHINOPHYMA) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",0-5-14-17-20-23-31-35-36-42-51-65-68-75-82-94-97-101-108-112-117-130-137-140-147-161-170-182-186-196-202,0-5-14-17-20-23-31-36-42-51-65-68-75-82-94-97-101-108-112-117-130-137-140-147-161-170-182-186-196-202,"Some patients go on to develop late stage ROSACEA, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.","Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia.",,42,118,42,1,128,49,TWrex-cause,810719,"Some patients go on to develop late-stage rosacea, characterized by coarse tissue hyperplasia of the cheeks and nose (rhinophyma) caused by tissue inflammation, collagen deposition, and sebaceous gland hyperplasia",rhinophyma,rosacea
724123695,5/21/2015 00:15:35,1639933401,5/21/2015 00:14:16,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION not,108-119-139,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123695,5/21/2015 00:16:27,1639933803,5/21/2015 00:16:15,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123695,5/21/2015 00:35:21,1639943376,5/21/2015 00:34:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123695,5/21/2015 00:39:50,1639946520,5/21/2015 00:38:39,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123695,5/21/2015 00:58:38,1639957458,5/21/2015 00:58:05,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123695,5/21/2015 01:03:01,1639959913,5/21/2015 01:02:53,false,elite,1,32306791,GBR,"","",109.200.26.4,119,79,,,129,86,INFARCTION,ASPIRIN,for myocardial INFARCTION but does not,104-108-119-130-134-139,58-61-79-87-95-99,of vascular ASPIRIN reduces the risk,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123695,5/21/2015 01:07:21,1639962485,5/21/2015 01:07:06,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123695,5/21/2015 01:08:17,1639963095,5/21/2015 01:07:59,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123695,5/21/2015 01:12:31,1639965631,5/21/2015 01:12:21,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,119,79,,,129,86,INFARCTION,ASPIRIN,myocardial INFARCTION,108-119,79,ASPIRIN,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123695,5/21/2015 01:30:26,1639975617,5/21/2015 01:30:17,false,neodev,1,31977841,USA,IL,Chicago,69.175.85.2,119,79,,,129,86,INFARCTION,ASPIRIN,risk for myocardial INFARCTION but does not,99-104-108-119-130-134-139,58-61-70-79-87-95-99,"of vascular disease, ASPIRIN reduces the risk","CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death.",119,79,119,79,-1,129,86,TWrex-cause,804440,"CONCLUSION  In participants who have no clinical evidence of vascular disease, aspirin reduces the risk for myocardial infarction but does not reduce the risk for stroke or vascular death",infarction,aspirin
724123696,5/20/2015 20:45:04,1639861658,5/20/2015 20:44:44,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123696,5/20/2015 20:59:42,1639867521,5/20/2015 20:59:19,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123696,5/20/2015 20:59:51,1639867568,5/20/2015 20:59:33,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,primaquine therapy for mild to moderate episodes of Pneumocystis carinii PNEUMONIA in patients with,55-66-74-78-83-86-104-108-121-130-140-143-152-95,29-32-35-39-51-55-66-74-78-83-86-95-104-108-121-130,RL et al. CLINDAMYCIN and primaquine therapy for mild to moderate episodes of Pneumocystis carinii pneumonia,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123696,5/20/2015 21:01:30,1639868235,5/20/2015 21:01:15,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,PNEUMONIA,130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123696,5/20/2015 21:03:37,1639868925,5/20/2015 21:03:19,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123696,5/20/2015 21:04:43,1639869366,5/20/2015 21:03:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123696,5/20/2015 21:19:16,1639875004,5/20/2015 21:19:00,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123696,5/20/2015 21:24:02,1639877081,5/20/2015 21:23:47,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123696,5/20/2015 21:24:56,1639877464,5/20/2015 21:24:42,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123696,5/20/2015 21:28:36,1639878566,5/20/2015 21:26:52,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,130,39,,,139,50,PNEUMONIA,CLINDAMYCIN,Pneumocystis carinii PNEUMONIA,108-121-130,39,CLINDAMYCIN,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044.",130,39,130,39,-1,139,50,TWrex-cause,803479,"Black JR, Feinberg J, Murphy RL et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of  Pneumocystis carinii  pneumonia in patients with AIDS: AIDS Clinical Trials Group 044",pneumonia,clindamycin
724123697,5/21/2015 00:37:53,1639945385,5/21/2015 00:36:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0-17,KERATOUVEITIS Inflammation,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123697,5/21/2015 00:45:56,1639950176,5/21/2015 00:44:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0-17,KERATOUVEITIS Inflammation,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123697,5/21/2015 01:00:36,1639958547,5/21/2015 01:00:09,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0-17,KERATOUVEITIS Inflammation,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123697,5/21/2015 01:08:33,1639963342,5/21/2015 01:08:21,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0-17,KERATOUVEITIS Inflammation,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123697,5/21/2015 01:09:48,1639964165,5/21/2015 01:09:35,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123697,5/21/2015 01:42:06,1639982464,5/21/2015 01:41:03,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123697,5/21/2015 02:01:00,1639991855,5/21/2015 02:00:47,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123697,5/21/2015 02:17:43,1639999753,5/21/2015 02:17:04,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123697,5/21/2015 02:22:13,1640001779,5/21/2015 02:21:26,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0-17,KERATOUVEITIS Inflammation,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123697,5/21/2015 02:26:46,1640004061,5/21/2015 02:26:26,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,42,0,,,48,13,CORNEA,KERATOUVEITIS,CORNEA,42,0,KERATOUVEITIS,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid.",42,0,42,0,-1,48,13,TWrex-cause,802539,"keratouveitis    Inflammation of both the cornea and the uveal tract (i.e., of both the cornea and the iris, ciliary body, and choroid",cornea,keratouveitis
724123698,5/20/2015 22:20:15,1639887514,5/20/2015 22:19:50,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,0-16,• PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123698,5/20/2015 22:28:22,1639890225,5/20/2015 22:27:36,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,16,PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123698,5/20/2015 22:34:01,1639892211,5/20/2015 22:33:39,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,96,16,,,106,18,THROMBOSIS,PV,"risk factors for THROMBOSIS,",79-84-92-96,0-2-13-16,• Management in PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123698,5/20/2015 22:37:46,1639893546,5/20/2015 22:37:29,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,96,16,,,106,18,THROMBOSIS,PV,"risk factors for THROMBOSIS, and childbearing potential.",79-84-92-96-108-112-125,0-2-13-16-19-26-29-44-47,"• Management in PV should be individualized by age,","• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123698,5/20/2015 22:39:26,1639894157,5/20/2015 22:39:04,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,96,16,,,106,18,THROMBOSIS,PV,"PV THROMBOSIS,",16-96,0-16-96,"• PV thrombosis,","• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123698,5/20/2015 22:39:41,1639894223,5/20/2015 22:39:29,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,96,16,,,106,18,THROMBOSIS,PV,"THROMBOSIS,",96,16,PV,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123698,5/20/2015 22:49:28,1639897903,5/20/2015 22:49:06,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,96,16,,,106,18,THROMBOSIS,PV,"risk factors for THROMBOSIS, and childbearing potential.",79-84-92-96-108-112-125,2-13-16-19-26-29,Management in PV should be individualized,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123698,5/20/2015 22:59:10,1639901307,5/20/2015 22:58:26,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,96,16,,,106,18,THROMBOSIS,PV,"PV THROMBOSIS,",96-16,16-96,"PV thrombosis,","• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123698,5/20/2015 23:00:57,1639902015,5/20/2015 23:00:53,false,instagc,1,31861996,USA,FL,Homestead,73.46.199.178,96,16,,,106,18,THROMBOSIS,PV,"risk factors for THROMBOSIS, and childbearing potential.",79-84-92-96-108-112-125,0-2-13-16-19-26-29,• Management in PV should be individualized,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123698,5/20/2015 23:13:02,1639906979,5/20/2015 23:11:08,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,96,16,,,106,18,THROMBOSIS,PV,"Management in PV THROMBOSIS,",2-13-16-96,2-13-16-79-84-96-92,"Management in PV risk factors for thrombosis,","• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential.",96,16,96,16,1,106,18,TWrex-cause,812730,"• Management in PV should be individualized by age, the presence or absence of risk factors for thrombosis, and childbearing potential",thrombosis,pv
724123699,5/20/2015 20:41:14,1639860334,5/20/2015 20:40:58,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123699,5/20/2015 20:52:00,1639864704,5/20/2015 20:50:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123699,5/20/2015 20:54:35,1639865770,5/20/2015 20:54:14,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123699,5/20/2015 20:55:29,1639865953,5/20/2015 20:55:17,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,delivery for a SUPRAVENTRICULAR TACHYCARDIA.,142-151-155-157-174,101-113-120-131-142,"PROPRANOLOL during pregnancy, labor, delivery","• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123699,5/20/2015 20:55:56,1639866201,5/20/2015 20:55:34,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,Hypoglycemia and respiratory depression delivery for a SUPRAVENTRICULAR TACHYCARDIA.,2-15-19-142-151-155-157-174-31,91-95-98-101-113-120-131-151-157-174,"160 mg of PROPRANOLOL during pregnancy, labor, for supraventricular tachycardia.","• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123699,5/20/2015 20:57:13,1639866698,5/20/2015 20:56:48,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123699,5/20/2015 21:00:36,1639867879,5/20/2015 21:00:18,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101-113-120,"PROPRANOLOL during pregnancy,","• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123699,5/20/2015 21:02:56,1639868695,5/20/2015 21:02:45,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123699,5/20/2015 21:16:17,1639873759,5/20/2015 21:16:04,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,101,PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123699,5/20/2015 21:20:16,1639875495,5/20/2015 21:19:17,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,157,101,,,185,112,SUPRAVENTRICULAR TACHYCARDIA,PROPRANOLOL,SUPRAVENTRICULAR TACHYCARDIA.,157-174,91-95-98-101,160 mg of PROPRANOLOL,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia.",157 174,101,157,101,-1,185,112,TWrex-cause,803991,"• Hypoglycemia and respiratory depression were reported in a newborn whose mother received 160 mg of propranolol during pregnancy, labor, and delivery for a supraventricular tachycardia",supraventricular tachycardia,propranolol
724123700,5/20/2015 20:45:38,1639861930,5/20/2015 20:45:23,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123700,5/20/2015 21:00:20,1639867795,5/20/2015 21:00:08,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,116,62,,,124,74,DISORDER,CLOMIPRAMINE,"Fluvoxamine versus clomipramine the treatment of obsessive compulsive DISORDER: a multicenter, randomized,",43-55-62-78-92-95-105-116-126-128-141-82,39-43-55-62-75-78-82-92-95-105-116,al. Fluvoxamine versus CLOMIPRAMINE in the treatment of obsessive compulsive disorder:,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123700,5/20/2015 21:00:39,1639867888,5/20/2015 21:00:06,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123700,5/20/2015 21:02:07,1639868440,5/20/2015 21:01:47,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-116-105,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123700,5/20/2015 21:04:19,1639869266,5/20/2015 21:04:00,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123700,5/20/2015 21:09:33,1639870995,5/20/2015 21:08:47,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123700,5/20/2015 21:19:49,1639875294,5/20/2015 21:19:33,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123700,5/20/2015 21:24:41,1639877342,5/20/2015 21:24:20,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123700,5/20/2015 21:26:09,1639877789,5/20/2015 21:25:50,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123700,5/20/2015 21:28:58,1639878674,5/20/2015 21:28:40,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,116,62,,,124,74,DISORDER,CLOMIPRAMINE,obsessive compulsive DISORDER:,95-105-116,62,CLOMIPRAMINE,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.",116,62,116,62,-1,124,74,TWrex-cause,800358,"Freeman CPL, Trimble MR, Deakin JFW et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison",disorder,clomipramine
724123701,5/20/2015 20:43:03,1639860871,5/20/2015 20:42:27,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,60-68,inhaled PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123701,5/20/2015 20:57:23,1639866750,5/20/2015 20:56:55,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,68,PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123701,5/20/2015 20:58:37,1639867172,5/20/2015 20:58:17,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,pentamidine for treating PNEUMOCYSTIS carinii pneumonia in AIDS:,68-80-84-95-108-117-127-130,45-57-60-68-80-84-95-108-127-130-117,Intravenous or inhaled PENTAMIDINE for treating Pneumocystis carinii pneumonia in AIDS:,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123701,5/20/2015 20:59:18,1639867415,5/20/2015 20:58:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,45-57-68-60,Intravenous or inhaled PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123701,5/20/2015 21:00:21,1639867809,5/20/2015 21:00:08,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,68,PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123701,5/20/2015 21:02:28,1639868535,5/20/2015 21:02:05,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,68,PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123701,5/20/2015 21:18:01,1639874500,5/20/2015 21:17:40,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia in AIDS:,95-108-117-127-130,45-57-60-68,Intravenous or inhaled PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123701,5/20/2015 21:22:36,1639876507,5/20/2015 21:22:17,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia,95-108-117,68,PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123701,5/20/2015 21:23:53,1639877003,5/20/2015 21:23:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS carinii pneumonia in AIDS:,95-108-117-127-130,45-57-60-68,Intravenous or inhaled PENTAMIDINE,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123701,5/20/2015 21:26:10,1639877795,5/20/2015 21:25:50,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,95,68,,,107,79,PNEUMOCYSTIS,PENTAMIDINE,Intravenous or inhaled pentamidine for treating PNEUMOCYSTIS carinii pneumonia in AIDS:,45-57-60-68-80-84-95-108-117-127-130,45-57-60-68-80-84-95-108-117-127-130,Intravenous or inhaled PENTAMIDINE for treating Pneumocystis carinii pneumonia in AIDS:,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial.",95,68,95,68,-1,107,79,TWrex-cause,800022,"Conte JE Jr, Chernoff D, Feigal DW Jr et al. Intravenous or inhaled pentamidine for treating   Pneumocystis carinii  pneumonia in AIDS: a randomized trial",pneumocystis,pentamidine
724123702,5/20/2015 20:40:28,1639859964,5/20/2015 20:40:14,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS,33-43-45-51,134-144-146-150-152-158,influenza A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123702,5/20/2015 20:47:48,1639862869,5/20/2015 20:46:18,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS,33-43-45-51,144-146-150-152-158,A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123702,5/20/2015 20:53:09,1639865182,5/20/2015 20:51:33,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,51,152,,,61,157,INFECTION,VIRUS,Avian Influenza Virus INFECTIONS,33-45-51-27,27-152-158-33,Avian Influenza VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123702,5/20/2015 20:54:32,1639865740,5/20/2015 20:54:15,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS Oral Dosage usually,33-43-45-51-73-79-86,144-146-150-152-158-169-173-178,A and B VIRUS infections has been recommended.,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123702,5/20/2015 20:55:02,1639865880,5/20/2015 20:54:38,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,51,152,,,61,157,INFECTION,VIRUS,Avian Influenza A Virus INFECTIONS Oral Dosage usually recommended.,27-33-43-45-51-73-79-86-178,73-144-146-150-152-158-169-173-79,Oral Dosage A and B VIRUS infections has been,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123702,5/20/2015 20:56:00,1639866255,5/20/2015 20:55:39,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS,33-43-45-51,144-146-150-152-158,A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123702,5/20/2015 20:56:33,1639866423,5/20/2015 20:56:05,false,instagc,1,23032978,USA,PA,Philadelphia,76.98.187.59,51,152,,,61,157,INFECTION,VIRUS,INFECTIONS,51,144-146-150-152-158,A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123702,5/20/2015 20:59:43,1639867519,5/20/2015 20:59:28,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS,33-43-45-51,152,VIRUS,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123702,5/20/2015 21:02:17,1639868500,5/20/2015 21:02:02,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,51,152,,,61,157,INFECTION,VIRUS,INFECTIONS,51,152,VIRUS,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123702,5/20/2015 21:03:21,1639868823,5/20/2015 21:02:43,false,fusioncash,1,31248728,USA,FL,Alachua,174.131.50.169,51,152,,,61,157,INFECTION,VIRUS,Influenza A Virus INFECTIONS,33-43-45-51,144-146-150-152-158,A and B VIRUS infections,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended.",51,152,51,152,1,61,157,TWrex-cause,815038,"104 ,   152  Prevention of Avian Influenza A Virus Infections   +  >     Oral  Dosage usually recommended for prophylaxis of seasonal influenza A and B virus infections has been recommended",infection,virus
724123703,5/21/2015 00:36:42,1639944546,5/21/2015 00:36:31,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123703,5/21/2015 00:43:43,1639948777,5/21/2015 00:42:37,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123703,5/21/2015 00:59:45,1639958068,5/21/2015 00:59:28,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123703,5/21/2015 01:08:00,1639962942,5/21/2015 01:07:48,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123703,5/21/2015 01:09:11,1639963796,5/21/2015 01:08:56,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,108,149,,,115,157,SEIZURE,EPILEPSY,SEIZURE,108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123703,5/21/2015 01:40:32,1639981410,5/21/2015 01:40:20,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123703,5/21/2015 01:56:27,1639989789,5/21/2015 01:56:23,false,neodev,1.0,32491845,USA,DE,Wilmington,199.115.115.209,108,149,,,115,157,SEIZURE,EPILEPSY,their child's febrile SEIZURE does not mean,86-92-100-108-116-121-125,138-141-145-149,or she has EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123703,5/21/2015 02:00:26,1639991627,5/21/2015 02:00:04,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123703,5/21/2015 02:16:46,1639999327,5/21/2015 02:16:12,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123703,5/21/2015 02:20:33,1640001041,5/21/2015 02:18:25,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,108,149,,,115,157,SEIZURE,EPILEPSY,febrile SEIZURE,100-108,149,EPILEPSY.,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy.",108,149,108,149,1,115,157,TWrex-cause,813513,"Again, it is easier to inform and instruct parents once they have been reassured that their child's febrile seizure does not mean that he or she has epilepsy",seizure,epilepsy
724123704,5/20/2015 20:47:15,1639862659,5/20/2015 20:47:05,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,32,0,,,36,9,LOUSE,MALATHION,LICE.,32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123704,5/20/2015 21:02:31,1639868546,5/20/2015 21:02:23,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,32,0,,,36,9,LOUSE,MALATHION,Malathion for treatment of head LICE.,0-14-24-27-32-10,0-10-14-24-27-32,MALATHION for treatment of head lice.,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123704,5/20/2015 21:03:01,1639868706,5/20/2015 21:02:46,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123704,5/20/2015 21:04:35,1639869344,5/20/2015 21:03:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,32,0,,,36,9,LOUSE,MALATHION,LICE.,32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123704,5/20/2015 21:06:53,1639870262,5/20/2015 21:06:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123704,5/20/2015 21:18:18,1639874605,5/20/2015 21:16:01,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123704,5/20/2015 21:21:38,1639876105,5/20/2015 21:21:27,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123704,5/20/2015 21:29:12,1639878708,5/20/2015 21:29:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123704,5/20/2015 21:32:18,1639879626,5/20/2015 21:32:04,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,32,0,,,36,9,LOUSE,MALATHION,head LICE.,27-32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123704,5/20/2015 21:34:34,1639880497,5/20/2015 21:34:19,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,32,0,,,36,9,LOUSE,MALATHION,LICE.,32,0,MALATHION,Malathion for treatment of head lice.,32,0,32,0,-1,36,9,TWrex-cause,804184,Malathion for treatment of head lice,louse,malathion
724123705,5/20/2015 23:26:06,1639911466,5/20/2015 23:25:38,false,prodege,1.0,2145087,USA,"","",40.143.102.85,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123705,5/21/2015 00:08:51,1639930062,5/21/2015 00:08:36,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123705,5/21/2015 00:12:14,1639931618,5/21/2015 00:11:12,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123705,5/21/2015 00:14:41,1639932788,5/21/2015 00:14:29,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123705,5/21/2015 00:28:32,1639939743,5/21/2015 00:27:28,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123705,5/21/2015 00:32:04,1639941555,5/21/2015 00:30:49,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123705,5/21/2015 00:38:52,1639945994,5/21/2015 00:38:35,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123705,5/21/2015 00:56:24,1639956223,5/21/2015 00:56:06,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123705,5/21/2015 01:01:40,1639959236,5/21/2015 01:01:28,false,elite,1.0,32306791,GBR,"","",109.200.26.4,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,lesion BACILLARY ANGIOMATOSIS caused by Bartonella,50-64-74-87-94-98,87-98-110-133,caused Bartonella SPECIES with,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123705,5/21/2015 01:05:36,1639961432,5/21/2015 01:05:20,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,64,110,,,86,117,BACILLARY ANGIOMATOSIS,SPECIES,BACILLARY ANGIOMATOSIS,64-74,98-110,Bartonella SPECIES,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella.",64 74,110,64,110,1,86,117,TWrex-cause,810007,"An uncommon red or purple nodular or pedunculated lesion may be bacillary angiomatosis caused by  Bartonella  species and associated with disseminated infection [ see 7:11 Infections Caused by Brucella, Francisella, Yersinia Pestis, and Bartonella",bacillary angiomatosis,species
724123706,5/20/2015 21:38:04,1639881667,5/20/2015 21:37:37,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,77,41,,,85,45,TOXICITY,DRUG,TOXICITY.,77,41,DRUG,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123706,5/20/2015 22:15:43,1639885983,5/20/2015 22:15:08,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,77,41,,,85,45,TOXICITY,DRUG,TOXICITY.,77,41,DRUG,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123706,5/20/2015 22:17:12,1639886512,5/20/2015 22:16:45,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,77,41,,,85,45,TOXICITY,DRUG,drug TOXICITY.,72-77,41,DRUG,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123706,5/20/2015 22:22:50,1639888396,5/20/2015 22:22:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,77,41,,,85,45,TOXICITY,DRUG,drug TOXICITY.,72-77,41-77,DRUG toxicity.,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123706,5/20/2015 22:30:40,1639890960,5/20/2015 22:30:11,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,77,41,,,85,45,TOXICITY,DRUG,drug TOXICITY.,72-77,41-46,"DRUG concentrations,","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123706,5/20/2015 22:35:10,1639892659,5/20/2015 22:34:47,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,77,41,,,85,45,TOXICITY,DRUG,"increase drug concentrations, producing drug TOXICITY.",41-46-62-72-77-32,2-12-16-32-41-46-62-72-77,"Rewarming may unintentionally increase DRUG concentrations, producing drug toxicity.","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123706,5/20/2015 22:37:19,1639893405,5/20/2015 22:37:01,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,77,41,,,85,45,TOXICITY,DRUG,"drug concentrations, TOXICITY.",41-77-46,41-72-77,DRUG drug toxicity.,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123706,5/20/2015 22:37:53,1639893578,5/20/2015 22:36:21,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,77,41,,,85,45,TOXICITY,DRUG,TOXICITY.,77,41,DRUG,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123706,5/20/2015 22:38:14,1639893687,5/20/2015 22:38:03,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,77,41,,,85,45,TOXICITY,DRUG,drug TOXICITY.,72-77,41-46,"DRUG concentrations,","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123706,5/20/2015 22:45:08,1639896245,5/20/2015 22:44:48,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,77,41,,,85,45,TOXICITY,DRUG,"concentrations, producing drug TOXICITY.",46-62-72-77,32-41-46-62-72-77,"increase DRUG concentrations, producing drug toxicity.","• Rewarming may unintentionally increase drug concentrations, producing drug toxicity.",77,41,77,41,1,85,45,TWrex-cause,810767,"• Rewarming may unintentionally increase drug concentrations, producing drug toxicity",toxicity,drug
724123707,5/21/2015 00:10:01,1639930538,5/21/2015 00:09:47,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,61,14,,,65,17,PAIN,PHN,"PAIN,",61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123707,5/21/2015 00:14:15,1639932622,5/21/2015 00:13:59,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123707,5/21/2015 00:16:14,1639933688,5/21/2015 00:15:52,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,61,14,,,65,17,PAIN,PHN,"PAIN,",61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123707,5/21/2015 00:34:57,1639943071,5/21/2015 00:32:50,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123707,5/21/2015 00:38:39,1639945881,5/21/2015 00:37:46,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123707,5/21/2015 00:58:04,1639957110,5/21/2015 00:57:50,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123707,5/21/2015 01:02:49,1639959801,5/21/2015 01:02:39,false,elite,1.0,32306791,GBR,"","",109.200.26.4,61,14,,,65,17,PAIN,PHN,"continuous dermatomal PAIN, on brief,",31-50-61-67-76,0-9-14-18,Patients with PHN experience,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123707,5/21/2015 01:07:05,1639962300,5/21/2015 01:06:47,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123707,5/21/2015 01:07:58,1639962909,5/21/2015 01:07:27,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",61-50,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123707,5/21/2015 01:12:20,1639965506,5/21/2015 01:12:10,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,61,14,,,65,17,PAIN,PHN,"dermatomal PAIN,",50-61,14,PHN,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed.",61,14,61,14,1,65,17,TWrex-cause,813039,"Patients with PHN experience a continuous burning dermatomal pain, on which brief, lancinating pains may be superimposed",pain,PHN
724123708,5/20/2015 23:24:45,1639910805,5/20/2015 23:24:34,false,prodege,1.0,2145087,USA,"","",40.143.102.85,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,58-71,(generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123708,5/20/2015 23:28:54,1639912924,5/20/2015 23:28:13,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN (generalized vulvodynia),0-2-14-58-71,2-14-58-71,Neuropathic pain (generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123708,5/21/2015 00:07:50,1639929571,5/21/2015 00:07:05,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,71,VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123708,5/21/2015 00:10:31,1639930802,5/21/2015 00:09:54,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,71,VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123708,5/21/2015 00:13:50,1639932419,5/21/2015 00:13:38,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,58-71,(generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123708,5/21/2015 00:23:40,1639937218,5/21/2015 00:21:44,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,14,71,,,18,81,PAIN,VULVODYNIA,Neuropathic PAIN,2-14,71,VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123708,5/21/2015 00:26:24,1639938573,5/21/2015 00:24:16,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,58-71,(generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123708,5/21/2015 00:37:55,1639945387,5/21/2015 00:37:44,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,14,71,,,18,81,PAIN,VULVODYNIA,Neuropathic PAIN,2-14,58-71,(generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123708,5/21/2015 00:54:59,1639955317,5/21/2015 00:54:36,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,14,71,,,18,81,PAIN,VULVODYNIA,• Neuropathic PAIN,0-2-14,58-71,(generalized VULVODYNIA),• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123708,5/21/2015 00:58:29,1639957358,5/21/2015 00:58:02,false,elite,1.0,32306791,GBR,"","",109.200.26.4,14,71,,,18,81,PAIN,VULVODYNIA,• PAIN be generalized,0-14-23-26,45-58-71-90,entire (generalized VULVODYNIA) coupled,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam.,14,71,14,71,1,18,81,TWrex-cause,813761,• Neuropathic pain can be generalized to the entire vulva (generalized vulvodynia) and is coupled with a normal physical exam,pain,vulvodynia
724123709,5/20/2015 21:24:55,1639877424,5/20/2015 21:24:38,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123709,5/20/2015 21:37:18,1639881382,5/20/2015 21:36:58,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123709,5/20/2015 22:14:19,1639885578,5/20/2015 22:13:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,"Erysipelothrix rhusiopathiae Infections Treatment of infections caused by Erysipelothrix rhusiopathiae , including ERYSIPELOID or endocarditis.",3-18-32-44-54-57-68-75-94-108-110-120-132-135-79,3-18-32-44-54-57-68-75-79-94-110-120-132-135,Erysipelothrix rhusiopathiae Infections Treatment of infections caused by ERYSIPELOTHRIX RHUSIOPATHIAE including erysipeloid or endocarditis.,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123709,5/20/2015 22:14:34,1639885642,5/20/2015 22:13:54,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,", ERYSIPELOID",108-120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123709,5/20/2015 22:16:20,1639886217,5/20/2015 22:15:45,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123709,5/20/2015 22:21:30,1639887882,5/20/2015 22:20:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123709,5/20/2015 22:29:46,1639890683,5/20/2015 22:29:18,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,57-68-75-79-94,infections caused by ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123709,5/20/2015 22:33:15,1639891893,5/20/2015 22:33:03,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,ERYSIPELOID,120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123709,5/20/2015 22:33:33,1639892044,5/20/2015 22:33:16,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,", ERYSIPELOID",108-120,79-94,ERYSIPELOTHRIX RHUSIOPATHIAE,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123709,5/20/2015 22:34:27,1639892342,5/20/2015 22:34:02,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,120,79,,,131,107,ERYSIPELOID,ERYSIPELOTHRIX RHUSIOPATHIAE,"infections caused by Erysipelothrix rhusiopathiae , including ERYSIPELOID or endocarditis.",57-68-75-94-108-110-120-132-135-79,57-68-75-79-94-110-120-132-135,infections caused by ERYSIPELOTHRIX RHUSIOPATHIAE including erysipeloid or endocarditis.,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis.",120,79 94,120,79,1,131,107,TWrex-cause,810117,"1  Erysipelothrix rhusiopathiae Infections  Treatment of infections caused by  Erysipelothrix rhusiopathiae , including erysipeloid or endocarditis",erysipeloid,Erysipelothrix rhusiopathiae
724123710,5/20/2015 22:22:32,1639888211,5/20/2015 22:21:45,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,36,99,,,45,103,REACTION,DRUG,Hypersensitivity drug REACTIONS,14-31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123710,5/20/2015 22:31:34,1639891277,5/20/2015 22:30:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,36,99,,,45,103,REACTION,DRUG,Hypersensitivity drug REACTIONS,14-31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123710,5/20/2015 22:36:27,1639893109,5/20/2015 22:36:01,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,36,99,,,45,103,REACTION,DRUG,Hypersensitivity drug REACTIONS,14-31-36,71-81-92-95-99,"intrinsic properties of the DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123710,5/20/2015 22:40:32,1639894545,5/20/2015 22:40:20,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,36,99,,,45,103,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123710,5/20/2015 22:40:45,1639894643,5/20/2015 22:40:26,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,36,99,,,45,103,REACTION,DRUG,Pathogenesis Hypersensitivity REACTIONS,0-36-14,14-99-0,"Pathogenesis Hypersensitivity DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123710,5/20/2015 22:43:51,1639895800,5/20/2015 22:43:30,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,36,99,,,45,103,REACTION,DRUG,"Pathogenesis Hypersensitivity drug REACTIONS can be influenced by the intrinsic properties of the drug,",0-14-31-36-46-50-53-64-67-71-81-92-99-95,53-64-67-71-81-92-95-99-105-109-125-129-133,"influenced by the intrinsic properties of the DRUG, its administration, and the host.","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123710,5/20/2015 22:51:27,1639898474,5/20/2015 22:51:05,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,36,99,,,45,103,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,81-92-95-99,"properties of the DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123710,5/20/2015 23:03:17,1639902845,5/20/2015 23:02:33,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,36,99,,,45,103,REACTION,DRUG,Pathogenesis Hypersensitivity REACTIONS,0-14-36,0-14-99,"Pathogenesis Hypersensitivity DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123710,5/20/2015 23:19:11,1639908552,5/20/2015 23:18:57,false,prodege,1.0,2145087,USA,"","",40.143.102.85,36,99,,,45,103,REACTION,DRUG,drug REACTIONS,31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123710,5/20/2015 23:36:09,1639916190,5/20/2015 23:35:58,false,clixsense,1.0,21933552,CAN,ON,Ottawa,70.49.14.161,36,99,,,45,103,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,99,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host.",36,99,36,99,1,45,103,TWrex-cause,812332,"Pathogenesis  Hypersensitivity drug reactions can be influenced by the intrinsic properties of the drug, its administration, and the host",reaction,drug
724123711,5/21/2015 01:15:06,1639967135,5/21/2015 01:14:48,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123711,5/21/2015 01:52:32,1639987836,5/21/2015 01:52:18,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123711,5/21/2015 02:05:29,1639994141,5/21/2015 02:05:12,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123711,5/21/2015 02:25:12,1640003203,5/21/2015 02:24:42,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,congenital malformations MALARIA,232-295-243,321-334-341-348,ANTIMALARIAL AGENTS during pregnancy.,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123711,5/21/2015 02:28:29,1640004976,5/21/2015 02:28:00,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123711,5/21/2015 02:31:57,1640006516,5/21/2015 02:31:36,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,control group without MALARIA or treatment with antimalarial agents during pregnancy.,273-281-287-295-303-306-316-321-334-341-348,306-316-321-334-341-348,treatment with ANTIMALARIAL AGENTS during pregnancy.,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123711,5/21/2015 02:34:39,1640007822,5/21/2015 02:34:19,false,prodege,1,23482077,USA,TX,Garland,71.164.238.226,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123711,5/21/2015 03:24:26,1640032371,5/21/2015 03:24:16,false,elite,1,31848723,USA,GA,Atlanta,209.191.162.15,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,control group without MALARIA or treatment with,273-281-287-295-303-306-316,203-303-316-321-334,gestation or with ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123711,5/21/2015 03:54:18,1640045969,5/21/2015 03:53:51,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,MALARIA,295,321-334,ANTIMALARIAL AGENTS,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123711,5/21/2015 04:04:23,1640049578,5/21/2015 04:02:41,false,neodev,1,32216655,NLD,07,Amsterdam,145.100.72.168,295,321,,,302,340,MALARIA,ANTIMALARIAL AGENT,overall rate of congenital malformations compared with a control group without MALARIA or treatment with antimalarial agents during pregnancy.,216-224-229-232-243-257-266-271-273-281-287-295-303-306-316-321-334-341-348,281-287-295-303-306-316-321-334-341-348-273,control group without malaria or treatment with ANTIMALARIAL AGENTS during pregnancy.,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy.",295,321 334,295,321,-1,302,340,TWrex-cause,803450,"180   In a study in women with  P. falciparum  malaria who received a 7-day regimen of oral quinine during various stages of pregnancy, there was no difference in the rate of stillbirths at >28 weeks of gestation or overall rate of congenital malformations compared with a control group without malaria or treatment with antimalarial agents during pregnancy",malaria,antimalarial agent
724123712,5/21/2015 00:39:27,1639946292,5/21/2015 00:38:20,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,21,95,,,26,108,COUGH,HYDROCHLORIDE,Alka Seltzer Plus ® COUGH and Cold,0-5-13-18-21-27-31,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123712,5/21/2015 01:02:32,1639959648,5/21/2015 01:01:56,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123712,5/21/2015 01:09:33,1639964016,5/21/2015 01:09:08,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,95-78,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123712,5/21/2015 01:10:45,1639964631,5/21/2015 01:10:26,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123712,5/21/2015 01:46:01,1639984733,5/21/2015 01:45:26,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,21,95,,,26,108,COUGH,HYDROCHLORIDE,Alka Seltzer Plus ® COUGH and Cold,5-13-18-21-27-31-0,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123712,5/21/2015 02:02:10,1639992484,5/21/2015 02:01:47,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH,21,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123712,5/21/2015 02:19:01,1640000363,5/21/2015 02:18:26,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,21,95,,,26,108,COUGH,HYDROCHLORIDE,Alka Seltzer Plus ® COUGH and Cold,5-13-18-21-27-31-0,95-143,"HYDROCHLORIDE, capsules","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123712,5/21/2015 02:23:51,1640002588,5/21/2015 02:23:13,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,21,95,,,26,108,COUGH,HYDROCHLORIDE,Alka Seltzer Plus ® COUGH and Cold capsules,0-5-13-18-21-27-31-143,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123712,5/21/2015 02:27:44,1640004552,5/21/2015 02:27:18,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,21,95,,,26,108,COUGH,HYDROCHLORIDE,COUGH and Cold,21-27-31,78-95,"dextromethorphan HYDROCHLORIDE,","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123712,5/21/2015 02:28:16,1640004902,5/21/2015 02:27:54,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,21,95,,,26,108,COUGH,HYDROCHLORIDE,Alka Seltzer Plus ® COUGH and Cold,5-13-18-21-27-31-0,0-5-21-27-52-69-78-95-110-114-128-31,"Alka Seltzer Cough and Cold chlorpheniramine maleate, dextromethorphan HYDROCHLORIDE, and phenylephrine hydrochloride)","Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information.",21,95,21,95,-1,26,108,TWrex-cause,804952,"Alka-Seltzer Plus ®  Cough and Cold (acetaminophen, chlorpheniramine maleate, dextromethorphan hydrochloride, and phenylephrine hydrochloride) capsules patient information",cough,hydrochloride
724123713,5/21/2015 01:12:34,1639965650,5/21/2015 01:12:24,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123713,5/21/2015 01:14:47,1639967009,5/21/2015 01:14:30,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123713,5/21/2015 01:52:16,1639987749,5/21/2015 01:51:55,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123713,5/21/2015 02:05:10,1639993974,5/21/2015 02:04:51,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0,NICOTINE,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123713,5/21/2015 02:24:41,1640002914,5/21/2015 02:24:19,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,36,0,,,45,8,PREGNANCY,NICOTINE,replacement PREGNANCY.,9-36,0-36-9,NICOTINE replacement pregnancy.,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123713,5/21/2015 02:27:59,1640004709,5/21/2015 02:27:42,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123713,5/21/2015 02:30:47,1640005998,5/21/2015 02:30:38,false,prodege,1.0,26499212,CAN,ON,Cambridge,70.27.23.230,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123713,5/21/2015 02:31:33,1640006335,5/21/2015 02:31:13,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,36,0,,,45,8,PREGNANCY,NICOTINE,replacement therapy during PREGNANCY.,9-21-29-36,0-9-21-36,NICOTINE replacement therapy pregnancy.,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123713,5/21/2015 02:34:14,1640007552,5/21/2015 02:33:54,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,36,0,,,45,8,PREGNANCY,NICOTINE,PREGNANCY.,36,0-9-21,NICOTINE replacement therapy,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123713,5/21/2015 03:24:14,1640032265,5/21/2015 03:24:01,false,elite,1.0,31848723,USA,GA,Atlanta,209.191.162.15,36,0,,,45,8,PREGNANCY,NICOTINE,therapy PREGNANCY.,21-36,0-29,NICOTINE during,Nicotine replacement therapy during pregnancy.,36,0,36,0,-1,45,8,TWrex-cause,803249,Nicotine replacement therapy during pregnancy,pregnancy,nicotine
724123714,5/20/2015 22:26:49,1639889754,5/20/2015 22:26:33,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123714,5/20/2015 22:39:54,1639894312,5/20/2015 22:37:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123714,5/20/2015 22:41:15,1639894831,5/20/2015 22:40:50,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123714,5/20/2015 22:51:39,1639898581,5/20/2015 22:51:13,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,29,145,,,38,149,HEMOLYSIS,AIHA,"With α - methyldopa type AIHA, HEMOLYSIS usually ceases within 3 wk;",0-5-6-7-18-23-29-39-47-54-61-63,124-129-136-145-151-161-168-173-177-182-185-193-198-202,"With hapten mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123714,5/20/2015 22:55:24,1639899771,5/20/2015 22:55:05,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,29,145,,,38,149,HEMOLYSIS,AIHA,"methyldopa type AIHA, HEMOLYSIS",7-18-23-29,124-129-136-145-151-161-168,"With hapten mediated AIHA, hemolysis ceases when","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123714,5/20/2015 23:10:55,1639906044,5/20/2015 23:09:31,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,29,145,,,38,149,HEMOLYSIS,AIHA,"methyldopa type AIHA, HEMOLYSIS",7-18-29-23,145-151,"AIHA, hemolysis","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123714,5/20/2015 23:21:10,1639909202,5/20/2015 23:20:55,false,prodege,1.0,2145087,USA,"","",40.143.102.85,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123714,5/21/2015 00:03:24,1639927575,5/21/2015 00:01:28,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123714,5/21/2015 00:04:13,1639928000,5/21/2015 00:03:46,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,29,145,,,38,149,HEMOLYSIS,AIHA,"α - methyldopa - type AIHA, HEMOLYSIS",5-6-17-18-23-29-7,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123714,5/21/2015 00:10:29,1639930791,5/21/2015 00:09:18,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,29,145,,,38,149,HEMOLYSIS,AIHA,HEMOLYSIS,29,129-136-145,"hapten mediated AIHA,","With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma.",29,145,29,145,1,38,149,TWrex-cause,814147,"With α-methyldopa-type AIHA, hemolysis usually ceases within 3 wk; however, a positive Coombs' test may persist for > 1 yr. With hapten-mediated AIHA, hemolysis ceases when the drug is cleared from the plasma",hemolysis,AIHA
724123715,5/20/2015 22:17:02,1639886473,5/20/2015 22:16:13,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY,124,214-218-223,GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123715,5/20/2015 22:18:06,1639886752,5/20/2015 22:17:40,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY,124,214-218-223,GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123715,5/20/2015 22:25:02,1639889120,5/20/2015 22:23:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY,124,214-218-223,GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123715,5/20/2015 22:31:51,1639891389,5/20/2015 22:31:18,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY in hepatic forms of GSD,124-137-140-148-154-157,198-211-214-218-223,cardiomegaly in GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123715,5/20/2015 22:36:01,1639892951,5/20/2015 22:35:32,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,124,218,,,136,225,HEPATOMEGALY,TYPE II,"within the organ cells (eg, HEPATOMEGALY in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly GSD type II.",96-103-107-113-119-124-137-140-148-154-157-161-165-170-180-188-198-214-218-223,170-180-198-211-214-218-223-188,"lysosomal storage diseases, cardiomegaly in GSD TYPE II.","Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123715,5/20/2015 22:38:05,1639893629,5/20/2015 22:37:42,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,124,218,,,136,225,HEPATOMEGALY,TYPE II,"HEPATOMEGALY lysosomal storage diseases,",124-170-180-188,38-218-223-48,substrate degradation TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123715,5/20/2015 22:38:37,1639893842,5/20/2015 22:38:26,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY,124,214-218-223,GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123715,5/20/2015 22:46:26,1639896682,5/20/2015 22:46:04,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,124,218,,,136,225,HEPATOMEGALY,TYPE II,"organ cells (eg, HEPATOMEGALY in hepatic",107-113-119-124-137-140,198-211-214-218-223,cardiomegaly in GSD TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123715,5/20/2015 22:46:47,1639896806,5/20/2015 22:45:50,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,124,218,,,136,225,HEPATOMEGALY,TYPE II,HEPATOMEGALY,124,218-223,TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123715,5/20/2015 22:55:34,1639899875,5/20/2015 22:53:51,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,124,218,,,136,225,HEPATOMEGALY,TYPE II,Organomegaly HEPATOMEGALY,0-124,0-218-223,Organomegaly TYPE II.,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II.",124,218 223,124,218,1,136,225,TWrex-cause,812625,"Organomegaly may reflect a failure in substrate degradation resulting in substrate accumulation within the organ cells (eg, hepatomegaly in hepatic forms of GSD and many lysosomal storage diseases, cardiomegaly in GSD type II",hepatomegaly,type ii
724123716,5/21/2015 01:16:17,1639967822,5/21/2015 01:15:53,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,43-55-58,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123716,5/21/2015 01:55:36,1639989339,5/21/2015 01:54:50,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,43-55-58,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123716,5/21/2015 02:06:18,1639994523,5/21/2015 02:06:04,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,43-55-58,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123716,5/21/2015 02:26:32,1640003933,5/21/2015 02:25:59,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,55,23,,,57,26,TB,PPD,QuantiFERON TB,43-55,23-43-55,PPD QuantiFERON TB,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123716,5/21/2015 02:29:23,1640005370,5/21/2015 02:29:10,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,43-55-58,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123716,5/21/2015 02:33:09,1640006985,5/21/2015 02:32:49,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold was 35.4%,43-55-58-63-67,4-16-19-23-31-35-43-55-58-63-67,specificity of the PPD mm) and QuantiFERON TB Gold was 35.4%,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123716,5/21/2015 02:38:23,1640009747,5/21/2015 02:37:47,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,43-55-58,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123716,5/21/2015 04:04:29,1640049619,5/21/2015 04:04:14,false,gifthunterclub,1,30901412,GBR,I3,Chatham,85.210.119.173,55,23,,,57,26,TB,PPD,"and the QuantiFERON TB Gold was 35.4% 98.1%, respectively,",35-39-43-55-58-63-67-77-84,4-16-19-23-31-35-43-55,specificity of the PPD mm) and QuantiFERON TB,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123716,5/21/2015 04:07:21,1640050523,5/21/2015 04:05:49,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,55,23,,,57,26,TB,PPD,"The specificity of the PPD and the QuantiFERON TB Gold was 35.4% and 98.1%,",0-4-16-23-35-39-43-55-58-63-67-73-77-19,0-4-16-19-23-35-39-43-55-58-63-67-73-77-175-184-187-201--1,"smear The specificity of the PPD and the QuantiFERON TB Gold was 35.4% and 98.1%, compared to smear/culture positive","The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123716,5/21/2015 04:08:45,1640051001,5/21/2015 04:07:42,false,bitcoinget,1,21614812,USA,PA,Erie,174.100.250.115,55,23,,,57,26,TB,PPD,QuantiFERON TB Gold,43-55-58,23,PPD,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB.",55,23,55,23,-1,57,26,TWrex-cause,803037,"The specificity of the PPD (10 mm) and the QuantiFERON-TB Gold was 35.4% and 98.1%, respectively, and the sensitivity was 65.8% and 89% for PPD and QuantiFERON, respectively, compared to smear/culture-positive active TB",TB,PPD
724123717,5/20/2015 22:23:54,1639888768,5/20/2015 22:23:26,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,44,2,,,48,14,PAIN,FIBROMYALGIA,PAIN,44,2,"FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123717,5/20/2015 22:33:19,1639891926,5/20/2015 22:32:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,44,2,,,48,14,PAIN,FIBROMYALGIA,PAIN,44,2,"FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123717,5/20/2015 22:37:17,1639893403,5/20/2015 22:36:51,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,44,2,,,48,14,PAIN,FIBROMYALGIA,widespread PAIN,33-44,2-16-30-33-44,"FIBROMYALGIA, characterized by widespread pain","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123717,5/20/2015 22:44:46,1639896100,5/20/2015 22:44:12,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,44,2,,,48,14,PAIN,FIBROMYALGIA,"Fibromyalgia, characterized by widespread PAIN and multiple tender points,",2-16-30-33-44-49-53-62-69,0-2-16-30-33-44-49-53-62-69,"• FIBROMYALGIA, characterized by widespread pain and multiple tender points,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123717,5/20/2015 22:52:40,1639898880,5/20/2015 22:52:15,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,44,2,,,48,14,PAIN,FIBROMYALGIA,characterized by widespread PAIN and multiple tender,16-30-33-44-49-53-62,2-16-30-33-44,"FIBROMYALGIA, characterized by widespread pain","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123717,5/20/2015 23:04:48,1639903623,5/20/2015 23:04:24,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,44,2,,,48,14,PAIN,FIBROMYALGIA,"Fibromyalgia, PAIN",2-44,2,"FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123717,5/20/2015 23:19:36,1639908641,5/20/2015 23:19:25,false,prodege,1.0,2145087,USA,"","",40.143.102.85,44,2,,,48,14,PAIN,FIBROMYALGIA,PAIN,44,0-2,"• FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123717,5/20/2015 23:36:35,1639916371,5/20/2015 23:36:21,false,clixsense,1.0,21933552,CAN,ON,Ottawa,70.49.14.161,44,2,,,48,14,PAIN,FIBROMYALGIA,widespread PAIN,44-33,2,"FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123717,5/20/2015 23:59:14,1639925765,5/20/2015 23:58:49,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,44,2,,,48,14,PAIN,FIBROMYALGIA,PAIN,44,2,"FIBROMYALGIA,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123717,5/21/2015 00:00:53,1639926542,5/20/2015 23:59:56,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,44,2,,,48,14,PAIN,FIBROMYALGIA,characterized by widespread PAIN and multiple tender,30-33-44-49-53-62-16,0-2-16-30-33-44-49-53-62-69,"• FIBROMYALGIA, characterized by widespread pain and multiple tender points,","• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group.",44,2,44,2,1,48,14,TWrex-cause,813484,"• Fibromyalgia, characterized by widespread pain and multiple tender points, occurs mostly among women (90% of the cases) and is most commonly seen in the 40 to 60 age group",pain,fibromyalgia
724123718,5/21/2015 00:36:30,1639944382,5/21/2015 00:36:15,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123718,5/21/2015 00:42:35,1639948161,5/21/2015 00:41:32,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,91-105-110-121,then IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123718,5/21/2015 00:59:26,1639957910,5/21/2015 00:59:00,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123718,5/21/2015 01:07:47,1639962785,5/21/2015 01:07:35,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105,IRON,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123718,5/21/2015 01:08:55,1639963609,5/21/2015 01:08:30,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123718,5/21/2015 01:30:54,1639975874,5/21/2015 01:30:47,false,neodev,1.0,31977841,USA,IL,Chicago,69.175.85.2,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,from non iron DEFICIENCY ANEMIAS.,128-133-137-142-153,87-91-96-105-110-121-128,and then separate IRON deficiency anemia from,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123718,5/21/2015 01:40:19,1639981321,5/21/2015 01:39:47,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-137-142-153,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123718,5/21/2015 01:56:22,1639989784,5/21/2015 01:56:07,false,neodev,1,32491845,USA,DE,Wilmington,199.115.115.209,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,from non iron DEFICIENCY ANEMIAS.,128-133-137-142-153,87-91-96-105-110-121-128,and then separate IRON deficiency anemia from,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123718,5/21/2015 02:00:01,1639991431,5/21/2015 01:58:57,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,non iron DEFICIENCY ANEMIAS.,133-142-153-137,105-110,IRON deficiency,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123718,5/21/2015 02:16:10,1639999124,5/21/2015 02:15:42,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,142,105,,,160,109,DEFICIENCY ANEMIA,IRON,"etiology, DEFICIENCY ANEMIAS.",142-153-17,105-110-121,IRON deficiency anemia,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias.",142 153,105,142,105,-1,160,109,TWrex-cause,804612,"• In determining etiology, first separate hemolytic anemias from nonhemolytic anemias, and then separate iron deficiency anemia from non-iron deficiency anemias",deficiency anemia,iron
724123719,5/21/2015 00:16:37,1639933857,5/21/2015 00:16:28,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,PAIN.,77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123719,5/21/2015 00:36:15,1639944197,5/21/2015 00:35:23,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,PAIN.,77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123719,5/21/2015 00:41:31,1639947468,5/21/2015 00:39:50,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,sympathetically maintained PAIN.,50-66-77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123719,5/21/2015 00:58:59,1639957664,5/21/2015 00:58:40,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,sympathetically maintained PAIN.,50-66-77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123719,5/21/2015 01:07:34,1639962637,5/21/2015 01:07:22,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,PAIN.,77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123719,5/21/2015 01:08:29,1639963297,5/21/2015 01:08:18,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,PAIN.,77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123719,5/21/2015 01:12:38,1639965669,5/21/2015 01:12:31,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,PAIN.,77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123719,5/21/2015 01:30:44,1639975779,5/21/2015 01:30:28,false,neodev,1.0,31977841,USA,IL,Chicago,69.175.85.2,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,involves sympathetically maintained PAIN.,41-50-66-77,0-8-17-22-31-41-50,COMPLEX REGIONAL PAIN SYNDROME sometimes involves sympathetically,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123719,5/21/2015 01:39:46,1639980967,5/21/2015 01:39:36,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,PAIN.,77,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123719,5/21/2015 01:53:04,1639988110,5/21/2015 01:52:55,false,zoombucks,1,4688131,CAN,BC,Vancouver,75.156.91.114,77,0,,,81,30,PAIN,COMPLEX REGIONAL PAIN SYNDROME,sympathetically maintained PAIN.,50-77-66,0-8-17-22,COMPLEX REGIONAL PAIN SYNDROME,Complex regional pain syndrome sometimes involves sympathetically maintained pain.,77,0 8 17 22,77,0,1,81,30,TWrex-cause,814334,Complex regional pain syndrome sometimes involves sympathetically maintained pain,pain,complex regional pain syndrome
724123720,5/20/2015 22:25:30,1639889277,5/20/2015 22:24:58,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123720,5/20/2015 22:36:18,1639892985,5/20/2015 22:35:50,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123720,5/20/2015 22:39:46,1639894262,5/20/2015 22:38:26,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,20-23-26-30,5% or 10% DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123720,5/20/2015 22:45:47,1639896438,5/20/2015 22:45:26,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,reduce the incidence of HYPOGLYCEMIA.,75-79-89-92-68,2-20-23-26-30-39-46-56-13,Administer either 5% or 10% DEXTROSE during quinidine infusion,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123720,5/20/2015 22:54:12,1639899396,5/20/2015 22:53:37,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,the incidence of HYPOGLYCEMIA.,75-79-89-92,20-23-26-30,5% or 10% DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123720,5/20/2015 23:07:30,1639904653,5/20/2015 23:07:01,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30-92,DEXTROSE hypoglycemia.,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123720,5/20/2015 23:20:19,1639908857,5/20/2015 23:20:08,false,prodege,1.0,2145087,USA,"","",40.143.102.85,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123720,5/21/2015 00:00:49,1639926539,5/21/2015 00:00:36,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,20-23-26-30,5% or 10% DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123720,5/21/2015 00:02:35,1639927298,5/21/2015 00:02:03,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,20-23-26-30-39-46-56,5% or 10% DEXTROSE during quinidine infusion,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123720,5/21/2015 00:10:11,1639930633,5/21/2015 00:10:04,false,instagc,1,31130954,USA,IL,Schaumburg,99.141.252.213,92,30,,,104,38,HYPOGLYCEMIA,DEXTROSE,HYPOGLYCEMIA.,92,30,DEXTROSE,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia.,92,30,92,30,-1,104,38,TWrex-cause,800750,• Administer either 5% or 10% dextrose during quinidine infusion to reduce the incidence of hypoglycemia,hypoglycemia,dextrose
724123721,5/20/2015 20:42:25,1639860679,5/20/2015 20:42:10,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123721,5/20/2015 20:56:54,1639866543,5/20/2015 20:56:32,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123721,5/20/2015 20:58:00,1639866985,5/20/2015 20:56:30,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123721,5/20/2015 20:58:16,1639867095,5/20/2015 20:57:59,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,Intestinal Lipodystrophy) WHIPPLE'S DISEASE is a rare illness caused by bacterium Tropheryma whippelii.,0-11-27-37-45-48-50-64-72-79-86-97-108,27-37-72-79-82-86-97-108-45,Whipple's disease is caused by the BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123721,5/20/2015 21:00:07,1639867679,5/20/2015 20:59:51,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,Intestinal Lipodystrophy) WHIPPLE'S DISEASE a,0-11-27-37-48,86,BACTERIUM,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123721,5/20/2015 21:02:04,1639868423,5/20/2015 21:01:42,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123721,5/20/2015 21:17:39,1639874288,5/20/2015 21:17:21,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123721,5/20/2015 21:22:13,1639876329,5/20/2015 21:21:47,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-108-97,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123721,5/20/2015 21:23:34,1639876823,5/20/2015 21:23:22,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,WHIPPLE'S DISEASE,27-37,86-97-108,BACTERIUM Tropheryma whippelii.,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123721,5/20/2015 21:26:10,1639877793,5/20/2015 21:25:44,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,27,86,,,44,95,WHIPPLE'S DISEASE,BACTERIUM,Intestinal Lipodystrophy) WHIPPLE'S DISEASE,0-11-27-37,86,BACTERIUM,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii.,27 37,86,27,86,1,44,95,TWrex-cause,810029,Intestinal Lipodystrophy)  Whipple's disease is a rare systemic illness caused by the bacterium  Tropheryma whippelii,whipple's disease,bacterium
724123722,5/21/2015 01:15:53,1639967594,5/21/2015 01:15:33,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,45,76,,,47,91,TB,M. TUBERCULOSIS,active TB,38-45,76-79,M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123722,5/21/2015 01:54:49,1639988942,5/21/2015 01:53:04,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,45,76,,,47,91,TB,M. TUBERCULOSIS,TB,45,76-79,M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123722,5/21/2015 02:06:02,1639994369,5/21/2015 02:05:48,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,45,76,,,47,91,TB,M. TUBERCULOSIS,TB,45,76-79,M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123722,5/21/2015 02:25:59,1640003653,5/21/2015 02:25:37,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,45,76,,,47,91,TB,M. TUBERCULOSIS,active TB,38-45,58-63-76-79-115-120,drug susceptible M. TUBERCULOSIS drug regimens,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123722,5/21/2015 02:29:09,1640005276,5/21/2015 02:28:49,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,45,76,,,47,91,TB,M. TUBERCULOSIS,TB,45,58-62-63-76-79,drug - susceptible M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123722,5/21/2015 02:32:46,1640006860,5/21/2015 02:32:24,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,45,76,,,47,91,TB,M. TUBERCULOSIS,treatment of active TB caused by drug,25-35-38-45-48-55-58,58-63-76-79-94-106-115,drug susceptible M. TUBERCULOSIS recommended multiple drug,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123722,5/21/2015 02:37:45,1640009429,5/21/2015 02:35:08,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,45,76,,,47,91,TB,M. TUBERCULOSIS,active TB,38-45,58-63-76-79,drug susceptible M. TUBERCULOSIS,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123722,5/21/2015 03:24:55,1640032521,5/21/2015 03:24:46,false,elite,1.0,31848723,USA,GA,Atlanta,209.191.162.15,45,76,,,47,91,TB,M. TUBERCULOSIS,treatment of active TB caused by drug,25-35-38-45-48-55-58,55-76-79-115,by M. TUBERCULOSIS drug,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123722,5/21/2015 04:04:13,1640049503,5/21/2015 04:03:54,false,gifthunterclub,1.0,30901412,GBR,I3,Chatham,85.210.119.173,45,76,,,47,91,TB,M. TUBERCULOSIS,treatment of active TB caused by drug susceptible M. tuberculosis,25-35-38-45-48-55-58-63-76-79,45-55-58-63-76-79-94-106-115-48,TB caused by drug susceptible M. TUBERCULOSIS recommended multiple drug,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123722,5/21/2015 04:05:45,1640050028,5/21/2015 04:04:56,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,45,76,,,47,91,TB,M. TUBERCULOSIS,treatment of active TB caused by drug susceptible M. tuberculosis recommended multiple - drug regimens,25-35-38-45-48-55-58-63-76-79-94-106-115-120-114,58-63-76-79-94-106-115-120-129-137-140-143-151-161,drug susceptible M. TUBERCULOSIS recommended multiple drug regimens consist of an initial intensive phase,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months.",45,76 79,45,76,1,47,91,TWrex-cause,810319,"141 ,   176  For initial treatment of active TB caused by drug-susceptible  M. tuberculosis , recommended multiple-drug regimens consist of an initial intensive phase (2 months) and a continuation phase (4 or 7 months",TB,m. tuberculosis
724123723,5/21/2015 01:06:48,1639962156,5/21/2015 01:06:27,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"HEADACHE,",172,138-147,MIGRAINE and,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123723,5/21/2015 01:11:43,1639965135,5/21/2015 01:11:20,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE,",151-159-167-172,138-147-151-159-167-172,"MIGRAINE and chronic tension type headache,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123723,5/21/2015 01:13:48,1639966351,5/21/2015 01:13:04,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE,",159-167-172-151,138-147-151-159-167-172,"MIGRAINE and chronic tension type headache,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123723,5/21/2015 01:50:09,1639986820,5/21/2015 01:49:19,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE,",151-159-167-172,138-147,MIGRAINE and,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123723,5/21/2015 02:04:18,1639993568,5/21/2015 02:03:54,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"HEADACHE,",172,138-147-151-159-167-172,"MIGRAINE and chronic tension type headache,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123723,5/21/2015 02:23:19,1640002374,5/21/2015 02:22:25,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"TYPES IN CDH CDH HEADACHE,",9-15-18-23-172,113-138-147-151-159-167-125,"chronic, transformed, MIGRAINE and chronic tension type","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123723,5/21/2015 02:26:55,1640004125,5/21/2015 02:26:09,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension - type HEADACHE,",151-159-167-172-166,138-147-151-159-167-172-166,"MIGRAINE and chronic tension - type headache,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123723,5/21/2015 02:30:03,1640005679,5/21/2015 02:29:48,false,prodege,1.0,26499212,CAN,ON,Cambridge,70.27.23.230,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE,",151-159-167-172,138-147-151-159-167-172,"MIGRAINE and chronic tension type headache,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123723,5/21/2015 02:30:31,1640005869,5/21/2015 02:30:07,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"chronic tension type HEADACHE,",151-159-167-172,113-122-125-138-147-172-167,"chronic, or transformed, MIGRAINE and type headache,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123723,5/21/2015 02:32:50,1640006881,5/21/2015 02:30:14,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,172,138,,,180,146,HEADACHE,MIGRAINE HEADACHE,"migraine and chronic tension type HEADACHE,",147-151-159-167-172-138,138-147-151-159-172-167,"MIGRAINE and chronic tension type headache,","HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population.",172,138 147,172,138,1,180,146,TWrex-cause,814535,"HEADACHE TYPES IN CDH  CDH of long duration (4 or more hours per attack) includes four different headache types: chronic, or transformed, migraine and chronic tension-type headache, which each account for about 50% of those with CDH, and the rare hemicrania continua and new daily persistent headache (0.1% of the general population",headache,migraine headache
724123724,5/20/2015 23:25:37,1639911316,5/20/2015 23:25:22,false,prodege,1.0,2145087,USA,"","",40.143.102.85,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123724,5/21/2015 00:08:35,1639929894,5/21/2015 00:08:19,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,31-25,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123724,5/21/2015 00:11:11,1639931115,5/21/2015 00:10:59,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123724,5/21/2015 00:14:28,1639932705,5/21/2015 00:14:16,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123724,5/21/2015 00:27:26,1639939172,5/21/2015 00:26:17,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123724,5/21/2015 00:30:48,1639940894,5/21/2015 00:29:46,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123724,5/21/2015 00:38:34,1639945781,5/21/2015 00:38:22,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123724,5/21/2015 00:56:05,1639955970,5/21/2015 00:55:45,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS,56-61-63-72,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123724,5/21/2015 01:01:24,1639958995,5/21/2015 01:01:08,false,elite,1.0,32306791,GBR,"","",109.200.26.4,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,patients TYPE 1 DIABETES MELLITUS rapid acting,42-56-61-63-72-86-92,10-25-31-42,replacement basal INSULIN patients,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123724,5/21/2015 01:05:18,1639961224,5/21/2015 01:05:01,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,56,31,,,80,38,TYPE 1 DIABETES MELLITUS,INSULIN,TYPE 1 DIABETES MELLITUS -,56-61-63-72-91,25-31,basal INSULIN,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.,56 61 63 72,31,56,31,-1,80,38,TWrex-cause,803670,Intensive replacement of basal insulin in patients with type 1 diabetes mellitus give rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime,type 1 diabetes mellitus,insulin
724123725,5/20/2015 20:41:44,1639860470,5/20/2015 20:41:32,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123725,5/20/2015 20:54:48,1639865818,5/20/2015 20:53:41,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123725,5/20/2015 20:56:02,1639866248,5/20/2015 20:55:04,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,CRYPTOCOCCAL MENINGITIS.,129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123725,5/20/2015 20:57:24,1639866754,5/20/2015 20:56:23,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,itraconazole versus fluconazole maintenance therapy for AIDS associated CRYPTOCOCCAL MENINGITIS.,54-67-74-89-109-113-118-129-142-101,51-54-67-74-86-89-101-109-113,of itraconazole versus FLUCONAZOLE as maintenance therapy for AIDS,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123725,5/20/2015 20:59:32,1639867470,5/20/2015 20:58:55,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,CRYPTOCOCCAL MENINGITIS.,129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123725,5/20/2015 21:01:15,1639868134,5/20/2015 21:00:59,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123725,5/20/2015 21:03:18,1639868816,5/20/2015 21:03:08,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,CRYPTOCOCCAL MENINGITIS.,129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123725,5/20/2015 21:17:01,1639874044,5/20/2015 21:16:48,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123725,5/20/2015 21:21:18,1639875947,5/20/2015 21:20:54,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,CRYPTOCOCCAL MENINGITIS.,129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123725,5/20/2015 21:23:03,1639876670,5/20/2015 21:22:51,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,129,74,,,152,85,CRYPTOCOCCAL MENINGITIS,FLUCONAZOLE,AIDS associated CRYPTOCOCCAL MENINGITIS.,113-118-129-142,74,FLUCONAZOLE,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.",129 142,74,129,74,-1,152,85,TWrex-cause,800338,"Saag MS, Cloud GA, Graybill JR et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis",cryptococcal meningitis,fluconazole
724123726,5/20/2015 22:24:24,1639888938,5/20/2015 22:23:55,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY absorption test,63-75-86-95-106,146-151-161,for TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123726,5/20/2015 22:35:01,1639892608,5/20/2015 22:33:22,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY absorption,63-75-86-95,151-161,TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123726,5/20/2015 22:37:57,1639893605,5/20/2015 22:37:18,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY absorption test,63-75-86-95-106,118-140-146-151-161,microhemagglutination assay for TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123726,5/20/2015 22:45:06,1639896228,5/20/2015 22:44:47,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,"serologic testing, including FLUORESCENT TREPONEMAL ANTIBODY absorption test or the microhemagglutination assay for Treponema pallidum",34-44-53-63-75-86-95-106-111-114-118-140-146-151-161,118-140-146-151-161-172-177-184-188-196-201,"microhemagglutination assay for TREPONEMA PALLIDUM Lyme titer, and Epstein Barr panel.","However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123726,5/20/2015 22:52:55,1639899005,5/20/2015 22:52:41,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,"serologic testing, including FLUORESCENT TREPONEMAL ANTIBODY",34-44-53-63-75-86,118-140-146-151-161-172-177,"microhemagglutination assay for TREPONEMA PALLIDUM Lyme titer,","However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123726,5/20/2015 23:06:20,1639904176,5/20/2015 23:04:53,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,"FLUORESCENT TREPONEMAL ANTIBODY Treponema pallidum Lyme titer, Epstein Barr",63-75-86-151-161-172-177-188-196,151-161-172-177-188-196,"TREPONEMA PALLIDUM Lyme titer, Epstein Barr","However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123726,5/20/2015 23:19:56,1639908711,5/20/2015 23:19:37,false,prodege,1.0,2145087,USA,"","",40.143.102.85,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY,63-75-86,151-161,TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123726,5/20/2015 23:36:48,1639916427,5/20/2015 23:36:37,false,clixsense,1.0,21933552,CAN,ON,Ottawa,70.49.14.161,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY absorption test,63-75-86-95-106,151-161,TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123726,5/20/2015 23:59:53,1639926115,5/20/2015 23:59:14,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,FLUORESCENT TREPONEMAL ANTIBODY,63-75-86,151-161,TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123726,5/21/2015 00:01:27,1639926855,5/21/2015 00:00:55,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,63,151,,,94,169,FLUORESCENT TREPONEMAL ANTIBODY,TREPONEMA PALLIDUM,"serologic testing, including FLUORESCENT TREPONEMAL ANTIBODY absorption test or microhemagglutination assay",34-44-53-63-75-86-95-106-111-118-140,118-140-146-151-161,microhemagglutination assay for TREPONEMA PALLIDUM,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel.",63 75 86,151 161,63,151,1,94,169,TWrex-cause,811251,"However, all patients should have serologic testing, including fluorescent treponemal antibody absorption test or the microhemagglutination assay for  Treponema pallidum , Lyme titer, and Epstein-Barr panel",fluorescent treponemal antibody,treponema pallidum
724123727,5/20/2015 20:49:03,1639863377,5/20/2015 20:48:50,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123727,5/20/2015 21:06:36,1639870145,5/20/2015 21:05:49,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,56,89,,,66,97,ORNITHOSIS,PSITTACI,Chlamydia psittaci.,79-89,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123727,5/20/2015 21:07:20,1639870370,5/20/2015 21:07:02,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,89-79,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123727,5/20/2015 21:08:42,1639870778,5/20/2015 21:08:28,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123727,5/20/2015 21:23:21,1639876723,5/20/2015 21:23:03,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123727,5/20/2015 21:30:11,1639878952,5/20/2015 21:29:43,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123727,5/20/2015 21:34:43,1639880614,5/20/2015 21:34:25,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,56,89,,,66,97,ORNITHOSIS,PSITTACI,psittacosis + (ORNITHOSIS),36-50-55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123727,5/20/2015 21:36:57,1639881274,5/20/2015 21:36:38,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,56,89,,,66,97,ORNITHOSIS,PSITTACI,psittacosis + (ORNITHOSIS),36-50-55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123727,5/20/2015 21:38:03,1639881664,5/20/2015 21:37:34,false,prodege,1.0,19907188,USA,MI,Adrian,50.37.37.250,56,89,,,66,97,ORNITHOSIS,PSITTACI,(ORNITHOSIS),55,79-89,Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123727,5/20/2015 21:59:41,1639882319,5/20/2015 21:59:21,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,56,89,,,66,97,ORNITHOSIS,PSITTACI,Chlamydial Infections Treatment of psittacosis + (ORNITHOSIS) caused by Chlamydia psittaci.,0-11-23-33-36-50-55-68-75-79-89,0-11-23-33-36-50-68-75-79-89-55,Chlamydial Infections Treatment of psittacosis + (ornithosis) caused by Chlamydia PSITTACI.,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci.,,89,56,89,1,66,97,TWrex-cause,810745,Chlamydial Infections  Treatment of psittacosis   +    (ornithosis) caused by  Chlamydia psittaci,ornithosis,psittaci
724123728,5/20/2015 22:44:07,1639895902,5/20/2015 22:43:31,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,116-122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123728,5/20/2015 22:44:32,1639896033,5/20/2015 22:43:47,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,116-122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123728,5/20/2015 22:53:37,1639899202,5/20/2015 22:53:17,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Success rates Overt STATUS EPILEPTICUS Subtle status epilepticus Lorazepam,102-110-116-122-129-146-153-160-172,292-318-346-352-361-365,Phenytoin 51.0% 19.5% DIAZEPAM and phenytoin,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123728,5/20/2015 22:58:35,1639901079,5/20/2015 22:57:52,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Success rates Overt STATUS EPILEPTICUS,102-110-116-122-129,292-318-346-352-361-365,Phenytoin 51.0% 19.5% DIAZEPAM and phenytoin,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123728,5/20/2015 23:21:05,1639909147,5/20/2015 23:20:13,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS Generalized convulsive status epilepticus,122-129-427-439-450-457,42-49-352,status epilepticus DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123728,5/20/2015 23:22:25,1639909528,5/20/2015 23:22:11,false,prodege,1.0,2145087,USA,"","",40.143.102.85,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,116-122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123728,5/21/2015 00:05:06,1639928318,5/21/2015 00:04:40,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS,122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123728,5/21/2015 00:07:14,1639929347,5/21/2015 00:06:14,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,122-129-116,292-318-346-352-365-378,Phenytoin 51.0% 19.5% DIAZEPAM phenytoin 59.6%,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123728,5/21/2015 00:11:44,1639931392,5/21/2015 00:11:27,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS,122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123728,5/21/2015 00:13:37,1639932335,5/21/2015 00:12:16,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,122,352,,,140,360,STATUS EPILEPTICUS,DIAZEPAM,Overt STATUS EPILEPTICUS,116-122-129,352,DIAZEPAM,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury.,122 129,352,122,352,-1,140,360,TWrex-cause,804239,Treatment success of 4 drug therapies for status epilepticus at 12 hours  Drug therapies              Success rates Overt status epilepticus      Subtle status epilepticus Lorazepam                 67.0%                       26.1% Phenobarbital             63.0%                       24.4% Phenytoin                 51.0%                       19.5% Diazepam and phenytoin    59.6%                       23.4%    COMMENTARY  Generalized convulsive status epilepticus requires prompt treatment to prevent death or serious brain injury,status epilepticus,diazepam
724123729,5/20/2015 23:24:33,1639910712,5/20/2015 23:24:18,false,prodege,1.0,2145087,USA,"","",40.143.102.85,82,46,,,89,57,MALARIA,CHLOROQUINE,Chloroquine resistant P. falciparum MALARIA,46-58-68-71-82,46-58-68-71-82,CHLOROQUINE resistant P. falciparum Malaria,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123729,5/20/2015 23:28:06,1639912565,5/20/2015 23:27:11,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,82,46,,,89,57,MALARIA,CHLOROQUINE,Uncomplicated Chloroquine resistant P. falciparum MALARIA mg,32-46-58-68-82-105-71,32-46-58-68-71-82,Uncomplicated CHLOROQUINE resistant P. falciparum Malaria,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123729,5/21/2015 00:07:04,1639929234,5/21/2015 00:06:31,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,82,46,,,89,57,MALARIA,CHLOROQUINE,Chloroquine resistant P. falciparum MALARIA,46-58-71-82-68,46-58-68-71,CHLOROQUINE resistant P. falciparum,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123729,5/21/2015 00:09:53,1639930452,5/21/2015 00:09:23,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,82,46,,,89,57,MALARIA,CHLOROQUINE,Uncomplicated Chloroquine resistant P. falciparum MALARIA,32-46-58-68-71-82,32-46,Uncomplicated CHLOROQUINE,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123729,5/21/2015 00:13:37,1639932337,5/21/2015 00:13:23,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,82,46,,,89,57,MALARIA,CHLOROQUINE,MALARIA,82,46,CHLOROQUINE,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123729,5/21/2015 00:21:44,1639936355,5/21/2015 00:20:45,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,82,46,,,89,57,MALARIA,CHLOROQUINE,MALARIA,82,46-58-68-71,CHLOROQUINE resistant P. falciparum,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123729,5/21/2015 00:24:15,1639937483,5/21/2015 00:22:47,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,82,46,,,89,57,MALARIA,CHLOROQUINE,resistant P. falciparum MALARIA,58-68-71-82,32-46-58-68-71,Uncomplicated CHLOROQUINE resistant P. falciparum,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123729,5/21/2015 00:37:42,1639945260,5/21/2015 00:37:24,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,82,46,,,89,57,MALARIA,CHLOROQUINE,P. falciparum MALARIA,68-71-82,46-58-68-71-82,CHLOROQUINE resistant P. falciparum Malaria,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123729,5/21/2015 00:54:31,1639955098,5/21/2015 00:54:08,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,82,46,,,89,57,MALARIA,CHLOROQUINE,falciparum MALARIA,71-82,32-46,Uncomplicated CHLOROQUINE,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123729,5/21/2015 00:57:53,1639956997,5/21/2015 00:57:26,false,elite,1.0,32306791,GBR,"","",109.200.26.4,82,46,,,89,57,MALARIA,CHLOROQUINE,falciparum MALARIA Oral: 100 mg,71-82-94-101-105,19-29-46-68-71,Treatment of CHLOROQUINE P. falciparum,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia.",82,46,82,46,-1,89,57,TWrex-cause,804992,"122 ,   123  >     Treatment of Uncomplicated Chloroquine-resistant P. falciparum Malaria  +  Oral:  100 mg twice daily for 7 days; used in conjunction with oral quinine sulfate (650 mg 3 times daily given for 3 days if infection was acquired in Africa or South America or for 7 days if acquired in Southeast Asia",malaria,chloroquine
724123730,5/20/2015 20:45:52,1639861994,5/20/2015 20:45:39,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-49-55,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123730,5/20/2015 21:00:37,1639867884,5/20/2015 21:00:21,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,55,96,,,62,103,DISEASE,VIRUS,fever with renal syndrome arthropod borne viral DISEASE caused by Hanta,0-6-11-33-43-49-55-63-70-73-17,0-6-11-79-85-88-96-17,fever with renal syndrome virus or related VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123730,5/20/2015 21:01:05,1639868087,5/20/2015 21:00:40,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-49-55,96-73,Hanta VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123730,5/20/2015 21:02:22,1639868509,5/20/2015 21:02:08,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-55-49,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123730,5/20/2015 21:04:34,1639869327,5/20/2015 21:04:21,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-49-55,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123730,5/20/2015 21:10:30,1639871326,5/20/2015 21:09:37,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-49-55,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123730,5/20/2015 21:20:04,1639875393,5/20/2015 21:19:50,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-49-55,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123730,5/20/2015 21:25:37,1639877509,5/20/2015 21:24:43,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,55,96,,,62,103,DISEASE,VIRUS,DISEASE,55,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123730,5/20/2015 21:26:26,1639877876,5/20/2015 21:26:10,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,55,96,,,62,103,DISEASE,VIRUS,arthropod - borne viral DISEASE,33-42-43-49-55,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123730,5/20/2015 21:30:05,1639878917,5/20/2015 21:28:59,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,55,96,,,62,103,DISEASE,VIRUS,arthropod borne viral DISEASE,33-43-49-55,96,VIRUSES.,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses.,55,96,55,96,1,62,103,TWrex-cause,810511,fever with renal syndrome     An arthropod-borne viral disease caused by Hanta virus or related viruses,disease,virus
724123731,5/20/2015 20:44:26,1639861497,5/20/2015 20:43:46,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123731,5/20/2015 20:58:34,1639867143,5/20/2015 20:58:07,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123731,5/20/2015 20:59:13,1639867403,5/20/2015 20:58:55,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,93,115,,,97,128,HFR,PUUMALA VIRUS,"Hemorrhagic fever with renal syndrome other hantaviruses causing HFRS are Seoul virus,",0-12-18-23-66-72-85-93-98-102-108-29,51-59-98-102-108-115-123-130-134-142-93,"Hantaan virus, HFRS are Seoul virus, PUUMALA VIRUS, and Dobrava Belgrade","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123731,5/20/2015 21:00:54,1639867996,5/20/2015 21:00:37,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123731,5/20/2015 21:01:54,1639868373,5/20/2015 21:00:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123731,5/20/2015 21:03:01,1639868710,5/20/2015 21:02:44,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123731,5/20/2015 21:18:40,1639874753,5/20/2015 21:18:19,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123731,5/20/2015 21:23:25,1639876752,5/20/2015 21:23:02,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123731,5/20/2015 21:24:27,1639877250,5/20/2015 21:24:12,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,93,115,,,97,128,HFR,PUUMALA VIRUS,HFRS,93,115-123,"PUUMALA VIRUS,","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123731,5/20/2015 21:26:39,1639877909,5/20/2015 21:26:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,93,115,,,97,128,HFR,PUUMALA VIRUS,"Hemorrhagic fever with renal syndrome Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava Belgrade virus.",0-12-18-23-29-40-46-51-59-66-72-85-93-98-102-108-115-123-130-134-142-151,0-12-18-23-29-40-46-51-59-66-72-85-93-98-102-108-115-123-130-134-142-151,"Hemorrhagic fever with renal syndrome Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, PUUMALA VIRUS, and Dobrava Belgrade virus.","Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus.",93,115 123,93,115,1,97,128,TWrex-cause,811229,"Hemorrhagic fever with renal syndrome   Along with Hantaan virus, other hantaviruses causing HFRS are Seoul virus, Puumala virus, and Dobrava/Belgrade virus",Hfr,puumala virus
724123732,5/21/2015 01:06:26,1639961972,5/21/2015 01:06:03,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123732,5/21/2015 01:11:20,1639964970,5/21/2015 01:11:03,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123732,5/21/2015 01:13:03,1639965935,5/21/2015 01:12:45,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123732,5/21/2015 01:49:17,1639986471,5/21/2015 01:48:54,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123732,5/21/2015 02:03:53,1639993372,5/21/2015 02:03:39,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123732,5/21/2015 02:22:23,1640001810,5/21/2015 02:22:00,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123732,5/21/2015 02:26:08,1640003729,5/21/2015 02:25:53,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123732,5/21/2015 02:29:47,1640005577,5/21/2015 02:29:32,false,prodege,1.0,26499212,CAN,ON,Cambridge,70.27.23.230,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123732,5/21/2015 02:30:05,1640005692,5/21/2015 02:29:37,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,"conditions that cause PANCYTOPENIA include hypoplastic myelodysplastic syndrome,",6-17-22-28-41-49-61-77,77-87-93-103,"syndrome, acute leukemia, MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123732,5/21/2015 02:30:11,1640005759,5/21/2015 02:29:48,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,28,103,,,40,118,PANCYTOPENIA,MEGALOBLASTOSIS,PANCYTOPENIA,28,103,"MEGALOBLASTOSIS,","Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia.",28,103,28,103,1,40,118,TWrex-cause,814020,"Other conditions that cause pancytopenia include hypoplastic myelodysplastic syndrome, acute leukemia, megaloblastosis, and large granular lymphocytic leukemia",pancytopenia,megaloblastosis
724123733,5/21/2015 01:07:09,1639962353,5/21/2015 01:06:50,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,37,21,,,41,24,PAIN,RSD,PAIN;,37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123733,5/21/2015 01:12:05,1639965329,5/21/2015 01:11:44,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,37,21,,,41,24,PAIN,RSD,regional PAIN;,37-28,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123733,5/21/2015 01:14:10,1639966601,5/21/2015 01:13:49,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,37,21,,,41,24,PAIN,RSD,PAIN;,37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123733,5/21/2015 01:51:18,1639987332,5/21/2015 01:50:10,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,37,21,,,41,24,PAIN,RSD,PAIN;,37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123733,5/21/2015 02:04:34,1639993738,5/21/2015 02:04:19,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,37,21,,,41,24,PAIN,RSD,PAIN;,37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123733,5/21/2015 02:24:01,1640002699,5/21/2015 02:23:20,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,37,21,,,41,24,PAIN,RSD,RSD PAIN;,21-37,13-21-18,Pain in RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123733,5/21/2015 02:27:15,1640004277,5/21/2015 02:26:57,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,37,21,,,41,24,PAIN,RSD,regional PAIN;,28-37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123733,5/21/2015 02:30:20,1640005804,5/21/2015 02:30:04,false,prodege,1.0,26499212,CAN,ON,Cambridge,70.27.23.230,37,21,,,41,24,PAIN,RSD,Pain in RSD is regional PAIN;,18-21-25-28-37-13,13-18-21-25-28-37,Pain in RSD is regional pain;,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123733,5/21/2015 02:30:53,1640006047,5/21/2015 02:30:34,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,37,21,,,41,24,PAIN,RSD,RSD is regional PAIN;,21-25-28-37,11-13-18-21-25-28-37-142-147,• Pain in RSD is regional pain; pain syndromes.,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123733,5/21/2015 02:33:27,1640007120,5/21/2015 02:32:55,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,37,21,,,41,24,PAIN,RSD,regional PAIN;,28-37,21,RSD,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes.",37,21,37,21,1,41,24,TWrex-cause,813447,"Rationale: • Pain in RSD is regional pain; it does not respect root or nerve territories, distinguishing it from mononeuropathy and radicular pain syndromes",pain,RSD
724123734,5/20/2015 23:25:17,1639911088,5/20/2015 23:25:04,false,prodege,1.0,2145087,USA,"","",40.143.102.85,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,89-94-104,oral clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123734,5/21/2015 00:08:18,1639929767,5/21/2015 00:08:07,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,104,HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123734,5/21/2015 00:10:59,1639930994,5/21/2015 00:10:45,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,104,HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123734,5/21/2015 00:14:14,1639932586,5/21/2015 00:14:04,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,104,HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123734,5/21/2015 00:26:16,1639938505,5/21/2015 00:24:27,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,94-104,clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123734,5/21/2015 00:29:45,1639940354,5/21/2015 00:28:01,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,mild to moderate HYPERTENSION.,121-126-129-138,89-94-104,oral clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123734,5/21/2015 00:38:21,1639945641,5/21/2015 00:38:10,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,mild to moderate HYPERTENSION.,126-129-138-121,89-94-104,oral clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123734,5/21/2015 00:55:44,1639955751,5/21/2015 00:55:20,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,94-104,clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123734,5/21/2015 01:01:01,1639958787,5/21/2015 01:00:40,false,elite,1.0,32306791,GBR,"","",109.200.26.4,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,mild moderate HYPERTENSION.,121-129-138,94-104-118-121-126,clonidine HYDROCHLORIDE in mild to,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123734,5/21/2015 01:05:00,1639961079,5/21/2015 01:04:40,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,138,104,,,150,117,HYPERTENSION,HYDROCHLORIDE,HYPERTENSION.,138,89-94-104,oral clonidine HYDROCHLORIDE,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension.",138,104,138,104,-1,150,117,TWrex-cause,800267,"106 ,   110 ,   115 ,   118  Transdermal clonidine has been successfully substituted for oral clonidine hydrochloride in mild to moderate hypertension",hypertension,hydrochloride
724123735,5/20/2015 22:27:07,1639889828,5/20/2015 22:26:51,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123735,5/20/2015 22:40:43,1639894626,5/20/2015 22:39:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123735,5/20/2015 22:41:52,1639895101,5/20/2015 22:41:16,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,clinically significant HEMORRHAGE,52-63-75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123735,5/20/2015 22:52:07,1639898651,5/20/2015 22:51:40,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant HEMORRHAGE or thrombosis,",0-3-5-13-18-28-44-48-52-63-75-86-89,3-5-13-18-28-44-48-52-63-75-86-89-0,"In a patient with ESSENTIAL THROMBOCYTHEMIA who has clinically significant hemorrhage or thrombosis,","In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123735,5/20/2015 22:56:11,1639900100,5/20/2015 22:55:25,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,has clinically significant HEMORRHAGE,48-52-63-75,18-28-44-48-52-75-63,ESSENTIAL THROMBOCYTHEMIA who has clinically significant hemorrhage,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123735,5/20/2015 23:12:06,1639906590,5/20/2015 23:11:00,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,essential thrombocythemia HEMORRHAGE,18-28-75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123735,5/20/2015 23:21:30,1639909261,5/20/2015 23:21:11,false,prodege,1.0,2145087,USA,"","",40.143.102.85,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123735,5/21/2015 00:03:47,1639927731,5/21/2015 00:03:25,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123735,5/21/2015 00:04:30,1639928051,5/21/2015 00:04:13,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123735,5/21/2015 00:12:15,1639931619,5/21/2015 00:10:30,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,75,18,,,85,43,HEMORRHAGE,ESSENTIAL THROMBOCYTHEMIA,HEMORRHAGE,75,18-28,ESSENTIAL THROMBOCYTHEMIA,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count.",75,18 28,75,18,1,85,43,TWrex-cause,813035,"In a patient with essential thrombocythemia who has clinically significant hemorrhage or thrombosis, good control of the platelet count can be achieved with oral hydroxyurea (15 mg/kg/day), with adjustments in the dosage as needed to lower the platelet count",hemorrhage,essential thrombocythemia
724123736,5/20/2015 22:21:15,1639887809,5/20/2015 22:20:46,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA,0-12,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123736,5/20/2015 22:29:57,1639890734,5/20/2015 22:29:09,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method LH,0-12-23-31,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123736,5/20/2015 22:35:19,1639892726,5/20/2015 22:34:47,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA,0-12,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123736,5/20/2015 22:39:59,1639894364,5/20/2015 22:39:39,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,AMENORRHEA medroxyprogesterone acetate,12-65-85,65-85-12,amenorrhea MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123736,5/20/2015 22:40:04,1639894402,5/20/2015 22:39:53,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method,0-12-23,65-85,MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123736,5/20/2015 22:43:12,1639895613,5/20/2015 22:42:46,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method LH luteinizing hormone MPA medroxyprogesterone acetate OR odds ratio PE pulmonary embolism PID,0-12-23-31-37-49-58-65-85-94-100-105-112-118-138-128,37-49-58-65-85-94-100-105-112,luteinizing hormone MPA MEDROXYPROGESTERONE ACETATE OR odds ratio PE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123736,5/20/2015 22:50:20,1639898162,5/20/2015 22:49:51,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method LH,0-12-23-31,37-49-58-65-85,luteinizing hormone MPA MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123736,5/20/2015 23:01:07,1639902108,5/20/2015 23:00:14,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA,0-12,0-65-85-12,lactational amenorrhea MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123736,5/20/2015 23:18:37,1639908385,5/20/2015 23:18:12,false,prodege,1.0,2145087,USA,"","",40.143.102.85,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA,0-12,37-49-58-65-85,luteinizing hormone MPA MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123736,5/20/2015 23:35:45,1639915977,5/20/2015 23:35:31,false,clixsense,1.0,21933552,CAN,ON,Ottawa,70.49.14.161,12,65,,,22,92,AMENORRHEA,MEDROXYPROGESTERONE ACETATE,lactational AMENORRHEA method,0-12-23,58-65-85,MPA MEDROXYPROGESTERONE ACETATE,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism.",12,65 85,12,65,-1,22,92,TWrex-cause,804447,"lactational amenorrhea method  LH  - luteinizing hormone  MPA  - medroxyprogesterone acetate  OR  - odds ratio  PE  - pulmonary embolism  PID  - pelvic inflammatory disease  POC  - progestin-only contraceptive pill  RR  - risk ratio  STD  - sexually transmitted disease  STI  - sexually transmitted infection  TOP  - termination of pregnancy, medical abortion  TSS  - toxic shock syndrome  UTI  - urinary tract infection  VTE  - venous thromboembolism",amenorrhea,medroxyprogesterone acetate
724123737,5/20/2015 22:54:38,1639899537,5/20/2015 22:54:26,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS in elective cancer surgery:,86-91-96-107-110-119-126,13-17-24-27-38-45-60-4,Efficacy and safety of ENOXAPARIN versus unfractionated heparin,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123737,5/20/2015 23:01:37,1639902249,5/20/2015 23:00:57,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,of deep vein THROMBOSIS,83-86-91-96,13-17-24-27,and safety of ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123737,5/20/2015 23:23:42,1639910174,5/20/2015 23:23:16,false,prodege,1.0,2145087,USA,"","",40.143.102.85,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123737,5/20/2015 23:24:16,1639910549,5/20/2015 23:23:41,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27-86-91-96,ENOXAPARIN deep vein thrombosis,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123737,5/21/2015 00:06:01,1639928808,5/21/2015 00:05:47,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123737,5/21/2015 00:08:50,1639930039,5/21/2015 00:08:38,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123737,5/21/2015 00:12:43,1639931921,5/21/2015 00:12:30,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123737,5/21/2015 00:18:35,1639934808,5/21/2015 00:17:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123737,5/21/2015 00:19:53,1639935575,5/21/2015 00:17:37,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123737,5/21/2015 00:36:16,1639944226,5/21/2015 00:34:52,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,96,27,,,106,37,THROMBOSIS,ENOXAPARIN,deep vein THROMBOSIS,86-91-96,27,ENOXAPARIN,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment.,96,27,96,27,-1,106,37,TWrex-cause,804767,1]  Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment,thrombosis,enoxaparin
724123738,5/21/2015 01:16:34,1639967971,5/21/2015 01:16:17,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123738,5/21/2015 01:56:19,1639989757,5/21/2015 01:55:36,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123738,5/21/2015 02:06:32,1639994659,5/21/2015 02:06:20,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123738,5/21/2015 02:27:05,1640004180,5/21/2015 02:26:33,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132-15,stones calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123738,5/21/2015 02:29:40,1640005551,5/21/2015 02:29:25,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123738,5/21/2015 02:33:34,1640007191,5/21/2015 02:33:12,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,64,132,,,70,141,STONE,PHOSPHATE,80% of calcium STONES are composed mostly,49-53-56-64-71-75-84,49-53-56-64-71-75-84-124-132,80% of calcium stones are composed mostly calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123738,5/21/2015 02:38:40,1640009839,5/21/2015 02:38:24,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123738,5/21/2015 04:04:47,1640049713,5/21/2015 04:04:30,false,gifthunterclub,1.0,30901412,GBR,I3,Chatham,85.210.119.173,64,132,,,70,141,STONE,PHOSPHATE,80% of calcium STONES are composed mostly calcium oxalate;,49-53-56-64-71-75-84-94-102,56-115-120-124-132-64,calcium stones rest are calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123738,5/21/2015 04:08:09,1640050800,5/21/2015 04:07:22,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,64,132,,,70,141,STONE,PHOSPHATE,about 80% of calcium STONES are composed mostly of calcium oxalate;,43-49-53-56-64-71-75-84-91-94-102,43-49-53-56-64-71-75-91-94-102-115-120-124-132-111,about 80% of calcium stones are composed of calcium oxalate; the rest are calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123738,5/21/2015 04:08:54,1640051059,5/21/2015 04:08:46,false,bitcoinget,1.0,21614812,USA,PA,Erie,174.100.250.115,64,132,,,70,141,STONE,PHOSPHATE,calcium STONES,56-64,124-132,calcium PHOSPHATE.,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate.",64,132,64,132,-1,70,141,TWrex-cause,803070,"• About 80% of stones contain calcium, and about 80% of calcium stones are composed mostly of calcium oxalate; the rest are calcium phosphate",stone,phosphate
724123739,5/20/2015 22:18:48,1639887042,5/20/2015 22:18:03,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME, 1 2 93",90-98-106-117-123-129,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123739,5/20/2015 22:19:17,1639887157,5/20/2015 22:18:39,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123739,5/20/2015 22:26:34,1639889663,5/20/2015 22:25:48,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123739,5/20/2015 22:33:03,1639891827,5/20/2015 22:32:36,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123739,5/20/2015 22:37:18,1639893408,5/20/2015 22:36:48,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"Serious cutaneous reactions, including STEVENS JOHNSON SYNDROME, 1 2 93 99 erythema multiforme.",59-69-80-90-98-106-117-123-129-136-141-150-51,0-12-23-40-51-59-69-80-90-98-106-117-123-129-136-141-150,"Sensitivity Reactions HYPERSENSITIVITY REACTIONS Serious cutaneous reactions, including Stevens Johnson syndrome, 1 2 93 99 erythema multiforme.","Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123739,5/20/2015 22:38:42,1639893878,5/20/2015 22:38:21,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME, erythema multiforme.",90-98-106-141-150,23-40-141-150,HYPERSENSITIVITY REACTIONS erythema multiforme.,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123739,5/20/2015 22:39:10,1639894074,5/20/2015 22:38:57,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123739,5/20/2015 22:48:39,1639897486,5/20/2015 22:47:45,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"cutaneous reactions, including STEVENS JOHNSON SYNDROME,",59-69-80-90-98-106,0-12-23-40,Sensitivity Reactions HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123739,5/20/2015 22:51:39,1639898582,5/20/2015 22:49:05,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"including STEVENS JOHNSON SYNDROME,",90-98-106-80,23-40,HYPERSENSITIVITY REACTIONS,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123739,5/20/2015 22:57:15,1639900559,5/20/2015 22:56:22,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,90,23,,,114,49,STEVENS JOHNSON SYNDROME,HYPERSENSITIVITY REACTION,"STEVENS JOHNSON SYNDROME,",90-98-106,23-40-90-98-106,"HYPERSENSITIVITY REACTIONS Stevens Johnson syndrome,","Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme.",90 98 106,23 40,90,23,1,114,49,TWrex-cause,815002,"Sensitivity Reactions  Hypersensitivity Reactions  Serious cutaneous reactions, including Stevens-Johnson syndrome,  1 ,   2 ,   93 ,   99   erythema multiforme",stevens johnson syndrome,hypersensitivity reaction
724123740,5/20/2015 20:48:07,1639862980,5/20/2015 20:47:52,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,of BLASTOMYCOSIS.,130-133,37-50,AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123740,5/20/2015 21:04:14,1639869230,5/20/2015 21:03:51,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,37-50,AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123740,5/20/2015 21:05:51,1639869628,5/20/2015 21:05:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,37-50,AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123740,5/20/2015 21:07:48,1639870453,5/20/2015 21:07:34,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,21-34-37-50,Conventional IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123740,5/20/2015 21:22:26,1639876459,5/20/2015 21:22:12,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,21-34-37-50,Conventional IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123740,5/20/2015 21:26:45,1639877949,5/20/2015 21:25:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,37-50,AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123740,5/20/2015 21:33:29,1639880099,5/20/2015 21:33:14,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,21-34-37-50,Conventional IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123740,5/20/2015 21:35:44,1639880981,5/20/2015 21:35:27,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,37-50,AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123740,5/20/2015 21:36:53,1639881267,5/20/2015 21:36:35,false,prodege,1.0,19907188,USA,MI,Adrian,50.37.37.250,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,21-34-37-50,Conventional IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123740,5/20/2015 21:59:22,1639882277,5/20/2015 21:56:46,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,133,37,,,146,51,BLASTOMYCOSIS,AMPHOTERICIN B,BLASTOMYCOSIS.,133,34-37-50,IV AMPHOTERICIN B,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis.",133,37 50,133,37,-1,146,51,TWrex-cause,800848,"291 ,   424 ,   436  Conventional IV amphotericin B or a lipid formulation of IV amphotericin B can be used for initial treatment of blastomycosis",blastomycosis,amphotericin b
724123741,5/20/2015 20:41:30,1639860426,5/20/2015 20:41:16,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,35-41-43-53-68,toxin 1 producing STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123741,5/20/2015 20:53:34,1639865323,5/20/2015 20:52:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53-68,STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123741,5/20/2015 20:55:03,1639865883,5/20/2015 20:54:37,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53-68,STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123741,5/20/2015 20:55:40,1639866095,5/20/2015 20:55:31,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,Prevalence of TOXIC SHOCK SYNDROME toxin 1 producing,0-11-14-20-26-35-41-43,35-41-43-53-68,toxin 1 producing STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123741,5/20/2015 20:56:22,1639866383,5/20/2015 20:55:57,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,Prevalence of TOXIC SHOCK SYNDROME Staphylococcus menstruating women.,0-11-14-20-26-53-143-130,35-41-43-53-68-75-79-83-92-95-127-130-143,toxin 1 producing STAPHYLOCOCCUS aureus and the presence of antibodies in menstruating women.,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123741,5/20/2015 20:58:54,1639867266,5/20/2015 20:57:14,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53,STAPHYLOCOCCUS,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123741,5/20/2015 21:00:58,1639868027,5/20/2015 21:00:37,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53-68,STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123741,5/20/2015 21:03:07,1639868774,5/20/2015 21:02:57,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,53,STAPHYLOCOCCUS,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123741,5/20/2015 21:16:47,1639873971,5/20/2015 21:16:17,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,35-41-43-53-68,toxin 1 producing STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123741,5/20/2015 21:20:52,1639875787,5/20/2015 21:20:21,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,14,53,,,34,67,TOXIC SHOCK SYNDROME,STAPHYLOCOCCUS,TOXIC SHOCK SYNDROME,14-20-26,35-41-43-53-68,toxin 1 producing STAPHYLOCOCCUS aureus,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.,14 20 26,53,14,53,1,34,67,TWrex-cause,810489,Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women,toxic shock syndrome,staphylococcus
724123742,5/20/2015 23:26:21,1639911609,5/20/2015 23:26:07,false,prodege,1.0,2145087,USA,"","",40.143.102.85,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123742,5/21/2015 00:09:06,1639930141,5/21/2015 00:08:53,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123742,5/21/2015 00:12:27,1639931801,5/21/2015 00:12:15,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123742,5/21/2015 00:15:06,1639933034,5/21/2015 00:14:42,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123742,5/21/2015 00:30:19,1639940652,5/21/2015 00:28:33,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123742,5/21/2015 00:33:12,1639942101,5/21/2015 00:32:04,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123742,5/21/2015 00:39:07,1639946126,5/21/2015 00:38:53,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123742,5/21/2015 00:56:42,1639956350,5/21/2015 00:56:26,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123742,5/21/2015 01:01:53,1639959355,5/21/2015 01:01:43,false,elite,1.0,32306791,GBR,"","",109.200.26.4,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,treating PULMONARY TUBERCULOSIS.,86-95-105,21-24-31-43-47-57,CW et RIFAPENTINE and isoniazid in,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123742,5/21/2015 01:06:16,1639961836,5/21/2015 01:05:57,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,95,31,,,117,42,PULMONARY TUBERCULOSIS,RIFAPENTINE,PULMONARY TUBERCULOSIS.,95-105,31,RIFAPENTINE,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis.",95 105,31,95,31,-1,117,42,TWrex-cause,800362,"Tam CM, Chan SL, Lam CW et al. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis",pulmonary tuberculosis,rifapentine
724123743,5/20/2015 20:40:09,1639859782,5/20/2015 20:39:36,false,neodev,1,30321275,USA,NV,Las Vegas,192.30.80.4,66,48,,,74,55,DIABETES,INSULIN,and dependent DIABETES mellitus 1 31,44-56-66-75-85-91,34-38-44-48-66-75,", 167 and INSULIN diabetes mellitus","1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123743,5/20/2015 20:40:13,1639859823,5/20/2015 20:39:56,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48-56-66-75,INSULIN dependent diabetes mellitus,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123743,5/20/2015 20:46:14,1639862171,5/20/2015 20:45:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48-66-75-56,INSULIN dependent diabetes mellitus,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123743,5/20/2015 20:51:32,1639864511,5/20/2015 20:50:32,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48-56-66-75,INSULIN dependent diabetes mellitus,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123743,5/20/2015 20:54:15,1639865635,5/20/2015 20:53:48,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48-56-66-75,INSULIN dependent diabetes mellitus,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123743,5/20/2015 20:54:37,1639865780,5/20/2015 20:54:03,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus 1 31 has occurred with or without hypoglycemia,48-56-66-75-85-91-170-174-183-188-191-209,34-38-44-48-56-66-75-209,", 167 and INSULIN dependent diabetes mellitus hypoglycemia","1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123743,5/20/2015 20:55:38,1639866074,5/20/2015 20:55:18,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,66,48,,,74,55,DIABETES,INSULIN,DIABETES mellitus,66-75,34-48,", INSULIN","1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123743,5/20/2015 20:56:04,1639866289,5/20/2015 20:55:41,false,instagc,1.0,23032978,USA,PA,Philadelphia,76.98.187.59,66,48,,,74,55,DIABETES,INSULIN,and insulin dependent DIABETES mellitus 1 31,44-48-56-66-75-85-91,34-38-44-48-56-66-75,", 167 and INSULIN dependent diabetes mellitus","1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123743,5/20/2015 20:59:27,1639867430,5/20/2015 20:59:07,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES,48-56-66,34-48-56-66,", INSULIN dependent diabetes","1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123743,5/20/2015 21:02:41,1639868615,5/20/2015 21:01:09,false,fusioncash,1.0,31248728,USA,FL,Alachua,174.131.50.169,66,48,,,74,55,DIABETES,INSULIN,insulin dependent DIABETES mellitus,48-56-66-75,48-56-66-75,INSULIN dependent diabetes mellitus,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy.",66,48,66,48,-1,74,55,TWrex-cause,800111,"1  Hyperglycemia  1 ,   81 ,   83 ,   167   and insulin-dependent diabetes mellitus  1 ,   31 ,   35 ,   52 ,   275   (which appears to be permanent in some cases)  52   has occurred with or without preceding hypoglycemia  1 ,   275   and ketoacidosis  1   in patients receiving parenteral therapy   31 ,   52   or oral inhalation of the drug;  275   these adverse effects sometimes occurred several months after discontinuance of parenteral therapy",diabetes,insulin
724123744,5/20/2015 22:24:57,1639889114,5/20/2015 22:24:26,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,0-6,116,ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123744,5/20/2015 22:35:49,1639892886,5/20/2015 22:35:02,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,0-6,116,ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123744,5/20/2015 22:38:25,1639893762,5/20/2015 22:37:59,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,6-0,102-111-116,isolated from ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123744,5/20/2015 22:45:25,1639896341,5/20/2015 22:45:06,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,6,116,,,15,121,POISONING,ERGOT,ergot POISONING SEE: under poisoning ergotrate audio,0-6-19-24-32-45-73,82-92-102-111-116-85,An active principle isolated from ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123744,5/20/2015 22:53:36,1639899199,5/20/2015 22:52:57,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,6,116,,,15,121,POISONING,ERGOT,POISONING SEE: under poisoning ergotrate,6-19-24-32-45,92-102-111-116,principle isolated from ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123744,5/20/2015 23:06:55,1639904388,5/20/2015 23:06:26,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,0-6,0-6-116,ergot poisoning ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123744,5/20/2015 23:20:07,1639908770,5/20/2015 23:19:57,false,prodege,1.0,2145087,USA,"","",40.143.102.85,6,116,,,15,121,POISONING,ERGOT,POISONING,6,116,ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123744,5/20/2015 23:36:57,1639916456,5/20/2015 23:36:49,false,clixsense,1.0,21933552,CAN,ON,Ottawa,70.49.14.161,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,0-6,116,ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123744,5/21/2015 00:00:35,1639926407,5/20/2015 23:59:54,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,6,116,,,15,121,POISONING,ERGOT,ergot POISONING,6-0,116,ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123744,5/21/2015 00:02:02,1639927017,5/21/2015 00:01:28,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,6,116,,,15,121,POISONING,ERGOT,POISONING An active principle isolated from ergot.,6-82-85-92-102-111-116,92-102-111-116-85,active principle isolated from ERGOT.,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot.,6,116,6,116,1,15,121,TWrex-cause,812173,ergot poisoning    SEE: under   poisoning    ergotrate    (              audio )  An active principle isolated from ergot,poisoning,ergot
724123745,5/20/2015 20:45:19,1639861783,5/20/2015 20:45:05,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123745,5/20/2015 21:00:04,1639867661,5/20/2015 20:59:44,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123745,5/20/2015 21:00:06,1639867700,5/20/2015 20:59:53,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia shows paroxysmal supraventricular TACHYCARDIA from AV nodal,0-11-54-60-71-88-100-105-108-28,0-11-28-40-42-45-54-60-71-88,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA A 12 lead shows paroxysmal supraventricular tachycardia,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123745,5/20/2015 21:01:46,1639868344,5/20/2015 21:01:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,TACHYCARDIA,88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123745,5/20/2015 21:03:59,1639869145,5/20/2015 21:03:37,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,71-88-60,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123745,5/20/2015 21:08:43,1639870788,5/20/2015 21:08:29,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123745,5/20/2015 21:19:31,1639875105,5/20/2015 21:19:18,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123745,5/20/2015 21:24:18,1639877181,5/20/2015 21:24:03,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123745,5/20/2015 21:25:41,1639877570,5/20/2015 21:24:57,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,paroxysmal supraventricular TACHYCARDIA,60-71-88,0-11-28,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123745,5/20/2015 21:29:47,1639878852,5/20/2015 21:28:32,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,88,0,,,99,39,TACHYCARDIA,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA,Paroxysmal Supraventricular Tachycardia A 12 lead ECG shows paroxysmal supraventricular TACHYCARDIA from AV nodal reentry (AVNRT.,0-11-28-40-42-45-50-54-60-71-88-100-105-108-114-122,0-11-28-40-42-45-50-54-60-71-88-100-105-108-114-122,PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA A 12 lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT.,88,0 11 28,88,0,1,99,39,TWrex-cause,814389,Paroxysmal Supraventricular Tachycardia A 12-lead ECG shows paroxysmal supraventricular tachycardia from AV nodal reentry (AVNRT,tachycardia,paroxysmal supraventricular tachycardia
724123746,5/20/2015 21:37:35,1639881522,5/20/2015 21:37:19,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,14,"PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123746,5/20/2015 22:14:29,1639885636,5/20/2015 22:14:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,"Avoid using podophyllin, podophyllotoxin, and imiquimod during PREGNANCY.",2-8-14-44-48-58-65-27,0-2-8-14-27-44-48-58-65,"• Avoid using PODOPHYLLIN, podophyllotoxin, and imiquimod during pregnancy.","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123746,5/20/2015 22:15:07,1639885799,5/20/2015 22:14:35,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,0-14,"• PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123746,5/20/2015 22:16:44,1639886365,5/20/2015 22:16:21,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,0-14,"• PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123746,5/20/2015 22:22:20,1639888149,5/20/2015 22:21:32,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,14,"PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123746,5/20/2015 22:30:11,1639890816,5/20/2015 22:29:47,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,0-2-8-14,"• Avoid using PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123746,5/20/2015 22:33:25,1639891949,5/20/2015 22:33:17,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,0-14,"• PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123746,5/20/2015 22:34:42,1639892439,5/20/2015 22:33:34,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,0-14,"• PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123746,5/20/2015 22:34:46,1639892504,5/20/2015 22:34:27,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,"podophyllin, podophyllotoxin, and imiquimod during PREGNANCY.",14-44-48-58-65-27,0-2-8-14-27-44-48-58-65,"• Avoid using PODOPHYLLIN, podophyllotoxin, and imiquimod during pregnancy.","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123746,5/20/2015 22:35:44,1639892858,5/20/2015 22:34:13,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,65,14,,,74,25,PREGNANCY,PODOPHYLLIN,PREGNANCY.,65,14,"PODOPHYLLIN,","• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy.",65,14,65,14,-1,74,25,TWrex-cause,803297,"• Avoid using podophyllin, podophyllotoxin, and imiquimod during pregnancy",pregnancy,podophyllin
724123747,5/20/2015 22:27:46,1639890037,5/20/2015 22:27:30,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,TUBERCULOSIS,41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123747,5/20/2015 22:42:32,1639895368,5/20/2015 22:41:29,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary and Extrapulmonary TUBERCULOSIS,12-22-26-41,123-130-137-151-105,"antimycobacterial agents (e.g., streptomycin, ISONIAZID)","b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123747,5/20/2015 22:42:53,1639895492,5/20/2015 22:42:28,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Extrapulmonary TUBERCULOSIS,26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123747,5/20/2015 22:52:51,1639898969,5/20/2015 22:52:28,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Advanced Pulmonary and Extrapulmonary TUBERCULOSIS Systemically as adjunctive therapy,3-12-22-26-41-55-68-71-82,105-123-130-137-151-162-165-174-189-197-200-204-211-224-233-236-240,"antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus","b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123747,5/20/2015 22:57:11,1639900526,5/20/2015 22:56:35,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary and Extrapulmonary TUBERCULOSIS,12-22-26-41,123-130-137-151-162-165-174,"agents (e.g., streptomycin, ISONIAZID) to suppress manifestations","b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123747,5/20/2015 23:15:10,1639907571,5/20/2015 23:13:17,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary Extrapulmonary TUBERCULOSIS,12-26-41,151-251-265-319-332-347,ISONIAZID) Mycobacterium tuberculosis pulmonary extrapulmonary tuberculosis.,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123747,5/20/2015 23:21:55,1639909400,5/20/2015 23:21:42,false,prodege,1.0,2145087,USA,"","",40.143.102.85,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Extrapulmonary TUBERCULOSIS,26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123747,5/21/2015 00:04:25,1639928035,5/21/2015 00:04:08,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Pulmonary and Extrapulmonary TUBERCULOSIS,12-22-26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123747,5/21/2015 00:05:32,1639928537,5/21/2015 00:04:50,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,b Advanced Pulmonary and Extrapulmonary TUBERCULOSIS,3-12-22-26-41-0,95-105-151-123,effective antimycobacterial agents ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123747,5/21/2015 00:11:11,1639931106,5/21/2015 00:10:54,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,41,151,,,53,160,TUBERCULOSIS,ISONIAZID,Extrapulmonary TUBERCULOSIS,26-41,151,ISONIAZID),"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",41,151,41,151,-1,53,160,TWrex-cause,804350,"b  Advanced Pulmonary and Extrapulmonary Tuberculosis  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, isoniazid) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis",tuberculosis,isoniazid
724123748,5/21/2015 00:40:49,1639947103,5/21/2015 00:40:36,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123748,5/21/2015 01:04:53,1639960997,5/21/2015 01:04:22,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123748,5/21/2015 01:10:08,1639964311,5/21/2015 01:09:51,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123748,5/21/2015 01:11:33,1639965051,5/21/2015 01:11:09,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123748,5/21/2015 01:46:48,1639985260,5/21/2015 01:46:31,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123748,5/21/2015 02:02:50,1639992817,5/21/2015 02:02:32,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123748,5/21/2015 02:20:48,1640001139,5/21/2015 02:19:43,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,343,212,,,352,220,PREGNANCY,WARFARIN,Exclusion criteria PREGNANCY,10-343-0,0-212-10,Exclusion criteria WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123748,5/21/2015 02:24:45,1640002929,5/21/2015 02:24:21,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY,343,212,WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123748,5/21/2015 02:28:45,1640005129,5/21/2015 02:28:19,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY or planning pregnancy;,343-353-356-365,192-209-212-222-234,contraindication to WARFARIN; objectively confirmed,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123748,5/21/2015 02:28:46,1640005139,5/21/2015 02:28:31,false,prodege,1.0,26499212,CAN,ON,Cambridge,70.27.23.230,343,212,,,352,220,PREGNANCY,WARFARIN,PREGNANCY or planning pregnancy;,343-353-356-365,182-184-192-209-212,3 months; contraindication to WARFARIN;,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up.",343,212,343,212,-1,352,220,TWrex-cause,803294,"Exclusion criteria were IgM anticardiolipin antibodies only; clinically significant bleeding diathesis; intracranial hemorrhage, stroke, or gastrointestinal bleeding in the previous 3 months; contraindication to warfarin; objectively confirmed recurrent thrombosis while receiving warfarin (target international normalized ratio [INR] ≥ 2.0); pregnancy or planning pregnancy; or geographic location that would prevent follow-up",pregnancy,warfarin
724123749,5/21/2015 01:15:32,1639967426,5/21/2015 01:15:08,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,12,IRON,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123749,5/21/2015 01:53:03,1639988099,5/21/2015 01:52:34,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,3-12-17,negative IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123749,5/21/2015 02:05:46,1639994268,5/21/2015 02:05:31,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,12,IRON,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123749,5/21/2015 02:25:37,1640003473,5/21/2015 02:25:12,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,12-45-56,IRON deficiency anemia,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123749,5/21/2015 02:28:48,1640005151,5/21/2015 02:28:30,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,3-12-17,negative IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123749,5/21/2015 02:32:22,1640006732,5/21/2015 02:31:59,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,"balance persists, then IRON DEFICIENCY ANEMIA",17-25-35-40-45-56,0-3-12-17-25-56-45,"If negative IRON balance persists, deficiency anemia","If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123749,5/21/2015 02:35:04,1640008042,5/21/2015 02:34:43,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,40-45-56,3-12-17,negative IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123749,5/21/2015 03:24:44,1640032445,5/21/2015 03:24:29,false,elite,1.0,31848723,USA,GA,Atlanta,209.191.162.15,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,"balance persists, then IRON DEFICIENCY ANEMIA is the result.",17-25-35-40-45-56-63-66-70,0-12-17,If IRON balance,"If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123749,5/21/2015 04:03:52,1640049383,5/21/2015 04:03:30,false,gifthunterclub,1.0,30901412,GBR,I3,Chatham,85.210.119.173,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,"negative iron balance persists, then IRON DEFICIENCY ANEMIA is the result.",3-17-25-35-40-45-56-63-66-70-12,0-3-12-17-25-35-40-45-56-70,"If negative IRON balance persists, then iron deficiency anemia result.","If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123749,5/21/2015 04:04:54,1640049728,5/21/2015 04:04:24,false,neodev,1.0,32216655,NLD,07,Amsterdam,145.100.72.168,40,12,,,62,16,IRON DEFICIENCY ANEMIA,IRON,"If negative iron balance persists, then IRON DEFICIENCY ANEMIA is the result.",0-3-17-25-35-40-45-56-63-66-70-12,0-3-12-17-25-35-40-45-56-63-66-70,"If negative IRON balance persists, then iron deficiency anemia is the result.","If negative iron balance persists, then iron deficiency anemia is the result.",40 45 56,12,40,12,-1,62,16,TWrex-cause,804416,"If negative iron balance persists, then iron deficiency anemia is the result",iron deficiency anemia,iron
724123750,5/20/2015 22:27:29,1639889966,5/20/2015 22:27:07,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,122-127-132,high dose ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123750,5/20/2015 22:41:29,1639894891,5/20/2015 22:40:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,132,ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123750,5/20/2015 22:42:26,1639895311,5/20/2015 22:41:56,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,198,132,,,200,139,MI,ASPIRIN,myocardial infarction,175-186,122-127-132,high dose ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123750,5/20/2015 22:52:26,1639898784,5/20/2015 22:52:09,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI), and death after CE.",175-186-197-203-207-213-219,119-122-127-132-140-144-153-167-175-186-197-203-207-213-219,"as high dose ASPIRIN for reducing perioperative stroke, myocardial infarction (MI), and death after CE.","PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123750,5/20/2015 22:56:35,1639900248,5/20/2015 22:56:12,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI), death",175-186-197-207,119-122-127-132-140-144-153,as high dose ASPIRIN for reducing perioperative,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123750,5/20/2015 23:13:13,1639907103,5/20/2015 23:12:12,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,198,132,,,200,139,MI,ASPIRIN,"carotid endarterectomy myocardial infarction (MI),",57-65-175-186-197,57-65-80-132,"carotid endarterectomy (CE), ASPIRIN","PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123750,5/20/2015 23:21:41,1639909293,5/20/2015 23:21:31,false,prodege,1.0,2145087,USA,"","",40.143.102.85,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,119-122-127-132,as high dose ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123750,5/21/2015 00:04:07,1639927948,5/21/2015 00:03:48,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,132,ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123750,5/21/2015 00:04:49,1639928179,5/21/2015 00:04:31,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,198,132,,,200,139,MI,ASPIRIN,"myocardial infarction (MI),",175-186-197,132,ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123750,5/21/2015 00:10:53,1639930982,5/21/2015 00:10:39,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,198,132,,,200,139,MI,ASPIRIN,"(MI),",197,132,ASPIRIN,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE.",,132,198,132,-1,200,139,TWrex-cause,800454,"PubMed ID: 10392981  QUESTION  In patients scheduled for carotid endarterectomy (CE), is low-dose aspirin as effective as high-dose aspirin for reducing perioperative stroke, myocardial infarction (MI), and death after CE",mi,aspirin
724123751,5/20/2015 23:24:17,1639910561,5/20/2015 23:24:01,false,prodege,1.0,2145087,USA,"","",40.143.102.85,105,70,,,110,72,FEVER,PC,in hospital FEVER,93-96-105,64-70,"Block PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123751,5/20/2015 23:27:06,1639912024,5/20/2015 23:25:53,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,105,70,,,110,72,FEVER,PC,FEVER cardiac surgery.,105-121-129,70-105-121-129,"PC, fever cardiac surgery.","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123751,5/21/2015 00:06:29,1639928986,5/21/2015 00:06:14,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,105,70,,,110,72,FEVER,PC,FEVER,105,64-70,"Block PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123751,5/21/2015 00:09:23,1639930249,5/21/2015 00:09:09,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,105,70,,,110,72,FEVER,PC,FEVER,105,61-70,"J, PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123751,5/21/2015 00:13:21,1639932223,5/21/2015 00:12:57,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,105,70,,,110,72,FEVER,PC,FEVER,105,70,"PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123751,5/21/2015 00:20:44,1639935881,5/21/2015 00:18:50,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,105,70,,,110,72,FEVER,PC,FEVER,105,64-70,"Block PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123751,5/21/2015 00:22:45,1639936789,5/21/2015 00:21:03,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,105,70,,,110,72,FEVER,PC,in hospital FEVER,93-96-105,70,"PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123751,5/21/2015 00:37:23,1639945018,5/21/2015 00:36:44,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,105,70,,,110,72,FEVER,PC,in hospital FEVER,93-96-105,64-70,"Block PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123751,5/21/2015 00:54:06,1639954798,5/21/2015 00:53:40,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,105,70,,,110,72,FEVER,PC,FEVER,105,70,"PC,","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123751,5/21/2015 00:55:59,1639955921,5/21/2015 00:55:02,false,elite,1.0,32306791,GBR,"","",109.200.26.4,105,70,,,110,72,FEVER,PC,Unexplained FEVER cardiac surgery.,81-105-121-129,54-61-70-74-77-81,"Newell J, PC, et al. Unexplained","1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery.",105,70,105,70,1,110,72,TWrex-cause,812740,"1]  Livelli FD Jr, Johnson RA, McEnany MT, Sherman E, Newell J, Block PC, et al. Unexplained in-hospital fever following cardiac surgery",fever,pc
724123752,5/20/2015 20:47:36,1639862775,5/20/2015 20:47:16,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,116-128-138,recombinant consensus INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123752,5/20/2015 21:03:24,1639868886,5/20/2015 21:03:02,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,138,INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123752,5/20/2015 21:04:54,1639869456,5/20/2015 21:04:37,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,138,INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123752,5/20/2015 21:07:15,1639870350,5/20/2015 21:06:54,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,138,INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123752,5/20/2015 21:20:50,1639875769,5/20/2015 21:18:24,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,116-128-138,recombinant consensus INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123752,5/20/2015 21:21:55,1639876195,5/20/2015 21:21:39,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,116-128-138,recombinant consensus INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123752,5/20/2015 21:32:42,1639879796,5/20/2015 21:32:19,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,116-128-138,recombinant consensus INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123752,5/20/2015 21:35:00,1639880727,5/20/2015 21:34:37,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,116-128-138,recombinant consensus INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123752,5/20/2015 21:36:13,1639881098,5/20/2015 21:34:37,false,prodege,1.0,19907188,USA,MI,Adrian,50.37.37.250,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,HAIRY CELL LEUKEMIA,49-55-60,116-128-138,recombinant consensus INTERFERON,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123752,5/20/2015 21:37:00,1639881296,5/20/2015 21:35:45,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,49,138,,,68,148,HAIRY CELL LEUKEMIA,INTERFERON,Treatment of HAIRY CELL LEUKEMIA with granulocyte colony - stimulating factor and recombinant consensus interferon or recombinant interferon - alpha - 2b.,36-46-49-55-60-69-74-86-93-105-112-116-128-138-149-152-164-174-175-180-181-92,36-46-49-55-60-69-74-86-92-93-105-112-116-128-138-149-152-164-174-175-181-180,Treatment of hairy cell leukemia with granulocyte colony - stimulating factor and recombinant consensus INTERFERON or recombinant interferon - alpha - 2b.,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.",49 55 60,138,49,138,-1,68,148,TWrex-cause,803921,"Glaspy JA, Souza L, Scates S et al. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b",hairy cell leukemia,interferon
724123753,5/21/2015 00:41:33,1639947480,5/21/2015 00:41:18,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123753,5/21/2015 01:06:01,1639961684,5/21/2015 01:05:46,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123753,5/21/2015 01:11:02,1639964779,5/21/2015 01:10:47,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123753,5/21/2015 01:12:44,1639965762,5/21/2015 01:12:26,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123753,5/21/2015 01:48:53,1639986313,5/21/2015 01:48:00,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123753,5/21/2015 02:03:38,1639993221,5/21/2015 02:03:25,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123753,5/21/2015 02:22:00,1640001640,5/21/2015 02:21:45,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123753,5/21/2015 02:25:52,1640003601,5/21/2015 02:25:34,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43,BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123753,5/21/2015 02:29:32,1640005455,5/21/2015 02:29:18,false,prodege,1.0,26499212,CAN,ON,Cambridge,70.27.23.230,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM,0,33-43-49-52-56,BOTULINUM TOXIN in the colon,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123753,5/21/2015 02:29:35,1640005496,5/21/2015 02:29:15,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,0,33,,,8,48,BOTULISM,BOTULINUM TOXIN,BOTULISM caused by production,0-9-16-19,19-30-33-43,production of BOTULINUM TOXIN,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum.,0,33 43,0,33,1,8,48,TWrex-cause,810555,Botulism caused by production of botulinum toxin in the colon following ingestion of spores of  Clostridium botulinum,botulism,botulinum toxin
724123754,5/20/2015 20:42:08,1639860591,5/20/2015 20:41:45,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123754,5/20/2015 20:56:26,1639866408,5/20/2015 20:54:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-58-55,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123754,5/20/2015 20:56:30,1639866411,5/20/2015 20:56:03,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123754,5/20/2015 20:57:58,1639866956,5/20/2015 20:57:25,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,"Ketoconazole shampoo the treatment of TINEA VERSICOLOR: a multicenter, randomized,",42-69-73-83-86-92-104-106-119-58,38-42-55-58-66-69-73-83-86-92,al. Ketoconazole 2% SHAMPOO in the treatment of tinea versicolor:,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123754,5/20/2015 20:59:50,1639867552,5/20/2015 20:59:33,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,58-73,SHAMPOO treatment,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123754,5/20/2015 21:01:40,1639868331,5/20/2015 21:01:16,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,"TINEA VERSICOLOR: randomized,",86-92-119,58-66-69-73,SHAMPOO in the treatment,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123754,5/20/2015 21:17:20,1639874159,5/20/2015 21:17:02,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123754,5/20/2015 21:21:44,1639876136,5/20/2015 21:21:20,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123754,5/20/2015 21:23:20,1639876734,5/20/2015 21:23:05,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,42-55-58,Ketoconazole 2% SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123754,5/20/2015 21:25:33,1639877492,5/20/2015 21:23:55,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,86,58,,,102,65,TINEA VERSICOLOR,SHAMPOO,TINEA VERSICOLOR:,86-92,58,SHAMPOO,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.",86 92,58,86,58,-1,102,65,TWrex-cause,800691,"Lange DS, Richards HM, Guarnieri J et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial",tinea versicolor,shampoo
724123755,5/20/2015 22:26:12,1639889542,5/20/2015 22:25:31,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,81-95,DEXAMETHASONE suppression,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123755,5/20/2015 22:36:46,1639893260,5/20/2015 22:36:22,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,81,DEXAMETHASONE,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123755,5/20/2015 22:40:24,1639894489,5/20/2015 22:39:47,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME vs.,26-36-45,81-95,DEXAMETHASONE suppression,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123755,5/20/2015 22:46:15,1639896599,5/20/2015 22:45:48,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,"In evaluating women for CUSHING'S SYNDROME vs. polycystic ovary syndrome,",2-5-16-22-26-36-45-49-60-66,66-76-78-81-95-107-110-119,"syndrome, 1 mg DEXAMETHASONE suppression or midnight cortisol","• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123755,5/20/2015 22:54:33,1639899495,5/20/2015 22:54:13,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,evaluating women for CUSHING'S SYNDROME,5-16-22-26-36,66-76-78-81-95-107-110-119,"syndrome, 1 mg DEXAMETHASONE suppression or midnight cortisol","• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123755,5/20/2015 23:08:31,1639905069,5/20/2015 23:07:36,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,"CUSHING'S SYNDROME polycystic ovary syndrome,",26-36-49-60-66,26-36-49-60-66-81,"Cushing's syndrome polycystic ovary syndrome, DEXAMETHASONE","• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123755,5/20/2015 23:20:33,1639908945,5/20/2015 23:20:21,false,prodege,1.0,2145087,USA,"","",40.143.102.85,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,76-78-81,1 mg DEXAMETHASONE,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123755,5/21/2015 00:01:07,1639926680,5/21/2015 00:00:53,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,76-78-81,1 mg DEXAMETHASONE,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123755,5/21/2015 00:03:10,1639927517,5/21/2015 00:02:36,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,66-76-78-81-95-107-110,"syndrome, 1 mg DEXAMETHASONE suppression or midnight","• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123755,5/21/2015 00:07:54,1639929578,5/21/2015 00:06:47,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,26,81,,,44,94,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME,26-36,81-95,DEXAMETHASONE suppression,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51.",26 36,81,26,81,-1,44,94,TWrex-cause,803065,"• In evaluating women for Cushing's syndrome vs. polycystic ovary syndrome, 1 mg dexamethasone suppression or midnight cortisol was found to have better discriminatory ability than UFC ( 51",cushing's syndrome,dexamethasone
724123756,5/20/2015 20:46:42,1639862301,5/20/2015 20:46:29,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123756,5/20/2015 21:01:40,1639868322,5/20/2015 21:01:17,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION, pityriasis rosea, lichen planus, must be distinguished from EDP.",0-17-36-47-54-61-174-179-182-196-201,114-124-132-145-162-166-174-179-196-201-182,"syphilis, macular amyloidosis, HEMOCHROMATOSIS, and argyria must be distinguished from EDP.","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123756,5/20/2015 21:02:21,1639868507,5/20/2015 21:01:53,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION, pityriasis rosea,",0-17-36-47,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123756,5/20/2015 21:03:14,1639868808,5/20/2015 21:02:54,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123756,5/20/2015 21:06:03,1639869813,5/20/2015 21:05:07,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,124-145,"macular HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123756,5/20/2015 21:14:23,1639873020,5/20/2015 21:13:17,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123756,5/20/2015 21:21:07,1639875909,5/20/2015 21:20:54,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123756,5/20/2015 21:27:45,1639878138,5/20/2015 21:26:57,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123756,5/20/2015 21:31:25,1639879413,5/20/2015 21:31:08,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION,",0-17,145,"HEMOCHROMATOSIS,","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123756,5/20/2015 21:33:54,1639880258,5/20/2015 21:32:28,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,17,145,,,34,160,HYPERPIGMENTATION,HEMOCHROMATOSIS,"Postinflammatory HYPERPIGMENTATION, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",0-17-36-47-54-61-69-75-80-90-98-107-114-124-132-145-162-166-174-179-182-196-201,0-17-36-47-54-61-69-75-80-90-98-107-114-124-132-145-162-166-174-179-182-196-201,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, HEMOCHROMATOSIS, and argyria must be distinguished from EDP.","Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP.",17,145,17,145,1,34,160,TWrex-cause,814568,"Postinflammatory hyperpigmentation, pityriasis rosea, lichen planus, fixed drug eruption, Addison disease, pinta, syphilis, macular amyloidosis, hemochromatosis, and argyria must be distinguished from EDP",hyperpigmentation,hemochromatosis
724123757,5/21/2015 00:09:34,1639930322,5/21/2015 00:09:22,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123757,5/21/2015 00:13:32,1639932323,5/21/2015 00:12:46,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123757,5/21/2015 00:15:33,1639933386,5/21/2015 00:15:23,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123757,5/21/2015 00:30:48,1639940902,5/21/2015 00:30:39,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123757,5/21/2015 00:36:10,1639944124,5/21/2015 00:34:25,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123757,5/21/2015 00:39:30,1639946334,5/21/2015 00:39:20,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,potentially life threatening ASCITES,179-191-196-208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123757,5/21/2015 00:57:30,1639956769,5/21/2015 00:57:13,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123757,5/21/2015 01:02:21,1639959559,5/21/2015 01:02:09,false,elite,1.0,32306791,GBR,"","",109.200.26.4,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,potentially ASCITES and hypovolemia.,179-208-216-220,0-8-25-34,OVARIAN HYPERSTIMULATION SYNDROME occurs,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123757,5/21/2015 01:06:27,1639961977,5/21/2015 01:06:14,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123757,5/21/2015 01:07:01,1639962288,5/21/2015 01:06:48,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,208,0,,,215,33,ASCITES,OVARIAN HYPERSTIMULATION SYNDROME,ASCITES,208,0-8-25,OVARIAN HYPERSTIMULATION SYNDROME,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia.",208,0 8 25,208,0,1,215,33,TWrex-cause,812960,"Ovarian hyperstimulation syndrome occurs in 10 to 20% of patients; ovaries can become massively enlarged, and intravascular fluid volume shifts into the peritoneal space, causing potentially life-threatening ascites and hypovolemia",ascites,ovarian hyperstimulation syndrome
724123758,5/21/2015 00:38:05,1639945464,5/21/2015 00:37:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123758,5/21/2015 00:47:21,1639950891,5/21/2015 00:45:57,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59-70,C. BOTULINUM organism,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123758,5/21/2015 01:01:09,1639958908,5/21/2015 01:00:38,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123758,5/21/2015 01:08:51,1639963559,5/21/2015 01:08:34,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123758,5/21/2015 01:10:05,1639964307,5/21/2015 01:09:49,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123758,5/21/2015 01:44:19,1639983814,5/21/2015 01:42:07,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123758,5/21/2015 02:01:26,1639992118,5/21/2015 02:01:03,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59-70,C. BOTULINUM organism,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123758,5/21/2015 02:18:04,1639999878,5/21/2015 02:17:44,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM, in",3-9-33,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123758,5/21/2015 02:22:35,1640001905,5/21/2015 02:22:15,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59-70,C. BOTULINUM organism,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123758,5/21/2015 02:27:15,1640004294,5/21/2015 02:26:47,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,3,56,,,17,68,WOUND BOTULISM,C. BOTULINUM,"WOUND BOTULISM,",3-9,56-59,C. BOTULINUM,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis.",3 9,56 59,3,56,1,17,68,TWrex-cause,810498,"In wound botulism, finding toxin in serum or isolating  C. botulinum  organism on anaerobic culture of the wound confirms the diagnosis",wound botulism,c. botulinum
724123759,5/21/2015 00:09:46,1639930409,5/21/2015 00:09:34,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123759,5/21/2015 00:13:58,1639932486,5/21/2015 00:13:36,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"microangiopathic hemolytic anemia, THROMBOCYTOPENIA,",39-56-66-74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123759,5/21/2015 00:15:51,1639933523,5/21/2015 00:15:34,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123759,5/21/2015 00:32:49,1639941932,5/21/2015 00:30:49,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123759,5/21/2015 00:37:45,1639945310,5/21/2015 00:36:11,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA, presence",74-100,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123759,5/21/2015 00:57:49,1639956962,5/21/2015 00:57:32,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123759,5/21/2015 01:02:35,1639959667,5/21/2015 01:02:24,false,elite,1.0,32306791,GBR,"","",109.200.26.4,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"microangiopathic THROMBOCYTOPENIA, and the presence",39-74-92-96-100,0-16-19-27,Common of TTP HUS,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123759,5/21/2015 01:06:46,1639962130,5/21/2015 01:06:28,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123759,5/21/2015 01:07:25,1639962523,5/21/2015 01:07:02,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123759,5/21/2015 01:12:09,1639965369,5/21/2015 01:11:49,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,74,19,,,90,22,THROMBOCYTOPENIA,TTP,"THROMBOCYTOPENIA,",74,19,TTP,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels.",74,19,74,19,1,90,22,TWrex-cause,813092,"Common features of TTP and HUS include microangiopathic hemolytic anemia, thrombocytopenia, and the presence of platelet fibrin thrombi in the small vessels",thrombocytopenia,TTP
724123760,5/20/2015 20:49:18,1639863473,5/20/2015 20:49:04,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,178-190-175,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123760,5/20/2015 21:07:06,1639870270,5/20/2015 21:06:42,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,141-149-138,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123760,5/20/2015 21:07:34,1639870415,5/20/2015 21:07:22,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,190,141,,,197,156,MALARIA,QUININE SULFATE,MALARIA.,190,141-149-171,QUININE SULFATE of,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123760,5/20/2015 21:09:04,1639870848,5/20/2015 21:08:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,190,141,,,197,156,MALARIA,QUININE SULFATE,falciparum MALARIA.,178-190,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123760,5/20/2015 21:23:40,1639876838,5/20/2015 21:23:23,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123760,5/20/2015 21:31:04,1639879275,5/20/2015 21:30:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,178-190-175,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123760,5/20/2015 21:35:22,1639880839,5/20/2015 21:34:45,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123760,5/20/2015 21:37:16,1639881370,5/20/2015 21:36:59,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,141-149,QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123760,5/20/2015 21:38:18,1639881776,5/20/2015 21:38:04,false,prodege,1.0,19907188,USA,MI,Adrian,50.37.37.250,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,138-141-149,IV QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123760,5/20/2015 22:09:39,1639883434,5/20/2015 22:07:54,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,190,141,,,197,156,MALARIA,QUININE SULFATE,P. falciparum MALARIA.,175-178-190,141-149,QUININE SULFATE,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria.,190,141 149,190,141,-1,197,156,TWrex-cause,804175,180   At least 1 case of fatal ventricular arrhythmia reported in a geriatric patient with preexisting prolonged QT interval who received IV quinine sulfate for treatment of  P. falciparum  malaria,malaria,quinine sulfate
724123761,5/20/2015 22:18:02,1639886742,5/20/2015 22:17:03,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,53,126,,,55,138,P.,TRIMETHOPRIM,P. carinii,53-56,126-157,TRIMETHOPRIM or,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123761,5/20/2015 22:18:38,1639886948,5/20/2015 22:18:07,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,53,126,,,55,138,P.,TRIMETHOPRIM,P. carinii,53-56,126-139-147,TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123761,5/20/2015 22:25:48,1639889423,5/20/2015 22:25:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,53,126,,,55,138,P.,TRIMETHOPRIM,"Pneumocystis jiroveci (formerly, P. carinii",18-31-41-53-56,109-121-126-139-147,prophylaxis with TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123761,5/20/2015 22:32:34,1639891675,5/20/2015 22:31:52,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,53,126,,,55,138,P.,TRIMETHOPRIM,P. carinii,53-56,101-109-121-126-139-147,routine prophylaxis with TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123761,5/20/2015 22:36:47,1639893261,5/20/2015 22:36:04,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,53,126,,,55,138,P.,TRIMETHOPRIM,"Pneumocystis jiroveci (formerly, P. carinii has essentially been eliminated by routine prophylaxis with trimethoprim sulfame thoxazole or an alternative agent.",18-31-41-53-56-66-70-82-87-98-101-109-121-126-139-147-157-160-163-175,101-109-121-126-139-147-157-160-163-175,routine prophylaxis with TRIMETHOPRIM sulfame thoxazole or an alternative agent.,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123761,5/20/2015 22:38:20,1639893740,5/20/2015 22:38:06,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,53,126,,,55,138,P.,TRIMETHOPRIM,P. prophylaxis,53-109,101-109-126,routine prophylaxis TRIMETHOPRIM,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123761,5/20/2015 22:38:56,1639894009,5/20/2015 22:38:38,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,53,126,,,55,138,P.,TRIMETHOPRIM,Pneumocystis jiroveci P. carinii,18-31-53-56,126-139-147,TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123761,5/20/2015 22:47:44,1639897127,5/20/2015 22:46:27,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,53,126,,,55,138,P.,TRIMETHOPRIM,"Pneumocystis jiroveci (formerly, P. carinii",18-31-41-53-56,101-109-121-126-139-147,routine prophylaxis with TRIMETHOPRIM sulfame thoxazole,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123761,5/20/2015 22:48:54,1639897580,5/20/2015 22:47:10,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,53,126,,,55,138,P.,TRIMETHOPRIM,P.,53,126,TRIMETHOPRIM,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123761,5/20/2015 22:56:16,1639900138,5/20/2015 22:55:39,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,53,126,,,55,138,P.,TRIMETHOPRIM,Pneumocystis jiroveci P.,18-31-53,18-31-126,Pneumocystis jiroveci TRIMETHOPRIM,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent.",53,126,53,126,-1,55,138,TWrex-cause,800344,"Other Infections  Pneumocystis jiroveci  (formerly,  P. carinii ) has essentially been eliminated by routine prophylaxis with trimethoprim-sulfame thoxazole or an alternative agent",p.,trimethoprim
724123762,5/20/2015 23:25:00,1639910954,5/20/2015 23:24:47,false,prodege,1.0,2145087,USA,"","",40.143.102.85,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123762,5/21/2015 00:08:07,1639929684,5/21/2015 00:07:50,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123762,5/21/2015 00:10:45,1639930938,5/21/2015 00:10:33,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123762,5/21/2015 00:14:03,1639932527,5/21/2015 00:13:51,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123762,5/21/2015 00:24:27,1639937582,5/21/2015 00:23:41,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123762,5/21/2015 00:28:01,1639939473,5/21/2015 00:26:26,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,32,57,,,34,60,TB,PPD,TB,32,48-50-54-57,x ray or PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123762,5/21/2015 00:38:09,1639945508,5/21/2015 00:37:56,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123762,5/21/2015 00:55:18,1639955510,5/21/2015 00:55:01,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123762,5/21/2015 01:00:24,1639958409,5/21/2015 00:59:55,false,elite,1.0,32306791,GBR,"","",109.200.26.4,32,57,,,34,60,TB,PPD,screened TB with a chest,19-32-35-40-42,48-50-57,x ray PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123762,5/21/2015 01:04:39,1639960843,5/21/2015 01:04:20,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,32,57,,,34,60,TB,PPD,TB,32,57,PPD.,Patients should be screened for TB with a chest x-ray or PPD.,32,57,32,57,-1,34,60,TWrex-cause,803017,Patients should be screened for TB with a chest x-ray or PPD,TB,PPD
724123763,5/20/2015 22:28:02,1639890118,5/20/2015 22:27:47,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123763,5/20/2015 22:43:29,1639895667,5/20/2015 22:42:55,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123763,5/20/2015 22:43:46,1639895775,5/20/2015 22:42:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123763,5/20/2015 22:53:16,1639899117,5/20/2015 22:52:52,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,98,142,,,104,145,ATAXIA,FFI,"affected persons develop ATAXIA, followed by dementia; patients with FFI are unable to sleep.",73-82-90-98-106-115-118-128-137-142-146-150-157-160,118-128-137-142-146-150-157-160,dementia; patients with FFI are unable to sleep.,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123763,5/20/2015 22:57:51,1639900778,5/20/2015 22:57:13,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,98,142,,,104,145,ATAXIA,FFI,"affected persons develop ATAXIA,",73-82-90-98,118-128-137-142-146-150-157-160,dementia; patients with FFI are unable to sleep.,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123763,5/20/2015 23:20:08,1639908781,5/20/2015 23:19:34,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,98,142,,,104,145,ATAXIA,FFI,"GSS, ATAXIA, dementia; FFI",98-118-142-11,11-98-118-142,"GSS, ataxia, dementia; FFI","40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123763,5/20/2015 23:22:09,1639909436,5/20/2015 23:21:57,false,prodege,1.0,2145087,USA,"","",40.143.102.85,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123763,5/21/2015 00:04:39,1639928117,5/21/2015 00:04:26,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123763,5/21/2015 00:06:13,1639928892,5/21/2015 00:05:32,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,98,142,,,104,145,ATAXIA,FFI,"transmitted as autosomal dominant trait, ATAXIA,",25-37-43-53-62-98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123763,5/21/2015 00:11:26,1639931248,5/21/2015 00:11:12,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,98,142,,,104,145,ATAXIA,FFI,"ATAXIA,",98,142,FFI,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep.",98,142,98,142,1,104,145,TWrex-cause,812762,"40,41   In GSS, which is transmitted as an autosomal dominant trait, the affected persons develop ataxia, followed by dementia; patients with FFI are unable to sleep",ataxia,FFI
724123764,5/20/2015 20:47:51,1639862873,5/20/2015 20:47:37,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108,CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123764,5/20/2015 21:03:50,1639869072,5/20/2015 21:03:25,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108-120-123-126,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123764,5/20/2015 21:05:09,1639869557,5/20/2015 21:04:55,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,GONORRHOEA,75,108,CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123764,5/20/2015 21:07:33,1639870406,5/20/2015 21:07:16,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,GONORRHOEA,75,108,CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123764,5/20/2015 21:21:45,1639876140,5/20/2015 21:20:55,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108-120-123-126,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123764,5/20/2015 21:22:10,1639876297,5/20/2015 21:21:57,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108-120-123-126,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123764,5/20/2015 21:33:12,1639880016,5/20/2015 21:32:44,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108-120-123-126,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123764,5/20/2015 21:35:24,1639880842,5/20/2015 21:35:03,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,GONORRHOEA,75,108,CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123764,5/20/2015 21:36:33,1639881192,5/20/2015 21:36:14,false,prodege,1.0,19907188,USA,MI,Adrian,50.37.37.250,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,acute uncomplicated GONORRHOEA,55-61-75,108-123-126-120,"CEFTRIAXONE Ro 13 9904,","Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123764,5/20/2015 21:56:45,1639881920,5/20/2015 21:56:14,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,75,108,,,85,119,GONORRHOEA,CEFTRIAXONE,GONORRHOEA,75,108,CEFTRIAXONE,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order.",75,108,75,108,-1,85,119,TWrex-cause,800986,"Eichmann A, Weidmann G, Havas L. One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin: a dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order",gonorrhoea,ceftriaxone
724123765,5/20/2015 22:54:12,1639899384,5/20/2015 22:53:51,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,subcutaneous insulin infusion therapy in patients with TYPE 1 DIABETES.,115-123-132-140-143-152-157-162-164-102,20-24-34-42-46-51-65-68-76-83-88-91-102-115-123-132,"The efficacy, safety, and pump compatibility of INSULIN ASPART used in continuous subcutaneous insulin infusion therapy","Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123765,5/20/2015 23:00:30,1639901854,5/20/2015 22:59:48,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,in patients with TYPE 1 DIABETES.,140-143-152-157-162-164,46-51-65-68-76,pump compatibility of INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123765,5/20/2015 23:22:37,1639909591,5/20/2015 23:21:59,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76-157-162-164,INSULIN ASPART type 1 diabetes.,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123765,5/20/2015 23:22:51,1639909722,5/20/2015 23:22:39,false,prodege,1.0,2145087,USA,"","",40.143.102.85,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123765,5/21/2015 00:05:32,1639928531,5/21/2015 00:05:20,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123765,5/21/2015 00:08:19,1639929769,5/21/2015 00:08:01,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123765,5/21/2015 00:12:15,1639931628,5/21/2015 00:12:03,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123765,5/21/2015 00:15:45,1639933472,5/21/2015 00:15:33,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123765,5/21/2015 00:16:28,1639933811,5/21/2015 00:14:48,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,TYPE 1 DIABETES.,157-162-164,68-76,INSULIN ASPART,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123765,5/21/2015 00:24:09,1639937442,5/21/2015 00:23:43,false,neodev,1.0,31789301,USA,CA,San Jose,23.27.248.79,157,68,,,172,82,TYPE 1 DIABETES,INSULIN ASPART,in patients with TYPE 1 DIABETES.,140-143-152-157-162-164,46-51-65-68-76-83-88-91,pump compatibility of INSULIN ASPART used in continuous,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.",157 162 164,68 76,157,68,-1,172,82,TWrex-cause,804269,"Bode BW, Strange P. The efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes",type 1 diabetes,insulin aspart
724123766,5/21/2015 00:38:19,1639945624,5/21/2015 00:38:05,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123766,5/21/2015 00:48:26,1639951531,5/21/2015 00:47:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123766,5/21/2015 01:01:55,1639959347,5/21/2015 01:01:11,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123766,5/21/2015 01:09:07,1639963760,5/21/2015 01:08:52,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123766,5/21/2015 01:10:25,1639964466,5/21/2015 01:10:06,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123766,5/21/2015 01:45:26,1639984349,5/21/2015 01:44:20,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123766,5/21/2015 02:01:46,1639992262,5/21/2015 02:01:27,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,160,144,,,166,148,ANEMIA,IRON,ANEMIA,160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123766,5/21/2015 02:18:25,1640000053,5/21/2015 02:18:05,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA,144-149-160,144-149-160,IRON deficiency anemia,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123766,5/21/2015 02:23:11,1640002277,5/21/2015 02:22:36,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,160,144,,,166,148,ANEMIA,IRON,ANEMIA,160,144-149,IRON deficiency,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123766,5/21/2015 02:27:51,1640004588,5/21/2015 02:27:15,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,160,144,,,166,148,ANEMIA,IRON,iron deficiency ANEMIA vs 1.6%),144-149-160-173-176,129-139-144-149-160-167-176-173,prevalent than IRON deficiency anemia (6.4% vs 1.6%),"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3.",160,144,160,144,-1,166,148,TWrex-cause,805293,"Recently, some clinicians have advocated investigation of iron deficiency in the absence of anemia, a condition that is far more prevalent than iron deficiency anemia (6.4% vs 1.6%)  (2, 3",anemia,iron
724123767,5/20/2015 22:26:32,1639889653,5/20/2015 22:26:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,136-149,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123767,5/20/2015 22:37:54,1639893575,5/20/2015 22:36:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,136-149,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123767,5/20/2015 22:40:49,1639894675,5/20/2015 22:40:25,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,136-149,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123767,5/20/2015 22:51:12,1639898410,5/20/2015 22:50:54,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG, caused by inhalation of hay dust containing thermophilic actinomycetes,",77-86-92-99-102-113-116-120-125-136-149,77-92-99-102-113-116-120-125-136-149-164-167-171-86,"farmer's lung, caused by inhalation of hay dust containing thermophilic ACTINOMYCETES, is the prototype.","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123767,5/20/2015 22:55:04,1639899691,5/20/2015 22:54:34,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG, caused by inhalation",77-86-92-99-102,120-125-136-149-164-167-171,"dust containing thermophilic ACTINOMYCETES, is the prototype.","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123767,5/20/2015 23:09:25,1639905459,5/20/2015 23:08:38,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,77-149-86,"farmer's lung, ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123767,5/20/2015 23:20:54,1639909064,5/20/2015 23:20:36,false,prodege,1.0,2145087,USA,"","",40.143.102.85,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,136-149,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123767,5/21/2015 00:01:28,1639926861,5/21/2015 00:01:08,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,136-149,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123767,5/21/2015 00:03:45,1639927714,5/21/2015 00:03:11,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,149-136,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123767,5/21/2015 00:09:17,1639930199,5/21/2015 00:07:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,77,149,,,90,162,FARMER'S LUNG,ACTINOMYCETE,"FARMER'S LUNG,",77-86,136-149,"thermophilic ACTINOMYCETES,","Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype.",77 86,149,77,149,1,90,162,TWrex-cause,810634,"Antigens are commonly categorized by type and occupation (see  Table 55-4 ); farmer's lung, caused by inhalation of hay dust containing thermophilic actinomycetes, is the prototype",farmer's lung,actinomycete
724123768,5/20/2015 21:24:21,1639877191,5/20/2015 21:24:01,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,mild DIARRHEA,260-265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123768,5/20/2015 21:36:12,1639881111,5/20/2015 21:35:50,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,mild DIARRHEA,260-265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123768,5/20/2015 21:37:59,1639881644,5/20/2015 21:37:43,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123768,5/20/2015 22:12:40,1639884983,5/20/2015 22:11:04,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123768,5/20/2015 22:12:48,1639885036,5/20/2015 22:10:45,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,difficile associated diarrhea and colitis (CDAD; also known as antibiotic associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild DIARRHEA to fatal colitis.,43-54-65-74-78-86-93-98-104-107-118-129-138-142-150-153-170-179-183-188-197-202-209-213-218-229-233-237-246-255-260-265-274-277-283-243,43-54-65-74-78-86-93-98-104-107-118-129-138-142-150-153-170-179-183-188-197-202-209-213-218-229-233-237-243-246-255-260-265-274-277-283,difficile associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives and may range in severity from mild diarrhea to fatal colitis.,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123768,5/20/2015 22:14:54,1639885759,5/20/2015 22:14:18,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123768,5/20/2015 22:19:20,1639887187,5/20/2015 22:18:28,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123768,5/20/2015 22:26:05,1639889492,5/20/2015 22:25:04,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123768,5/20/2015 22:28:44,1639890369,5/20/2015 22:28:12,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,mild DIARRHEA,260-265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123768,5/20/2015 22:33:15,1639891892,5/20/2015 22:32:41,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,265,107,,,273,137,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,265,107-118-129,ANTIBIOTIC ASSOCIATED DIARRHEA,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis.",265,107 118 129,265,107,1,273,137,TWrex-cause,814917,"1 ,   19 ,   20 ,   21 ,   22 ,   23    C. difficile -associated diarrhea and colitis (CDAD; also known as antibiotic-associated diarrhea and colitis or pseudomembranous colitis) has been reported with nearly all anti-infectives and may range in severity from mild diarrhea to fatal colitis",diarrhea,antibiotic associated diarrhea
724123769,5/20/2015 23:01:46,1639902290,5/20/2015 23:01:38,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,(Donovanosis) Treatment of GRANULOMA INGUINALE,25-40-50-53-63,87-94-98-117,caused by Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123769,5/20/2015 23:24:00,1639910338,5/20/2015 23:23:44,false,prodege,1.0,2145087,USA,"","",40.143.102.85,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123769,5/20/2015 23:25:47,1639911386,5/20/2015 23:24:21,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE Calymmatobacterium granulomatis.,53-63-98-117,5-25-98-117-15,Granuloma Inguinale (Donovanosis) Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123769,5/21/2015 00:06:13,1639928884,5/21/2015 00:06:03,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123769,5/21/2015 00:09:07,1639930152,5/21/2015 00:08:51,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123769,5/21/2015 00:12:55,1639932045,5/21/2015 00:12:44,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123769,5/21/2015 00:18:49,1639934970,5/21/2015 00:18:36,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123769,5/21/2015 00:21:02,1639935986,5/21/2015 00:19:54,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE,53-63,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123769,5/21/2015 00:36:44,1639944558,5/21/2015 00:36:18,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,Treatment of GRANULOMA INGUINALE,40-53-63-50,117-98,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123769,5/21/2015 00:50:42,1639952847,5/21/2015 00:48:17,false,instagc,1,32367246,USA,CO,Denver,65.128.111.113,53,117,,,72,129,GRANULOMA INGUINALE,GRANULOMATIS,GRANULOMA INGUINALE caused by Calymmatobacterium granulomatis.,53-63-87-94-98-117,98-117,Calymmatobacterium GRANULOMATIS.,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis.,53 63,117,53,117,1,72,129,TWrex-cause,810527,102  Granuloma Inguinale (Donovanosis)  Treatment of granuloma inguinale (donovanosis) caused by  Calymmatobacterium granulomatis,granuloma inguinale,granulomatis
724123770,5/20/2015 20:46:10,1639862144,5/20/2015 20:45:54,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123770,5/20/2015 21:00:55,1639868007,5/20/2015 21:00:39,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,alosetron in patients who develop ISCHEMIC COLITIS.,19-32-41-45-53-62-29,19-29-32-41-45-53-62,ALOSETRON in patients who develop ischemic colitis.,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123770,5/20/2015 21:01:22,1639868186,5/20/2015 21:01:06,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123770,5/20/2015 21:02:36,1639868574,5/20/2015 21:02:24,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123770,5/20/2015 21:04:49,1639869443,5/20/2015 21:04:35,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123770,5/20/2015 21:11:52,1639871899,5/20/2015 21:10:35,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123770,5/20/2015 21:20:30,1639875606,5/20/2015 21:20:06,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123770,5/20/2015 21:26:38,1639877914,5/20/2015 21:26:27,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123770,5/20/2015 21:30:42,1639879134,5/20/2015 21:30:06,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,ISCHEMIC COLITIS.,53-62,19,ALOSETRON,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123770,5/20/2015 21:30:51,1639879208,5/20/2015 21:29:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,53,19,,,69,28,ISCHEMIC COLITIS,ALOSETRON,Do not resume alosetron in patients who develop ISCHEMIC COLITIS.,5-8-12-19-32-41-45-53-62-29,5-8-12-19-29-32-41-45-53-62,Do not resume ALOSETRON in patients who develop ischemic colitis.,1 •  Do not resume alosetron in patients who develop ischemic colitis.,53 62,19,53,19,-1,69,28,TWrex-cause,803162,1 •  Do not resume alosetron in patients who develop ischemic colitis,ischemic colitis,alosetron
724123771,5/20/2015 20:44:43,1639861595,5/20/2015 20:44:27,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123771,5/20/2015 20:59:18,1639867414,5/20/2015 20:58:35,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123771,5/20/2015 20:59:33,1639867476,5/20/2015 20:59:14,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,131,91,,,141,101,INFARCTION,DALTEPARIN,"noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial INFARCTION at 1 month",37-49-60-64-73-82-91-110-116-120-131-142-145-147-102,64-73-82-91-102-110-116-120-131,"unstable coronary disease, DALTEPARIN reduced death and myocardial infarction","CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123771,5/20/2015 21:01:14,1639868123,5/20/2015 21:00:55,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123771,5/20/2015 21:03:19,1639868822,5/20/2015 21:03:02,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123771,5/20/2015 21:03:47,1639869066,5/20/2015 21:01:58,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123771,5/20/2015 21:18:59,1639874887,5/20/2015 21:18:42,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123771,5/20/2015 21:23:45,1639876875,5/20/2015 21:23:27,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91,DALTEPARIN,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123771,5/20/2015 21:24:41,1639877341,5/20/2015 21:24:28,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,131,91,,,141,101,INFARCTION,DALTEPARIN,myocardial INFARCTION,120-131,91-102-110,DALTEPARIN reduced death,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123771,5/20/2015 21:28:24,1639878462,5/20/2015 21:26:41,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,131,91,,,141,101,INFARCTION,DALTEPARIN,"CONCLUSION In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial INFARCTION at 1 month but not at 3 months.",0-12-15-24-28-37-49-60-64-73-82-91-102-110-116-120-131-142-145-147-153-157-161-164-166,0-12-15-24-28-37-49-60-64-73-82-91-102-110-116-120-131-142-145-147-153-157-161-164-166,"CONCLUSION In patients who received noninvasive management for unstable coronary disease, DALTEPARIN reduced death and myocardial infarction at 1 month but not at 3 months.","CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months.",131,91,131,91,-1,141,101,TWrex-cause,803951,"CONCLUSION  In patients who received noninvasive management for unstable coronary disease, dalteparin reduced death and myocardial infarction at 1 month but not at 3 months",infarction,dalteparin
724123772,5/21/2015 00:09:22,1639930229,5/21/2015 00:09:07,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,HISTOPLASMOSIS:,85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123772,5/21/2015 00:12:44,1639931941,5/21/2015 00:12:28,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,disseminated HISTOPLASMOSIS:,72-85,123-136,AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123772,5/21/2015 00:15:22,1639933220,5/21/2015 00:15:07,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,HISTOPLASMOSIS:,85,123-136,AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123772,5/21/2015 00:30:37,1639940786,5/21/2015 00:30:21,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,disseminated HISTOPLASMOSIS:,72-85,123-136,AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123772,5/21/2015 00:34:24,1639942674,5/21/2015 00:33:13,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,severe disseminated HISTOPLASMOSIS:,65-72-85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123772,5/21/2015 00:39:20,1639946262,5/21/2015 00:39:08,false,instagc,1.0,23287154,USA,CA,San Jose,130.65.251.20,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,severe disseminated HISTOPLASMOSIS:,65-72-85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123772,5/21/2015 00:57:11,1639956595,5/21/2015 00:56:43,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,disseminated HISTOPLASMOSIS:,72-85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123772,5/21/2015 01:02:06,1639959452,5/21/2015 01:01:56,false,elite,1.0,32306791,GBR,"","",109.200.26.4,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,to disseminated HISTOPLASMOSIS: regimen of,62-72-85-109-117,109-120-123-136-138-144-148,regimen IV AMPHOTERICIN B given for at,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123772,5/21/2015 01:06:13,1639961805,5/21/2015 01:05:37,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,severe disseminated HISTOPLASMOSIS:,65-72-85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123772,5/21/2015 01:06:47,1639962145,5/21/2015 01:06:16,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,85,123,,,99,137,HISTOPLASMOSIS,AMPHOTERICIN B,HISTOPLASMOSIS:,85,120-123-136,IV AMPHOTERICIN B,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months.",85,123 136,85,123,-1,99,137,TWrex-cause,800602,"441  HIV-infected infants and children with moderately severe to severe disseminated histoplasmosis: Initial regimen of IV amphotericin B given for at least 1-2 weeks, followed by itraconazole (oral solution) 2-5 mg/kg (up to 200 mg) 3 times daily for 3 days, then 2-5 mg/kg (up to 200 mg) twice daily for 12 months",histoplasmosis,amphotericin b
724123773,5/20/2015 20:40:42,1639860115,5/20/2015 20:40:30,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,4-14-28,overnight DEXAMETHASONE test,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123773,5/20/2015 20:49:48,1639863670,5/20/2015 20:47:52,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14-28,DEXAMETHASONE test,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123773,5/20/2015 20:53:37,1639865362,5/20/2015 20:53:10,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,4-14-28,overnight DEXAMETHASONE test,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123773,5/20/2015 20:55:03,1639865896,5/20/2015 20:54:33,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,overnight dexamethasone test is the procedure of choice CUSHING'S SYNDROME.,4-14-28-33-36-40-50-77-87-53,4-14-28-33-36-40-50-53-60-63-73-77-87,overnight DEXAMETHASONE test is the procedure of choice in screening for Cushing's syndrome.,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123773,5/20/2015 20:55:17,1639865921,5/20/2015 20:55:03,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,dexamethasone test in screening for CUSHING'S SYNDROME.,14-60-63-73-77-87-28,0-4-14-28-33-36-40-60-63-73-77-87,The overnight DEXAMETHASONE test is the procedure in screening for Cushing's syndrome.,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123773,5/20/2015 20:56:20,1639866366,5/20/2015 20:56:03,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14,DEXAMETHASONE,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123773,5/20/2015 20:56:43,1639866497,5/20/2015 20:56:33,false,instagc,1.0,23032978,USA,PA,Philadelphia,76.98.187.59,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14,DEXAMETHASONE,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123773,5/20/2015 20:59:56,1639867617,5/20/2015 20:59:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14,DEXAMETHASONE,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123773,5/20/2015 21:02:31,1639868545,5/20/2015 21:02:18,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14,DEXAMETHASONE,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123773,5/20/2015 21:03:53,1639869105,5/20/2015 21:03:23,false,fusioncash,1.0,31248728,USA,FL,Alachua,174.131.50.169,77,14,,,95,27,CUSHING'S SYNDROME,DEXAMETHASONE,CUSHING'S SYNDROME.,77-87,14,DEXAMETHASONE,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome.,77 87,14,77,14,-1,95,27,TWrex-cause,803004,The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome,cushing's syndrome,dexamethasone
724123774,5/21/2015 00:36:57,1639944701,5/21/2015 00:36:43,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123774,5/21/2015 00:44:53,1639949497,5/21/2015 00:43:44,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123774,5/21/2015 01:00:08,1639958253,5/21/2015 00:59:47,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123774,5/21/2015 01:08:19,1639963107,5/21/2015 01:08:02,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123774,5/21/2015 01:09:34,1639964023,5/21/2015 01:09:12,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,56-50,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123774,5/21/2015 01:41:02,1639981724,5/21/2015 01:40:32,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123774,5/21/2015 02:00:45,1639991764,5/21/2015 02:00:26,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,BLINDNESS,56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123774,5/21/2015 02:17:03,1639999462,5/21/2015 02:16:47,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123774,5/21/2015 02:21:26,1640001470,5/21/2015 02:20:34,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123774,5/21/2015 02:26:24,1640003861,5/21/2015 02:24:57,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,56,15,,,65,34,BLINDNESS,ONCHOCERCA VOLVULUS,river BLINDNESS,50-56,15-26,ONCHOCERCA VOLVULUS,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease.",56,15 26,56,15,1,65,34,TWrex-cause,811034,"Life cycle of  Onchocerca volvulus , which causes river blindness and severe skin disease",blindness,onchocerca volvulus
724123775,5/20/2015 21:38:25,1639881778,5/20/2015 21:38:05,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123775,5/20/2015 22:16:12,1639886201,5/20/2015 22:15:44,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123775,5/20/2015 22:17:39,1639886611,5/20/2015 22:17:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123775,5/20/2015 22:23:36,1639888697,5/20/2015 22:22:50,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,Fructose 1 - phosphate aldolase DEFICIENCY,0-9-10-11-21-61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123775,5/20/2015 22:31:16,1639891167,5/20/2015 22:30:41,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY causes the clinical syndrome of hereditary fructose intolerance.,61-72-79-83-92-101-104-115-124,83-92-101-104-115-124,clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123775,5/20/2015 22:35:31,1639892798,5/20/2015 22:35:11,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,Fructose 1 - phosphate aldolase (aldolase B) deficiency: This DEFICIENCY causes the clinical syndrome hereditary fructose intolerance.,0-9-10-11-21-30-40-43-56-61-72-79-83-92-104-115-124,61-72-79-92-101-104-115-124-83,deficiency causes the clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123775,5/20/2015 22:37:41,1639893522,5/20/2015 22:37:19,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY clinical syndrome of hereditary fructose,61-83-92-101-104-115,11-21-30-43-104-115-124-40,phosphate aldolase (aldolase B) deficiency: HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123775,5/20/2015 22:38:25,1639893761,5/20/2015 22:38:14,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123775,5/20/2015 22:39:57,1639894332,5/20/2015 22:38:13,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,DEFICIENCY,61,104-115-124,HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123775,5/20/2015 22:46:03,1639896524,5/20/2015 22:45:09,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,61,104,,,71,135,DEFICIENCY,HEREDITARY FRUCTOSE INTOLERANCE,This DEFICIENCY causes the clinical syndrome,56-61-72-79-83-92,83-92-101-104-115-124,clinical syndrome of HEREDITARY FRUCTOSE INTOLERANCE.,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance.,61,104 115 124,61,104,1,71,135,TWrex-cause,814093,Fructose 1-phosphate aldolase (aldolase B) deficiency:  This deficiency causes the clinical syndrome of hereditary fructose intolerance,deficiency,hereditary fructose intolerance
724123776,5/20/2015 20:48:48,1639863307,5/20/2015 20:48:35,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:05:18,1639869598,5/20/2015 21:04:55,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:07:01,1639870269,5/20/2015 21:06:49,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53,BRUCELLA,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:08:28,1639870671,5/20/2015 21:08:12,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS caused by Brucella melitensis.,30-42-49-53-62,30-42-49-53-62,brucellosis caused by BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:23:02,1639876666,5/20/2015 21:22:50,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:29:38,1639878823,5/20/2015 21:28:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:34:24,1639880405,5/20/2015 21:34:10,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:36:34,1639881193,5/20/2015 21:36:14,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:37:33,1639881512,5/20/2015 21:37:17,false,prodege,1.0,19907188,USA,MI,Adrian,50.37.37.250,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,BRUCELLOSIS,30,53-62,BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:58:44,1639882200,5/20/2015 21:58:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,Brucellosis Treatment of BRUCELLOSIS caused by Brucella melitensis.,4-17-27-30-42-49-53-62,4-17-30-42-49-53-62-27,Brucellosis Treatment of brucellosis caused by BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123776,5/20/2015 21:59:06,1639882222,5/20/2015 21:58:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,30,53,,,41,61,BRUCELLOSIS,BRUCELLA,Brucellosis Treatment of BRUCELLOSIS caused by Brucella melitensis.,4-17-27-30-42-49-53-62,4-17-30-42-49-53-62-27,Brucellosis Treatment of brucellosis caused by BRUCELLA melitensis.,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis.,30,53,30,53,1,41,61,TWrex-cause,811056,26  Brucellosis  Treatment of brucellosis caused by  Brucella melitensis,brucellosis,Brucella
724123777,5/20/2015 20:39:32,1639859526,5/20/2015 20:38:53,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA pneumophila,0-35,0-24-35-53-59,LEGIONELLA LEGIONELLA PNEUMOPHILA often causes,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123777,5/20/2015 20:39:55,1639859666,5/20/2015 20:39:40,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS,0-12,24-35,LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123777,5/20/2015 20:45:00,1639861650,5/20/2015 20:43:44,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS,0-12,24-35,LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123777,5/20/2015 20:50:31,1639863999,5/20/2015 20:48:42,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS pneumophila,0-12-35,12-24-35,INFECTIONS LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123777,5/20/2015 20:53:48,1639865441,5/20/2015 20:53:05,false,clixsense,1.0,30130805,USA,MI,Wyandotte,63.141.31.35,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS Legionella pneumophila,0-12-24-35,0-12-24-35-48-53-59,LEGIONELLA INFECTIONS LEGIONELLA PNEUMOPHILA most often causes,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123777,5/20/2015 20:54:02,1639865524,5/20/2015 20:53:44,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,"LEGIONELLA INFECTIONS Legionella pneumophila causes pneumonia,",0-12-24-35-59-66,0-12-24-35-59-66,"LEGIONELLA INFECTIONS LEGIONELLA PNEUMOPHILA causes pneumonia,","LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123777,5/20/2015 20:55:18,1639865915,5/20/2015 20:54:59,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS Legionella pneumophila,0-12-24-35,0-12-24-35,LEGIONELLA INFECTIONS LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123777,5/20/2015 20:55:40,1639866092,5/20/2015 20:55:08,false,instagc,1.0,23032978,USA,PA,Philadelphia,76.98.187.59,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS Legionella pneumophila,0-12-24-35,0-12-24-35-48-53-59,LEGIONELLA INFECTIONS LEGIONELLA PNEUMOPHILA most often causes,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123777,5/20/2015 20:59:06,1639867348,5/20/2015 20:58:43,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA INFECTIONS,0-12,24-35,LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123777,5/20/2015 21:01:08,1639868096,5/20/2015 20:59:26,false,fusioncash,1.0,31248728,USA,FL,Alachua,174.131.50.169,0,24,,,10,46,LEGIONELLA,LEGIONELLA PNEUMOPHILA,LEGIONELLA Legionella pneumophila,0-24-35,24-35,LEGIONELLA PNEUMOPHILA,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features.",0,24 35,0,24,1,10,46,TWrex-cause,815078,"LEGIONELLA  INFECTIONS  Legionella pneumophila  most often causes pneumonia, with extrapulmonary features",legionella,legionella pneumophila
724123778,5/20/2015 22:20:45,1639887657,5/20/2015 22:20:16,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,112,90,,,121,99,HEPATITIS,RIBAVIRIN,HEPATITIS C,112-122,90,RIBAVIRIN,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123778,5/20/2015 22:29:03,1639890413,5/20/2015 22:28:24,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,112,90,,,121,99,HEPATITIS,RIBAVIRIN,HEPATITIS C,112-122,90,RIBAVIRIN,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123778,5/20/2015 22:34:47,1639892499,5/20/2015 22:34:02,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,112,90,,,121,99,HEPATITIS,RIBAVIRIN,chronic HEPATITIS C,104-112-122,90-100-104-112-122,RIBAVIRIN for chronic hepatitis C,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123778,5/20/2015 22:38:23,1639893754,5/20/2015 22:37:47,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,112,90,,,121,99,HEPATITIS,RIBAVIRIN,ribavirin for chronic HEPATITIS C in patients who have failed to achieve sustained response to interferon alone:,90-100-104-112-122-124-127-136-140-145-152-155-163-173-185-196-182,78-83-86-90-100-104-112,alfa 2b and RIBAVIRIN for chronic hepatitis,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123778,5/20/2015 22:39:39,1639894216,5/20/2015 22:39:27,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,112,90,,,121,99,HEPATITIS,RIBAVIRIN,ribavirin HEPATITIS,112-90,90-100-104-112,RIBAVIRIN for chronic hepatitis,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123778,5/20/2015 22:39:53,1639894285,5/20/2015 22:39:42,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,112,90,,,121,99,HEPATITIS,RIBAVIRIN,chronic HEPATITIS C,104-112-122,90,RIBAVIRIN,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123778,5/20/2015 22:49:50,1639898060,5/20/2015 22:49:29,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,112,90,,,121,99,HEPATITIS,RIBAVIRIN,ribavirin for chronic HEPATITIS C,90-100-104-112-122,78-83-86-90-100-104-112,alfa 2b and RIBAVIRIN for chronic hepatitis,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123778,5/20/2015 23:00:08,1639901687,5/20/2015 22:59:15,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,112,90,,,121,99,HEPATITIS,RIBAVIRIN,HEPATITIS C,112-122,90-112-122,RIBAVIRIN hepatitis C,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123778,5/20/2015 23:13:38,1639907344,5/20/2015 23:13:03,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,112,90,,,121,99,HEPATITIS,RIBAVIRIN,interferon alfa 2b and ribavirin for chronic HEPATITIS C,67-78-83-86-90-100-104-112-122,78-83-86-90-100-104-112-122-67,interferon alfa 2b and RIBAVIRIN for chronic hepatitis C,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123778,5/20/2015 23:18:11,1639908251,5/20/2015 23:17:20,false,prodege,1.0,2145087,USA,"","",40.143.102.85,112,90,,,121,99,HEPATITIS,RIBAVIRIN,HEPATITIS C,112-122,90,RIBAVIRIN,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.",112,90,112,90,-1,121,99,TWrex-cause,800040,"Schvarcz R, Ando Y, Sonnerborg A et al. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience",hepatitis,ribavirin
724123779,5/20/2015 22:44:35,1639896046,5/20/2015 22:44:09,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,shock Resistant VENTRICULAR FIBRILLATION.,78-84-94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123779,5/20/2015 22:45:22,1639896327,5/20/2015 22:44:33,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,shock Resistant VENTRICULAR FIBRILLATION.,78-84-94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123779,5/20/2015 22:53:50,1639899292,5/20/2015 22:53:37,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,Amiodarone compared with lidocaine for shock Resistant VENTRICULAR FIBRILLATION.,36-50-59-74-78-84-94-106-64,36-47-50-59-64-74-78-84-94-106,Amiodarone as compared with LIDOCAINE for shock Resistant ventricular fibrillation.,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123779,5/20/2015 22:59:47,1639901543,5/20/2015 22:58:36,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,for shock Resistant VENTRICULAR FIBRILLATION.,74-78-84-94-106,47-50-59-64,as compared with LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123779,5/20/2015 23:21:45,1639909320,5/20/2015 23:21:09,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,shock Resistant VENTRICULAR FIBRILLATION.,78-84-94-106,64-78-84-94-106,LIDOCAINE shock Resistant ventricular fibrillation.,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123779,5/20/2015 23:22:38,1639909600,5/20/2015 23:22:27,false,prodege,1.0,2145087,USA,"","",40.143.102.85,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,shock Resistant VENTRICULAR FIBRILLATION.,78-84-94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123779,5/21/2015 00:05:19,1639928440,5/21/2015 00:05:07,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.174,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,shock Resistant VENTRICULAR FIBRILLATION.,78-84-94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123779,5/21/2015 00:08:00,1639929640,5/21/2015 00:07:15,false,instagc,1.0,15864091,USA,OK,Oklahoma City,104.0.113.133,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,shock Resistant VENTRICULAR FIBRILLATION.,78-84-94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123779,5/21/2015 00:12:01,1639931524,5/21/2015 00:11:44,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,VENTRICULAR FIBRILLATION.,94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123779,5/21/2015 00:14:48,1639932823,5/21/2015 00:13:38,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,94,64,,,118,73,VENTRICULAR FIBRILLATION,LIDOCAINE,shock Resistant VENTRICULAR FIBRILLATION.,78-84-94-106,64,LIDOCAINE,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation.",94 106,64,94,64,-1,118,73,TWrex-cause,803985,"Dorian P, Cass D, Schwartz B et al. Amiodarone as compared with lidocaine for shock-Resistant ventricular fibrillation",ventricular fibrillation,lidocaine
724123780,5/21/2015 01:07:29,1639962563,5/21/2015 01:07:11,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123780,5/21/2015 01:12:23,1639965543,5/21/2015 01:12:05,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123780,5/21/2015 01:14:29,1639966830,5/21/2015 01:14:11,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123780,5/21/2015 01:51:53,1639987566,5/21/2015 01:51:18,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123780,5/21/2015 02:04:50,1639993837,5/21/2015 02:04:36,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59,BABESIA,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123780,5/21/2015 02:24:18,1640002764,5/21/2015 02:24:02,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,30,59,,,40,66,BABESIOSIS,BABESIA,Treatment BABESIOSIS,17-30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123780,5/21/2015 02:27:42,1640004521,5/21/2015 02:27:16,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,30,59,,,40,66,BABESIOSIS,BABESIA,Babesiosis Treatment of BABESIOSIS,5-17-27-30,48-55-59-67,caused by BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123780,5/21/2015 02:30:37,1640005926,5/21/2015 02:30:20,false,prodege,1.0,26499212,CAN,ON,Cambridge,70.27.23.230,30,59,,,40,66,BABESIOSIS,BABESIA,Babesiosis Treatment of BABESIOSIS,5-17-27-30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123780,5/21/2015 02:31:10,1640006197,5/21/2015 02:30:55,false,neodev,1.0,32087449,GBR,"","",77.245.71.12,30,59,,,40,66,BABESIOSIS,BABESIA,Babesiosis Treatment of BABESIOSIS caused by Babesia,5-17-27-30-48-55-59,5-17-43-48-55-59-67-30,Babesiosis Treatment babesiosis + caused by BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123780,5/21/2015 02:33:51,1640007376,5/21/2015 02:33:29,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,30,59,,,40,66,BABESIOSIS,BABESIA,BABESIOSIS,30,59-67,BABESIA microti.,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti.,30,59,30,59,1,40,66,TWrex-cause,812472,164  Babesiosis  Treatment of babesiosis   +    caused by  Babesia microti,babesiosis,babesia
724123781,5/20/2015 22:19:49,1639887353,5/20/2015 22:19:18,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY,83-88-90-101,83-88-90-101,HTLV I associated myelopathy,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123781,5/20/2015 22:20:08,1639887429,5/20/2015 22:18:50,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY tropical spastic paraparesis.,83-88-90-101-112-121-129,83-88-90-101,HTLV I associated myelopathy,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123781,5/20/2015 22:27:33,1639889986,5/20/2015 22:26:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY tropical spastic paraparesis.,83-88-90-101-112-121-129,83-88-90-101-112-121-129,HTLV I associated myelopathy tropical spastic paraparesis.,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123781,5/20/2015 22:33:38,1639892082,5/20/2015 22:33:04,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY,83-88-90-101,83-88-90-101,HTLV I associated myelopathy,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123781,5/20/2015 22:37:29,1639893458,5/20/2015 22:37:19,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY tropical spastic paraparesis.,83-88-90-101-112-121-129,65-69-78-83-88-90-101-112-121-129,200 patients with HTLV I associated myelopathy tropical spastic paraparesis.,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123781,5/20/2015 22:39:03,1639894052,5/20/2015 22:38:43,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,101,83,,,111,89,MYELOPATHY,HTLV-I,MYELOPATHY tropical spastic paraparesis.,101-112-121-129,83-88-101-112,HTLV I myelopathy tropical,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123781,5/20/2015 22:39:28,1639894167,5/20/2015 22:39:11,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV - I - associated MYELOPATHY tropical spastic paraparesis.,83-87-88-89-90-101-121-129-112,83-88,HTLV I,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123781,5/20/2015 22:49:05,1639897660,5/20/2015 22:48:40,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I associated MYELOPATHY tropical,83-88-90-101-112,65-69-78-83-88,200 patients with HTLV I,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123781,5/20/2015 22:54:33,1639899497,5/20/2015 22:53:40,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,101,83,,,111,89,MYELOPATHY,HTLV-I,MYELOPATHY,101,83-88,HTLV I,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123781,5/20/2015 22:58:21,1639900977,5/20/2015 22:57:19,false,points4rewards,1.0,28703583,USA,"","",97.73.90.127,101,83,,,111,89,MYELOPATHY,HTLV-I,HTLV I MYELOPATHY tropical spastic paraparesis.,83-88-101-112-121-129,83-88-101-112-121-129,HTLV I myelopathy tropical spastic paraparesis.,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.",101,83 88,101,83,1,111,89,TWrex-cause,815017,"Nakagawa M, Nakahara K, Maruyama Y, et al: Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis",myelopathy,HTLV-I
724123782,5/20/2015 20:43:35,1639861091,5/20/2015 20:43:07,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.152.57,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123782,5/20/2015 20:58:06,1639867005,5/20/2015 20:57:24,false,neodev,1.0,31670127,USA,FL,Key West,162.233.108.112,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123782,5/20/2015 20:58:54,1639867268,5/20/2015 20:58:38,false,prodege,1.0,3587109,CAN,NS,Sydney,142.166.207.11,53,319,,,62,322,HEMATURIA,RCC,"◊ HEMATURIA Symptoms suggesting possible metastatic disease,",39-53-65-74-85-94-105,50-294-306-315-319-53,of hematuria Examination Elements for RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123782,5/20/2015 21:00:17,1639867771,5/20/2015 20:59:27,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123782,5/20/2015 21:00:36,1639867869,5/20/2015 21:00:23,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123782,5/20/2015 21:02:43,1639868623,5/20/2015 21:02:28,false,instagc,1.0,30326470,USA,CA,Santee,99.44.37.73,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123782,5/20/2015 21:18:17,1639874578,5/20/2015 21:18:02,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123782,5/20/2015 21:22:58,1639876647,5/20/2015 21:22:38,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123782,5/20/2015 21:24:10,1639877163,5/20/2015 21:23:54,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,53,319,,,62,322,HEMATURIA,RCC,Episodes of HEMATURIA,41-53-50,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123782,5/20/2015 21:26:50,1639877992,5/20/2015 21:26:11,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,53,319,,,62,322,HEMATURIA,RCC,HEMATURIA,53,319,RCC.,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC.",53,319,53,319,1,62,322,TWrex-cause,812817,"• Ask about: ◊ Abdominal or flank pain ◊ Episodes of hematuria ◊ Symptoms suggesting possible metastatic disease, including: — Cough — Fever or night sweats — Weight loss — Bone pain — Fatigue ◊ A close family history of RCC may suggest a genetic predilection • See table  History and Physical Examination Elements for RCC",hematuria,RCC
724123783,5/20/2015 21:24:37,1639877327,5/20/2015 21:24:22,false,instagc,1.0,24252915,GBR,B7,Bristol,92.236.71.128,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123783,5/20/2015 21:36:57,1639881276,5/20/2015 21:36:13,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123783,5/20/2015 21:38:17,1639881775,5/20/2015 21:38:01,false,instagc,1.0,19080822,USA,MD,Reisterstown,96.26.47.22,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123783,5/20/2015 22:13:34,1639885348,5/20/2015 22:12:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"HRT is contraindicated in women who smoke or in women with a history of an estrogen dependent breast cancer, endometrial cancer, THROMBOEMBOLIC DISEASE, acute liver disease, and vaginal bleeding of unknown cause.",0-4-7-23-26-32-36-42-45-48-54-59-61-69-72-75-84-94-101-109-121-129-144-153-159-165-174-178-186-195-198-206,0-4-7-23-26-32-36-42-45-48-54-59-61-69-72-75-84-94-101-109-121-129-144-153-159-165-174-178-186-195-198-206,"HRT is contraindicated in women who smoke or in women with a history of an ESTROGEN dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123783,5/20/2015 22:13:53,1639885418,5/20/2015 22:12:42,false,clixsense,1.0,6375330,CAN,ON,Ottawa,209.195.106.138,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75,ESTROGEN,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123783,5/20/2015 22:15:44,1639885992,5/20/2015 22:14:56,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123783,5/20/2015 22:20:46,1639887666,5/20/2015 22:19:21,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123783,5/20/2015 22:29:17,1639890464,5/20/2015 22:28:45,false,elite,1.0,32173500,GBR,E4,Rayleigh,176.24.16.182,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123783,5/20/2015 22:33:02,1639891822,5/20/2015 22:32:49,false,neodev,1.0,11382239,AUS,02,Strathfield,60.241.129.81,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75-84-94-101,"ESTROGEN dependent breast cancer,","HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123783,5/20/2015 22:33:35,1639892074,5/20/2015 22:31:58,false,quickrewards,1.0,8672587,USA,TX,El Paso,209.194.208.150,129,75,,,151,83,THROMBOEMBOLIC DISEASE,ESTROGEN,"THROMBOEMBOLIC DISEASE,",129-144,75,ESTROGEN,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause.",129 144,75,129,75,-1,151,83,TWrex-cause,803197,"HRT is contraindicated in women who smoke or in women with a history of an estrogen-dependent breast cancer, endometrial cancer, thromboembolic disease, acute liver disease, and vaginal bleeding of unknown cause",thromboembolic disease,estrogen
724123784,5/21/2015 00:40:36,1639946994,5/21/2015 00:39:28,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724123784,5/21/2015 01:04:21,1639960695,5/21/2015 01:02:34,false,neodev,1.0,11001780,AUS,07,Elwood,14.201.215.31,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724123784,5/21/2015 01:09:50,1639964189,5/21/2015 01:09:35,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724123784,5/21/2015 01:11:08,1639964878,5/21/2015 01:10:46,false,clixsense,1.0,10032240,USA,FL,Naples,76.101.211.223,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724123784,5/21/2015 01:46:30,1639985025,5/21/2015 01:46:04,false,memolink,1.0,6556053,USA,IL,Zion,76.245.204.32,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724123784,5/21/2015 02:02:30,1639992655,5/21/2015 02:02:12,false,clixsense,1.0,32609988,USA,IL,Chicago,172.56.13.97,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724123784,5/21/2015 02:19:43,1640000705,5/21/2015 02:19:02,false,prodege,1.0,28592189,CAN,ON,Toronto,99.231.49.180,63,29,,,77,32,CONJUNCTIVITIS,DKC,"Ophthalmic CONJUNCTIVITIS,",63-0,27-29-0,Ophthalmic : DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724123784,5/21/2015 02:24:18,1640002765,5/21/2015 02:23:52,false,cotter,1.0,29964039,USA,NV,Reno,71.94.24.147,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724123784,5/21/2015 02:28:30,1640004982,5/21/2015 02:28:12,false,prodege,1.0,26499212,CAN,ON,Cambridge,70.27.23.230,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
724123784,5/21/2015 02:29:09,1640005280,5/21/2015 02:27:48,false,prodege,1.0,23482077,USA,TX,Garland,71.164.238.226,63,29,,,77,32,CONJUNCTIVITIS,DKC,"CONJUNCTIVITIS,",63,29,DKC,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium.",63,29,63,29,1,77,32,TWrex-cause,813390,"Ophthalmic system findings : DKC reportedly is associated with conjunctivitis, blepharitides, and pterygium",conjunctivitis,DKC
